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 ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
  
ﺎ ﺍﻟﻤﻘﺩﺭﺓ ﻤﻬﻟ ﻨﻭﻋﻴﻥ ﻤﻥ ﺍﻷﻗﺭﺍﺹ ﻟﺘﻁﻭﻴﺭ 32 ﺍﺴﺘﺨﺩﺍﻡ ﺍﻟﺘﺼﻤﻴﻡ ﺍﻷﺤﺼﺎﺌﻰ ﺘﻡ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﻓﻰ
 ﺼﻴﺎﻏﺘﻬﺎ ﺼﻤﻎ ﻓﻲ ﻴﺩﺨل  ﺍﻟﺘﻲ ﻭ ﻓﻨﺎﻙ ﺼﻭﺩﻴﻭﻡ  ﺩﻴﻜﻠﻭ ﺍﻟﺘﺴﻠﻴﻡ ﺍﻟﻘﻭﻟﻭﻨﻲ ﻟﻠﻌﻘﺎﺭ ﺍﻟﻤﺤﻤلﻋﻠﻰ
  ﺍﻟﻤﺼﻔﻭﻓﺔ ﻭ ﺍﻷﻗﺭﺍﺹ ﺍﻟﻤﻜﺴﻴﺔ ﻭﺫﻟﻙ ﻟﺩﺭﺍﺴﺔﹶ ﺘﺄﺜﻴﺭﺍﻷﻗﺭﺍﺹﺍﻟﻘﻭﺍﺭ ﻜﻤﺎﺩﺓ ﺃﺴﺎﺴﻴﺔ ﻫﻤﺎ 
 ﺍﻟﺘﺼﻨﻴﻌﻴﺔ ﻋﻠﻰ ﻜﻔﺎﺀﺓ ﺘﻭﺯﻴِﻊ ﺍﻟﻌﻘﺎﺭ ﺍﻟﻘﻭﻟﻭﻨِﻲ ﻟﻬﺫﻩ ﻭﺍﻟﻤﻌﺎﻟﺠﺔﺍﻟﻤﺘﻐﻴﺭﺍِﺕ ﺍﻟﻤﺭﺘﺒﻁﺔ ﺒﺎﻟﺼﻴﺎﻏِﺔ 
 ﺍﻥ ﺍﻟﺯﻴﺎﺩﺓ ﻓﻰ ﻤﺤﺘﻭﻯ ﺼﻤﻎ ﺍﻟﻘﻭﺍﺭ ﻓﻰ ﺍﻟﻨﻭﻋﻴﻥ ﻤﻥ ﺍﻷﻗﺭﺍﺹ ﺍﻟﺩﺭﺍﺴﺔﺍﻭﻀﺤﺕ . ﺍﻷﻗﺭﺍﺹ
 ﺍﻟﻬﻼﻡ ﺍﻟﻤﺘﻜﻭﻥ ﺤﻭل ﺍﻷﻗﺭﺍﺹ ﻭﺒﺎﻟﺘﺎﻟﻰ ﻟﻬﺎ ﺘﺄﺜﻴﺭ ﺴﺎﻟﺏ ﻋﻠﻰ ﻤﻌﺩل ﺘﻤﺎﺴﻙﺘﺅﺩﻯ ﺍﻟﻰ ﺯﻴﺎﺩﺓ ﻗﻭﺓ 
 ﻜﻤﺎ ﻭﺠﺩ ﺍﻴﻀﺎ ﺍﻥ ﻤﺴﺘﻭﻯ ﺘﺤﻤﻴل ﺼﻤﻎ ﺍﻟﻐﻭﺍﺭ ﻴﺅﺜﺭ ﻋﻠﻰ ﻫﺸﺎﺸِﺔ ﺍﻷﻗﺭﺍﺹﻔﺎﺥ ﻭ ﺘﺂﻜِل ﺍﻨﺘ
ﻜﺫﻟﻙ ﻋﻜﺴﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺍﻷﺜﺭ ﺍﻟﻤﺒﺎﺸﺭ .  ﻓﻰ ﺤﺎﻟﺔ ﺍﻷﻗﺭﺍﺹ ﺍﻟﻤﻜﺴﻴﺔﺨﺎﺼﺔﺍﻷﻗﺭﺍِﺹ ﺍﻟﻤﺼﻨﻌﺔ 
  .  ﺍﻟﻨﻭﻋﻴﻥ ﻤﻥ ﺍﻷﻗﺭﺍﺹﻓﻲ ﺨﺎﺼﻴﺔ ﺇﻁﻼِﻕ ﺍﻟﻌﻘﺎﺭ ﺍﻟﻤﺤﻤل ﻋﻠﻰﻟﻤﺤﺘﻭﻯ ﺼﻤﻎ ﺍﻟﻘﻭﺍﺭ 
 ﻭﺴِﻁ ﺍﻟﺤل ﻟﺘﹶﻘﻠﻴﺩ ﺇﻟﻰ     ﻤﺤﺘﻭﻴﺎﺕ ﻗﻭﻟﻭﻥ ﺍﻟﻔﺎﺭﻤﻥ v/w %4  ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﺇﻀﺎﻓﺔ ﺃﺸﺎﺭﺕﹾ 
 ﺍﻟﻌﻘﺎﺭ ﺍﻟﻤﺤﻤل ﻤﻥ ﺍﻷﻗﺭﺍﺹ ﺇﻁﻼِﻕ ﻤﻌﺩل ﻓﻲﻪ ﺯﻴﺎﺩﺓ ﻤﻠﺤﻭﻅﺔ ﻨ ﻋﻨﺘﺞ  ﺍﻟﻘﻭﻟﻭﻨِﻲ ﻗﺩﺍﻟﺴﺎﺌِل
 ﻋﻠﻰ ﺍﻟﺘﺴﻠﻴﻡ ﺍﻟﻘﻭﻟﻭﻨﻲ ﻟﻠﻌﻘﺎﺭ ﺍﻟﻤﺤﻤل ﺍﻷﻗﺭﺍﺹ ﻤﻘﺩﺭﺓ ﻫﺫﻩ ﺃﻥﺨﺎﺼﺔ ﺍﻟﻤﻜﺴﻴﺔ ﻤﻨﻬﺎ ﻤﻤﺎ ﻴﺅﻜﺩ 
  .ﺍﻟﻘﻭﺍﺭ ﺍﻟﻘﻭﻟﻭﻥ ﻋﻠﻰ ﺼﻤﻎ ﻓﻲ ﺍﻟﻤﺘﻭﺍﺠﺩﺓ  ﺍﻟﻼﻫﻭﺍﺌﻴﻪﺒﻜﺘﺭﻴﺎ ﺍﻟﺇﻨﺯﻴﻤﺎﺕ ﻋﻤل ﺇﻟﻰ  ﻴﻌﺯﻯﺃﻥﻴﻤﻜﻥ 
 ﻜﻔﺎﺀﺓ ﺃﻜﺜﺭ ﺍﻟﻤﻜﺴﻴﺔ ﺒﺼﻤﻎ ﺍﻟﻘﻭﺍﺭ  ﺍﻷﻗﺭﺍﺹ ﻋﻠﻰ ﺍﻟﻨﺘﺎﺌﺞ ﺍﻟﻤﺘﺤﺼل ﻋﻠﻴﻬﺎ ﻓﻘﺩ ﻭﺠﺩ ﺍﻥ ﺍﺴﺘﻨﺎﺩﺍ 
 ﺍﻟﺩﻴﻜﻠﻭﻓﻨﺎﻙ ﺼﻭﺩﻴﻭﻡ  ﺍﻷﻗﺭﺍﺹ ﺍﻟﻤﺼﻔﻭﻓﺔ ﺒﺼﻤﻎ ﺍﻟﻘﻭﺍﺭ ﻓﻴﻤﺎ ﻴﺨﺘﺹ ﺒﺎﻟﺘﺴﻠﻴﻡ ﺍﻟﻘﻭﻟﻭﻨﻲ ﻟﻌﻘﺎﺭﻤﻥ
  . 
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Abstract  
 
In order to examine the impact of formulation and processing variables 
on colonic drug delivery, 23 factorial design was applied in this study to 
develop guar gum-based matrix and compression coated colon-specific 
tablets. 
The influence of guar gum loading level on tablet friability was found to 
be more profound with compression coated tablets whereas best matrix 
friability was associated with low loading level of MCC regardless of the 
drug: guar gum ratio. In both cases, increasing the content of guar gum in 
the formulations has resulted in formation of high strength gel. With 
matrix formulations, the desired maximum swelling and minimum 
erosion tendencies among different formulations tested were shown to be 
associated with high loading level of guar gum. However, with 
compression coated formulations, the retarding influence (enhancing 
erosion effect) of MCC on swelling and erosion in these tablet 
formulation is somewhat noticeable. Although it has been found that the 
maximum % erosion among these formulations was more sensitive to pH 
variation, statistical analysis revealed no significant effect of pH variation 
on swelling and/or erosion behaviors of the tested formulations (p≥0.05).  
When present as matrixing and/or coating material, content of guar gum 
was found to be a determining factor for the in vitro drug delivery 
control. Addition of 4% w/v of rat caecal content to dissolution medium 
to mimic colonic fluid was found to enhance the drug release from matrix 
and/or compression coated guar gum based tablets. The result has 
indicated that the enhanced release of the drug in presence of rat caecal 
content is due to anaerobic microbial enzymatic action on the swollen 
guar gum. Moreover, it has been shown that the enhanced effect of rat 
caecal content on drug release from guar gum based compression coated 
formulations is more prominent than with matrix formulations. 
In vitro drug release studies showed that guar gum matrix and 
compression coated formulations were able to deliver 78% and 89% of 
the loaded drug, respectively, in environment similar to colonic 
conditions by the end of 24hrs with a chance for 22% and 11% of the 
loaded dose to be released before reaching the colon from the two types 
of formulations, respectively. Consequently, guar gum in form of coating 
material is confirmed to be more effective than when present as matrixing 
agent for colonic diclofenac sodium delivery, at least under the conditions 
of this study. 
 3
1. Literature Review 
 
1.1.Tablet Dosage Forms:  
During the past three and a half decades, the pharmaceutical industry has 
invested vast amounts of time and money in the study of tablet 
compaction. This expenditure is quite reasonable when one considers 
how valuable tablets, as a dosage form, are to the industry. As oral dosage 
forms they can be self administered by the patient, are obviously more 
profitable to manufacture than parenteral dosage forms, which usually 
must administered by trained personal (Rudnic and Schwartz, 2000). 
Tablets are solid preparations each containing a single dose of one or 
more active substances and usually obtained by compressing uniform 
volumes of particles. Tablets are intended for oral administration. Some 
are swallowed whole, some after being chewed, some are dissolved or 
dispersed in water before being administered and some are retained in the 
mouth where active substance is liberated.  
Tablets’ formulations consist of one or more active substances with or 
without excipients such as diluents, binders, disintegrating agents, 
glidants, lubricants, substances capable of modifying the behavior of 
preparation in the digestive tract, coloring matter authorized by the 
component authority and flavoring substances.  
Tablets are usually right, circular solid cylinders, the surfaces of which 
are flat or convex and the edges of which may be beveled. They may 
have lines or break-marks and may bear a symbol or other markings. 
Tablets may be coated. 
Several categories of tablets for oral use may be distinguished. Broadly, 
tablets could be classified into two main categories. These are 
conventional and non-conventional tablets (BP, 2003). 
 
1.1.1. Conventional Tablets:   
The most common solid dosage form in contemporary practice is tablets, 
which may be defined as unit forms of solid medicaments prepared by 
compaction. Most consist of a mixture of powders that are compacted in a 
die to produce a single and rigid body.  
Among the different types of conventional tablets are (a) swallowed 
tablets which are the most common type of tablets and intended to be 
swallowed as whole and then disintegrated and release their medicaments 
in the gastrointestinal tract (GIT); (b) dissolution or dispersion tablets 
which are formulated to allow dissolution or dispersion in water before 
administration; (c) chewable tablets that are designed to be masticated 
(chewed) and are often used when absorption from buccal cavity is 
desired; (d) lozenges that are characterized by high hardness level and are 
intended to dissolve slowly in the mouth to provide local activity of the 
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drug; and (e) sublingual and buccal tablets which are designed to be 
placed under the tongue (sublingual) or between the teeth and gum 
(buccal) and rapidly release their medicament into the blood stream 
(Rudnic and Schwartz, 2000).  
 
1.1.2. Non-conventional Tablets: 
These are tablets in which either the release of the drug or the drug 
delivery location is being controlled by applying different pharmaceutical 
techniques. Some non-conventional tablets apply both mechanisms to 
achieve the therapeutic aim behind their formulation (Singh and Kim, 
2002). There is now much type of tablet formulations that provide for the 
release of medicament to be delayed or to control the rate of the drug 
availability. Some of these preparations are highly sophisticated and are 
rightly referred to as “complete drug delivery systems” (Rudnic and 
Schwartz, 2000). Among different types of non-conventional tablets are 
controlled release, gastroretentive, enteric coated, bioadhesive, osmotic 
and targeted tablets. Some will be detailed later.  
 
1.1.3.   Tablet Coating: 
Coated tablets are tablets covered with one or more layers of mixture of 
various substances such as natural or synthetic resins, gums, gelatin, 
inactive and insoluble fillers, sugars, plasticizers, polios, waxes, coloring 
matter authorized by the competent authority and sometimes flavoring 
substances and active substances. The substances used as coatings are 
usually applied as a solution or suspension in condition in which 
evaporation of the vehicle occurs. When the coating is a very thin 
polymeric coating, the tablets are termed as film –coated tablets (Eur.P, 
2002). 
 
1.1.3.1. Reasons for Coating Tablets: 
The reasons why tablets are coated are numerous. The major ones can be 
summarized as follows: (a) ingredients may need protection from the 
environment, particularly light and moisture; (b) many drugs have a bitter 
or otherwise unpleasant taste and coat mask such taste; (c) ease of 
swallow of coated tablets; (d) colored coatings also masks any batch 
differences in the appearance of raw materials and hence allay patient 
concern over tablets of differing appearance; (e) colored coatings aid in 
the rapid identification of product by the manufacturer, the dispensing 
pharmacist and the patient; and (f) functional film coatings are used to 
impart enteric or controlled release properties to the coated tablet or, 
more usually, to coated multiparticulates (Rwalins, 2002).  
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1.1.3.2. Types of Tablet Coating: 
Classification concerning types of different tablet coatings differs widely 
from one literature source to another. However, four major types of tablet 
coatings have been mentioned generally in the relevant citations  
 
1.1.3.2.1. Sugar Coatings:  
This is a traditional coating. It imparts a smooth, rounded, elegant 
appearance to tablet. Now it is considered as history of the art and no 
longer being applied for coating tablets since it is time and material 
consuming, moreover, the process needs high skilled person to run. The 
process comprises three main steps, namely sealing, subcoating and 
smoothing steps (Rwalins, 2002). 
 
1.1.3.2.2. Film Coating: 
Sugar coating doubles the weight and increases the size of a tablet and 
this is obviously undesirable if the tablet, in the uncoated state, is already 
large. Film coating provides an alternative means of masking the taste of 
the medicament and providing protection against adverse climatic 
conditions without significantly altering the tablet weight or size.  
Film coating technique might be classified into aqueous and non-aqueous 
film coating based on the nature of the solvent in the film formulation. 
The film formulation contains the film forming agent, plasticizer, 
colorant, opaquing material, wetting agent and solvent. 
The obvious advantages of excluding water from the coating process in 
the nonaqueous film may be secured with film forming polymers, such as 
ethyl cellulose, polyvinyl pyrrolidone or hydroxyl methyl propyl 
cellulose, that are soluble in both water and anhydrous organic solvents. 
Some 3 to 10 per cent of the foregoing materials can be dissolved in an 
acetone/alcohol mixture together with 5 to 10 per cent of diethyl 
phthalate or other plasticizer to produce a film coating solution which 
may be applied by the pan technique (Rwalins, 2002).  
 
1.1.3.2.3. Enteric Coating: 
Tablets are enteric coated if the medicament is decomposed in the acid 
secretions of the stomach, if it causes gastric irritation, or if it is intended 
to exert its main effect only on the intestine. Some official tablets coated 
in this way include those containing biscodyl, bismuth and emetine iodide 
and erythromycin. Enteric coatings resist the acid conditions of the 
stomach but readily dissolve in the more nearly neutral fluids of the small 
intestine.  
Formalized gelatin, keratin, salol, shellac, sandarac, stearic acid and cetyl 
alcohol have all been used to produce enteric coatings but are either 
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difficult to apply or erratic in their action. The compositions of the fluids 
in the gastrointestinal tract are not constant but vary with time and from 
person to person. It is clearly important that the enteric action shall 
largely be independent of such variations in compositions (Rwalins, 
2002). 
 
1.1.3.2.4. Compression Coating: 
As noted earlier it is desirable on occasion to separate tablet ingredients 
to avoid incompatibilities, to facilitate manufacture or to produce a 
sustained action product. Layer tablets provide an acceptable means for 
ingredient separation but the protective effect of the coat enveloping the 
tablet is lacking. It is not an easy matter to ensure a sugar coat of the 
same thickness for all tablets in a batch by pan coating and although 
reasonable variation in coat thickness and weight is not significant in 
plain sugar coating such variation can not be tolerated if the coat contains 
a potent medicament (Rwalins, 2002).  
The idea of applying granular coating materials to a preformed core was 
conceived earlier but could not be commercially exploited until the 
problem of core penetration and the automatic rejection of coreless tablets 
has been solved. The expected advantages of a compression coating 
process are: 
Core tablets are not subjected to a abrasive action and need be especially 
hard, the process is “anhydrous” and sealing coats are not required, the 
disintegration time of coated can be compared with that of the uncoated 
variety, good control of coating weight can be obtained, chemically 
incompatible ingredients may be separated, the core and coat may be 
formulated for different properties e.g., for a sustained action tablet the 
coating would provide the prompt dose and the core the sustaining dose, 
the process is continuous, completely mechanized and removes much of 
the element of skill from tablet coating (Rwalins, 2002).  
 
1.1.3.2.4.1. Compression Coating Machines: 
The essential stages of coating by compression are , deposition of the 
bottom fill of coating granules, transfer and centration of the core tablet, 
deposition of the side and top fill and finally compression to bond the 
coat to the core. The machine described by White House (1954), the 
Kalian Prescoter, used preformed cores which were fed in to holes on the 
periphery of transfer disc and deposited on the lower fill of coating 
granules at the lower punch dropped in readiness for the top fill.  
The core was centered by a light tap of the top punch, the top fill 
deposited and the coated bonded to the core by compression. The force 
developed during compaction in the presence of a core was sufficient to 
cause slight deflection of the over load release but failed to do so in the 
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absence of a core. A switch connected to the over load release provided 
an electrical signal which, when fed to a memory unit actuated agate on 
the collection chute such that coreless tablets were rejected. 
The Manestey Drycota comprises tow rotary presses coupled by a transfer 
unit. The spring –loaded arms of the transfer unit engage with small 
collars on the upper turret to ensure accurate ejection of the core tablet in- 
to a cup fitted with a free sliding weighed plunger. Next, the cup passes 
over “bridge” where dust is removed to avoid contamination of the 
coating granules and then engages with the collar the upper turret of the 
coating press. As the bottom punch drops, the tablet is pushed out of the 
cup on  the center of the bottom fill of coating granules by the action of 
the weighed plunger. The cavity is then filled with granules for the sides 
and top of the coating, which are bonded to the core by compression. As 
the cup passes round the transfer unit the plungers are examined by 
feelers which operate micro switches. If the cup fails to pick up or to 
deposit a core at the appropriate stage in the cycle the signal from the 
micro switches initiates action for the rejection of core less tablets 
(Rwalins, 2002).  
 
1.2. Problems and Barriers to Oral Drug Delivery: 
The biggest problem in oral drug delivery is low and erratic 
bioavailability, which mainly results from one or more factors such as 
poor aqueous solubility, slow dissolution rate, low intestinal permeability, 
instability in GI milieu, high first-pass metabolism through liver and/or 
intestine variable GI transit, and P-gp mediated efflux. This, in turn, may 
lead to irreproducible clinical response or a therapeutic failure in some 
cases due to sub therapeutic plasma drug levels. Indeed, the incomplete 
and variable oral bioavailability will have its most serious impact for 
drugs with a narrow “therapeutic window” (Thummel, 1997).  
From an economic point of view, low oral bioavailability results in the 
wasting of a large portion of an oral dose, and adds to the cost of drug 
therapy, especially when the drug is an expensive one (Singh and Kim, 
2000; Aungst, 2000). It is, therefore, extremely important that these 
issues be considered and a suitable technique (or an animal model) be 
used while estimating the contributions from each factor responsible for 
low and/or variable bioavailability. 
 
1.2.1. Physicochemical Barriers to Oral Drug Delivery:  
It has long been recognized that before an orally administered drug 
becomes available for absorption at specific sites within the GIT, it must 
be dissolved in the GI fluid. Since both the dissolution rate and the 
maximum amount of a drug that can be dissolved are dictated by the 
solubility of the drug in the medium (Yalkowski and Valvani, 1980), 
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aqueous solubility of a drug could be regarded as a key factor responsible 
for low oral bioavailability of poorly water-soluble drugs, thereby 
limiting their therapeutic potential. This problem is further exacerbated 
when attempts are made to develop controlled release dosage forms 
(Hirayama and Uekama, 1999) and consequently, various approaches 
are utilized to improve aqueous solubility, which mainly include chemical 
modification (Fleisher, et al., 1996), complexation (Loftsson, 1999), 
micronization (Chaumeil, 1998), solubilization using surfactants, solid 
dispersion (Serajuddin, 1999), and design of drug delivery systems.  
The lipophilicity of drugs is another physicochemical character that 
contributes to the drug absorption and has long been recognized as a 
prerequisite for transcellular diffusion across the intestinal membrane. In 
general, compounds with low partition coefficients are poorly absorbed, 
whereas those with large partition coefficients offer satisfactory 
absorption (Krämer, 1999). It is important, however, that the drug 
possess an optimum lipophilicity, as too low or too high lipophilicity may 
result in less than optimum oral bioavailability. Some studies have shown 
that increase the partition coefficient of the drug might not guarantee the 
improvement of oral drug absorption (Mori, et al., 1988; Wils, et al., 
1994).  
The aqueous boundary layer or the unstirred water layer (UWL) is a more 
or less stagnant layer, about 30–100 µm in thickness, composed of water, 
mucus, and glycocalyx adjacent to the intestinal wall that is created by 
incomplete mixing of the luminal contents near the intestinal mucosal 
surface (Lennernäs, 1998). Until recently, the resistance of the UWL to 
intestinal absorption was believed to be correlated to the effective 
intestinal permeability values of the solutes; however, considerable 
evidence suggests instead that the available surface of the apical 
membrane of the intestinal mucosa is the main barrier for both actively 
and passively absorbed solutes (Lennernäs, 1998).  
Some viscous soluble dietary fibers, such as pectin, guar gum and sodium 
carboxymethylcellulose may increase the thickness of UWL by reducing 
intraluminal mixing (Fuse, et al., 1989) and could possibly decrease the 
intestinal exsorption of lipophilic drugs like quinidine and thiopental 
(Huang, 1990). 
 
1.2.2. Biological Barriers to Oral Drug Delivery:  
The intestinal epithelial layer that lines the GIT represents the major 
physical barrier to oral drug absorption. Structurally, it is made up of a 
single layer of columnar epithelial cells, primarily enterocytes and 
intercalated goblet cells (mucus secreting cells) joined at their apical 
surfaces by tight junctions or zonula occludens. In fact, 
electrophysiological studies have suggested that epithelium gets tighter as 
 9
it progresses distally, which has been implicated in a reduced paracellular 
absorption in the colon (Davis, et al., 1982). 
The extent of drug absorption from different regions of the GI tract is 
different, which in fact partly constitutes a basis for the biopharmaceutic 
classification scheme for drugs administered as extended-release (ER) 
products (Corrigan, 1997). Thus, indirectly the extent of absorption is 
determined by the GI transit time (GITT) of the dosage form rather than 
its control release properties or delivery program (Sakr, 1999). In 
general, the GITT of most drug products is relatively short (8–12 h), 
which in turn impedes the formulation of a once daily dosage form. 
From the oral delivery standpoint, both gastric emptying time (GET) and 
small intestinal transit time (SITT) are considered important since the 
majority of drugs are preferentially absorbed in the upper parts of the GIT 
(stomach, duodenum, and jejunum).  
Moreover, the stomach and intestines have a limited site for drug 
absorption. This is known as an “absorption window.” The relatively 
short GET (1–3 h) and SITT (3–5 h) thus provide limited time for drug 
absorption through the major absorption zone. These problems are further 
aggravated by the highly variable nature of the gastric emptying process, 
which can vary depending on several physiological factors, such as food, 
age, posture, exercise, body mass index, circadian rhythm, etc.; 
pathological factors, such as stress, diabetes, Crohn's disease, and motility 
disorders; and pharmaceutical factors, such as size and density of 
formulation and coadministration of drugs like anticholinergic and 
prokinetic agents (Singh and Kim, 2000).  
The co-administration of drugs with food is known to result in decreased, 
delayed, increased, or accelerated drug absorption, which may have 
pharmacokinetic and pharmacodynamic implications (Singh, 1999). Most 
often, the food effect is nonspecific and manifested as an interplay 
between physiological effects of food, physicochemical characteristics of 
the drug, or its formulation. In general, drugs that are most influenced are 
those that are primarily absorbed from the upper regions of the GIT 
and/or are poorly water-soluble.  
Apparently, food does not have a clinically significant effect on the 
absorption of moderately soluble drugs having a pH-independent 
solubility, and those that are completely absorbed from the GIT. 
Furthermore, food may indirectly influence the drug absorption by 
affecting drug release from both hydrophilic matrix as well as lipid 
matrix formulations. In the former case, the effect has been attributed to 
increased hydrodynamic mechanical stress, which is caused by increased 
gastric motility (Abrahamsson, et al., 1999). In the latter, the effect is 
due to increased pancreatic and biliary secretions, which in turn affect the 
integrity of matrix (Gai, et al., 1999). 
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1.2.3. Metabolic and Biochemical Barriers to Oral Drug Delivery:  
Orally administered drugs are subject to presystemic metabolism, which 
is comprised of three subtypes of mechanisms:  
(a) First-pass intestinal metabolism which includes brush border 
metabolism and intracellular metabolism. The former occurs at the 
surface of the enterocytes by the enzymes present within the brush border 
membrane. Furthermore, the brush border activity is generally greater in 
the proximal small intestine (duodenum ≈ jejunum > ileum >> colon) and 
involves enzymes such as alkaline phosphatase, sucrase, isomaltase, and a 
considerable number of peptidases (Barthe, et al., 1999). 
It is obvious that intestinal epithelium as a site of preabsorptive 
metabolism may significantly contribute to the low bioavailability of 
therapeutic peptides and ester type drugs like aspirin, although it could 
serve as a key site for targeted delivery of ester or amide prodrugs 
(Thummel, et al., 1997). 
(b) First-pass hepatic metabolism in which fraction of the administered 
dose is biotransformed before it reaches the systemic circulation as an 
absorbed drug reaches the liver through the portal circulation. In 
comparison with intestine, the liver dominates the process of first-pass 
metabolism for most drugs by virtue of its large mass, multiplicity of 
enzyme families present, and its unique anatomical position (Thummel, 
et al., 1997). It is important to emphasize here that efficiency of first-pass 
metabolism (both hepatic and intestinal) varies considerably among 
different animal species and human subjects, which should be taken into 
account when deriving the estimates of oral bioavailability, particularly in 
the case of poorly soluble drugs. 
(c) P-Glycoprotein and other efflux systems where in this case P-Gp can 
significantly contribute to the barrier function of the intestinal mucosa. In 
the small intestine and colon, P-Gp is expressed almost exclusively 
within the brush border membrane of mature enterocytes, where it acts as 
an energy-dependent drug efflux pump. Although P-gp appears to be 
distributed throughout the GI tract, its levels are higher in more distal 
regions (stomach<jejunum < colon) (Fricker, et al., 1996). Moreover, 
several studies have shown that P-Gp and CYP3A4 have similar substrate 
specificity as reviewed by Benet, et al. (1999).  
The co-localization of P-Gp and CYP3A4 in the mature enterocytes and 
their overlapping substrate specificity reasonably suggest that the 
function of these two proteins may be synergistic and appear to be 
coordinately regulated (Watkins, 1997). This mechanism not only limits 
the absorption of a wide variety of drugs, including peptides, but also 
poses a threat for potential drug interactions when attempts are made to 
inhibit CYP3A4 or P-Gp (Dresser, et al., 2000). Other mechanisms of 
 11
drug efflux process may involve organic cation and anion transporters, 
which have been fully described earlier (Arimori and Nakano, 1998). 
 
1.3. Technologies in Oral Drug Delivery: 
Over the last 3 decades, many novel oral drug therapeutic systems have 
been invented along with the appreciable development of drug delivery 
technology. Although these advanced delivery systems are manufactured 
or fabricated in traditional pharmaceutical formulations, such as tablets, 
capsules, sachets, suspensions, emulsions, and solutions, they are superior 
to the conventional oral dosage forms in terms of their therapeutic 
efficacies, toxicities, and stabilities (Takada and Yoshikawa, 1999). 
Based on the desired therapeutic objectives, oral DDS may be assorted 
into three categories: immediate release preparations, controlled release 
preparations, and targeted release preparations. 
 
1.3.1. Immediate Release Preparations: 
These preparations are primarily intended to achieve faster onset of action 
for drugs such as analgesics, antipyretics, and coronary vasodilators 
(Hirayama and Uekama, 1999). Other advantages include enhanced oral 
bioavailability through transmucosal delivery and pregastric absorption, 
convenience in drug administration to dysphagic patients, especially the 
elderly and bed ridden, and new business opportunities (Sastry, et al., 
2000).  
Conventional immediate release formulations include fast disintegrating 
tablets and granules that use effervescent mixtures, such as sodium 
carbonate (or sodium bicarbonate) and citric acid (or tartaric acid), and 
super disintegrants, such as sodium starch glycolate, croscarmellose 
sodium, and crospovidone.  
Current technologies in fast-dispersing dosage forms include modified 
tableting systems, floss or Shear form technology, which employs 
application of centrifugal force and controlled temperature, and freeze 
drying (Sastry, et al., 2000).  
 
1.3.2. Controlled Release Preparations:  
The currently employed controlled release technologies for oral drug 
delivery are diffusion controlled systems, solvent activated systems, and 
chemically controlled systems (Singh and Kim, 2000; Bruna, et al., 
1998). Diffusion controlled systems include monolithic and reservoir 
devices in which diffusion of the drug is the rate limiting step, 
respectively, through a polymer matrix or a polymeric membrane.  
Solvent activated systems may be either osmotically controlled or 
controlled by polymer swelling. Chemically controlled systems release 
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drugs via polymeric degradation (surface or bulk matrix erosion) or 
cleavage of drug from a polymer chain (Bruna, et al., 1998).  
It is worth mentioning here that the so-called programmed-release 
(“tailored-release”) profile of a final controlled release product is rarely 
the outcome of a single pharmaceutical principle. Depending on the 
specific physicochemical properties of the drug in question and desired 
therapeutic objectives, different formulation and controlled release 
principles may be proportionally combined within the same dosage form. 
This task appears to be simpler when realized in terms of appropriate 
selection of polymers and excipients that incorporate desired principles. 
 
1.3.3. Targeted Release Preparations:  
Site-specific oral drug delivery requires spatial placement of a drug 
delivery device at a desired site within the gastrointestinal tract (GIT). 
Although it is virtually possible to localize a device within each part of 
GIT, the attainment of site-specific delivery in the oral cavity and the 
rectum is relatively easier than in the stomach and the small and large 
intestines. The latter requires consideration of both longitudinal and 
transverse aspects of GI constraints (Rubinstein and Friend, 1994). 
Some of the potential controlled release and site-specific drug delivery 
systems will be described under herewith. 
 
1.3.3.1. Gastroretentive Systems:  
Gastroretentive systems (GRDDS) are designed on the basis of delayed 
gastric emptying and controlled release principles, and are intended to 
restrain and localize the drug delivery device in the stomach or within the 
upper parts of the small intestine until all the drug is released.  
Various mechanisms (approaches) of achieving gastric retention include 
floatation or buoyancy (floating systems) (Nur and Zhang, 2000), 
mucoadhesion (bioadhesive systems) (Nur, et al., 2004), sedimentation 
(high-density systems), expansion (swelling and expanding systems), and 
geometry (modified-shaped systems). Other approaches include 
coadministration of drugs or fatty acid salts, or sham feeding of 
indigestible (e.g., polycarbophil) or enzyme-digestible hydrogels 
(Hwang, et al., 1998) that convert the motility pattern of the stomach to a 
fed state. 
Based on the previously published literature, applications of GRDDS may 
be summarized for several different drugs with various physicochemical 
and biopharmaceutical properties such as drugs required to exert local 
therapeutic action in the stomach, drugs exhibiting site-specific 
absorption in the stomach or upper parts of the small intestine, drugs 
unstable in lower part of GIT, drugs insoluble in intestinal fluids and 
drugs with variable bioavailability.  
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It is obvious that drugs which have nonspecific, wide absorption sites and 
so are well absorbed along the entire GIT, may not be suitable candidates 
for GRDDS. Also, drugs that are irritant to the gastric mucosa (Singh 
and Kim, 2000) and those undergoing significant first-pass metabolism 
may have some limitations (Rouge, et al., 1996).  
 
1.3.3.2. Mucoadhesive Systems:  
The term mucoadhesion is commonly used to describe an interaction 
between the mucin layer, which lines the entire GIT, and a bioadhesive 
polymer, which could be natural or synthetic in origin (Gupta, et al., 
1990). 
From the oral delivery standpoint, these systems are used to immobilize 
and localize a drug delivery device in the selected regions of the GI tract, 
which could be an oral cavity (buccal and sublingual routes), the 
esophagus, stomach, small intestine, or colon (oral route). For the most 
part, research in this area has focused on the design of polymeric micro- 
and nanoparticulate systems that use hydrophilic polymers, primarily due 
to their propensity to interact with the mucosal surface (Ponchel and 
Irache, 1998). 
The various proposed mechanisms of mucoadhesion include lowering of 
interfacial tension, interpenetration of the mucoadhesive polymer and 
mucin, formation of an electrical double layer at the adhesive/mucin 
interface, and formation of a hydrogen bond and/or van der Waals' forces 
of attraction (Gupta, et al., 1990). 
 
1.3.3.3. Enteric Coated Systems:  
Enteric coated systems (ECS) utilize polymeric coatings that are 
insoluble in the gastric media and therefore, prevent or retard drug release 
in the stomach. Various types of ionizable polymers are commercially 
available. They dissolve at various pH ranging between 4.8 and 7.2 
(Healey, 1989).  
ECS are generally applicable to four major types of drugs (Chambliss, 
1992): drugs that are unstable in the gastric milieu, drugs that are an 
irritant to the gastric mucosa and cause unpleasant side effects such as 
nausea and vomiting, drugs which are suitable candidates for delayed-
release (“time-controlled release”) dosage forms, which provide a lag 
time between 3 and 4 h, and drugs with site-specific absorption in the 
intestines. 
 
1.3.3.4. Colon-Specific Drug Delivery Systems:  
The challenge of targeting drugs specifically to the colonic region of GIT 
is one that has been emarced by scientists over the past two decades. 
Previously thought of as a relatively innocuous, concerned solely with 
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absorption of water and electrolytes, and formation and temporary storage 
of stool, the colon has recently become accepted as an increasingly 
important site for drug delivery (Cheng, et al;  2004). 
Colonic drug delivery via the oral route is not without its challenges. The 
colon constitutes the most distal segment of the GIT and so an orally 
administer formulation must retard drug release in the upper 
gastrointestinal regions but release the drug promptly on entry into the 
colon. Retardation of drug release in the diverse and hostile conditions of 
the stomach and small intestine is not easily achieved, since the dosage 
form will be subjected to a physical and chemical assault that is designed 
to break down ingested materials (Wilson, 1997; Chourasia and Jain, 
2003) 
While in the colon, the low fluid environment and viscous nature of 
luminal contents may hinder the dissolution and release of the drug from 
the formulation. Moreover, the resident colonic micro flora may impact 
on the stability of the released drug via metabolic degradation 
(Chourasia and Jain, 2003). In spite of these potential difficulties, a 
variety of approaches have been used and systems have been developed 
for the purpose of achieving colonic targeting. Targeted drug delivery is 
reliant on the identification and exploitation of a characteristic that is 
specific to the target organ. In context of colonic targeting, the 
exploitable gastrointestinal features include pH, transit time, pressure and 
bacteria (Ibekwe, et al., 2004). 
Currently, a novel oral colon specific -drug delivery system (CDDS) has 
been one of the site-specific drug delivery systems. This delivery system, 
by means of combination of one or more controlled release mechanisms, 
hardly release drug in the upper part of the gastrointestinal (GI) tract, but 
rapidly releases drug in the colon following administration (Cheng, et al;  
2004). 
During the last decades there has been interest in developing site-specific 
formulations for targeting drug delivery to the colon. The colon is a site 
where both local and systemic drug delivery can take place. A local 
means of drug delivery could allow topical treatment of inflammatory 
bowel disease, e.g. ulcerative colitis or Crohn's disease. Such 
inflammatory conditions are usually treated with glucocorticoids and 
sulphasalazine (Watts and Illum, 1997; Yang, et al., 2002). Treatment 
might be more effective if the drug substances were targeted directly on 
the site of action in the colon. Lower doses might be adequate and, if so, 
systemic side effect might be reduced.  
A number of other serious diseases of the colon, e.g. colorectal cancer, 
might also be capable of being treated more effectively if drugs were 
targeted on colon. In fact, site-specific means of drug delivery could also 
allow oral administration of peptide and protein drugs, which normally 
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become inactivated in the upper parts of the gastrointestinal tract (Watts 
and Illum, 1997; Yang, et al., 2002). Moreover, these systems could 
also be used in conditions in which diurnal rhythm is evident, e.g. asthma, 
rheumatic disease, ulcer disease and ischemic heart disease (Yang, et al., 
2002).  
The incidence of asthmatic attacks is, for example, greatest during the 
early hours of the morning. Because dosage forms remain longer in the 
large intestine than in the small intestine, colon-specific formulations 
could be used to prolong drug delivery.  
 
1.3.3.4.1. Approaches for Targeting Drugs to the Colon: 
The different approaches for targeting orally administered drugs to the 
colon include coating with pH-dependent polymers, design of timed-
release dosage forms, application of pressure controlled devices and the 
utilization of carriers that are degraded exclusively by colonic bacteria 
(Leopold, 1999).  
 
1.3.3.4.1.1. pH-controlled Systems: 
There is a pH gradient in gastrointestinal tract with values ranging from 
1.2 in the stomach through 6.6 in the proximal small intestine to a peak of 
about 7.5 in the distal small intestine (Leopold, 1999). This pH 
differential between the stomach and small intestine has historically been 
exploited to deliver drugs to the small intestine by way of pH sensitive 
enteric coatings. 
These polymer coatings are recalcitrant to the acidic conditions of the 
stomach but ionize and dissolve above certain threshold pH found in the 
small intestine. Thus, it is also possible to apply this concept to deliver 
drugs to the terminal ileum/colon by use of enteric polymers with a 
relatively high threshold pH for dissolution (Cheng, et al., 2004). 
The most commonly utilized polymers for this purpose are Eudragit® S 
and Eudragit® FS (copolymers of methacrylic acid/methylmethacrylate 
and methacrylic acid/methylacrylate, respectively), and which dissolve at 
a pH ≥7. Commercial examples include Asacol® Salofalk®, Claversal®, 
and Mesasal®. 
 
1.3.3.4.1.2. Time-controlled Systems:  
These systems rely on the relatively consistent small intestinal transit 
time, which approximates between 3 and 5 h. Obviously, drug release 
from such systems occurs after a predetermined lag phase (i.e., ≥5 h), 
which can be precisely programmed by adjusting the thickness and/or 
composition of the barrier (e.g., coating) formulation. Examples include 
TIME-CLOCK system (tlag = 8.85 ± 0.90 h) (Steed, et al., 1997), 
Pulsincap® system (tlag = 5.40 ± 2.53 h) (Wilson, et al., 1997), 
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Geomatrix® systems (tlag = 17.3 h in fasted, 12.5 h in fed) (Wilding, et 
al., 1995), and Chronotopic® system (tlag = 5–6 h) (Sangalli, et al., 1998). 
However, a side from gastric emptying, and contrary to popular belief, 
small intestinal transit and colonic transit are also subject to considerable 
inter-and intra-subject variability, as well as diurnal variability. This 
clearly limits the utility of the timed-release approach for colonic delivery 
(Ibekwe, et al., 2004). 
 
1.3.3.4.1.3. Pressure-controlled Systems:  
These systems rely on the strong peristaltic waves in the colon that 
temporarily increase the luminal pressure.  These novel delivery systems 
utilize the increase in pressure of the luminal contents of the colon 
resulting from the reabsorption of water in the region.  
A pressure-controlled colon delivery capsule (PCDC) has been described 
in the literature (Shibata, et al., 1998). Such system has been assessed for 
its ability to deliver model drugs in beagle dogs and humans. The authors 
have shown that the thickness of the ethyl cellulose coating can be 
manipulated to effect drug release in vivo. However, non of the in vivo 
studies have followed the transit of the capsules by gamma scintigraphy, 
which would allow the time and location of capsule disintegration to be 
accurately determined, but have compared the appearance of drug in the 
plasma with reported values for colon arrival times in dogs and in man.  
It has not been conclusively shown that the capsules have disintegrated in 
the colon. Moreover, there is no data on the luminal pressure of different 
regions of the gastrointestinal tract, and whether these are subject to inter-
and intra-subject variation as is pH and intestinal transit time. Therefor, it 
remains to be seen whether the PCDC represents a viable means of colon 
specific delivery (Ibekwe, et al., 2004). 
 
1.3.3.4.1.4. Enzyme-controlled Systems: 
These systems also are known as microbially controlled systems. They 
exploit the enzymatic activity of the colonic microflora and therefore, 
mainly use saccharide-containing polymers or azopolymers, which 
respectively undergo glycosidic degradation or azoreduction. 
Alternatively prodrug approach is utilized in which promoieties are 
resistant to hostile environment of stomach and small intestine, but are 
susceptible to degradation in the colon.  
The first bacterially activated system marketed to maintain remission in 
ulcerative colitis patients was sulphsalazine, a pro-drug consisting of the 
active ingredient 5-amino salicylic acid (5-ASA) linked by azo bond to 
sulphasalazine. 5-ASA lone is well absorbed from the small intestine, but 
when administered as a pro-drug is not released until it reaches the colon 
where the azo bond undergoes a reduction reaction to liberate the active 
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ingredient at the site of inflammation (Azad Khan, 1982). A variety of 
other drugs are successfully targeted to the colon using this prodrug 
approach. 
Researchers have long since realized the benefits of producing a universal 
system based on a bacteria-dependent system, and Saffaran et al., were 
the first to demonstrate this principle by using polymers cross-linked with 
azo-aromatic groups to coat pellets and deliver insulin and vasopressin to 
the rat colon (Saffran, et al., 1986). However, the use of azo polymers 
has so far been hindered as some azo-aromatic compounds are known to 
be potential carcinogens.  
Polysaccharides offer an alternative substrate for the bacterial enzymes 
present in the colon. Many of these polymers are already used as 
excipients in drug formulations, or are constituents of the human diet and 
are therefor generally regarded as safe. Although specifically degraded in 
the colon, many of these polymers are hydrophilic in nature, and swell 
under exposure to upper gastrointestinal conditions, which would result in 
premature drug release. To overcome this problem the natural 
polysaccharides are either chemically modified or mixed with 
hydrophobic, water insoluble polymers.  
This has the effect of limiting the swelling in the upper gastrointestinal 
tract, but still permitting a partial solubilization of the matrix or coating in 
the colon due to bacterial degradation resulting in drug release. The 
number of polysaccharide investigated to date is large, and a 
comprehensive review is not possible here, but materials used include 
amylose, chitosan, chondroitin sulphate, dextran, guar gum, inulin and 
pectin. 
Ashford et al., have investigated the ability of a direct compression coat 
of pectin USP to achieve colon delivery. Tablets were manufactured by 
directly compression pectin USP around a core tablet. A minimum of 700 
mg pectin was needed to prevent release of a model drug, fluorescein, in 
simulated mouth to colon condition. When tested in man, the 700mg 
coated tablets all disintegrated in the colon in regions varying from the 
caecum to the splenic flexure after a time of between 5.5 and 8.8 hours. 
Although the system was successful in vivo, the method of manufacture 
is not conducive for scale-up, and patient acceptability would be poor due 
to the cumbersome nature of the tablets (Ashford, et al., 1993)  
One polysaccharides that has been rigorously investigated is amylose. It 
is one of the major components of starch, accounting for 12-25% of the 
total weight. The glassy form of amylose has good film forming 
properties and is resistant to pancreatic enzymes in the small intestine but 
will undergo degradation due to fermentation by broad range of bacterial 
enzymes present in the colon. In combination with the water-insoluble 
polymer ethylcellulose, amylose has been exploited as film coating for 
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colonic drug delivery (COLALTM). This single coating can be applied 
directly to tablets or pellets by conventional coating methods with 
equipment that is widely available, and so is amenable to industrial scale 
up. A series of gamma scintigraphic and pharmacokinetic studies in man 
have provided evidence for the targeting performance of the COLALTM 
delivery system (Cummings, et al., 1996). 
Hydrophilic polymers are widely used in the formulation of modified-
release oral dosage forms. Various synthetic polymers (hydroxypropyl 
methylcellulose, polymethyl methacrylate, sodium 
carboxymethylcellulose, ect.) and natural materials (xanthan gum, guar 
gum, chitosan, ect.) have been tried by various researchers (Khan, et al., 
2000; Halsas, et al., 2001; Fan, et al., 2001; Yang, et al., 2002). It has 
been shown that in case of hydrophilic matrices, swelling and erosion of 
the polymer occurs simultaneously and both of them contribute to the 
overall drug release rate. 
Some times two or more matrixing agents are used to overcome the 
disadvantages of a particular matrixing agent or to achieve a desired 
drug-release pattern. Very few researchers have tried a combination of a 
hydrophilic polymer and a wax to achieve the desired drug release pattern 
(Miyagawa, et al., 1996). Nur, et al. has reported that the release rate of 
captopril increases linearly with the increase in the concentration of 
stearyl alcohol (up to 20%) in the hydroxypropyl methylcellulose 
matrices (Nur, et al., 2005).  
 
1.4. Guar Gum:  
Guar gum is a polysaccharide derived from the seeds of Cyamopsis 
tetragonolobus and many reports in the literature has proved its efficacy 
for colonic drug delivery. It consists of linear chains of (1→ 4)-b-D-
manopyranosyl units with α-D-galactopyranosyl units attached by (1→ 6) 
linkages as shown in the figure attached under herewith (Goldsten, et al., 
1992).   
 
  
 
Chemical structure of guar gum 
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Guar gum contains about 80% galactomannan, 12% water, 5% protein, 
2% acid insoluble ash, 0.7% ash and 0.7% fat.  
Guar gum hydrates and swells in cold water forming viscous colloidal 
dispersion or sols and this gelling retards the drug release from the tablets 
(Cheetham and Mashimba, 1991; Bhalla and Shah, 1991; Jain, et al., 
1992). The pH of 1%w/v aqueous dispersion varies from 5 to 7 and is 
stable over a wide pH ranges. It is non-ionic and hence the viscosity of 
dispersion is unaffected by pH and is same in both acidic and alkaline 
medium.  
In pharmaceutical formulations, guar gum is used as binder (up to 10%) 
and disintegrating agent in solid dosage forms. It is also used as 
suspending, thickening and stabilizing agent (up to 2.5%) in liquid oral 
and topical products.  
Investigators have used guar gum, either alone or in combination for 
fabricating sustained release dosage forms (Bhalla and Shah, 1991; 
Jain, et al., 1992; Chourasia and Jain, 2003). Its characteristics can be 
modified by thermal or chemical treatment for successful use in modified 
release preparations (Misra and Baweja, 1997; Gohel, et al., 1998). An 
uncontrolled rate of hydration and high intrinsic viscosity limits the use 
of guar gum as a sustained release agent. 
Guar gum was crosslinked with increasing amounts of trisodium 
trimetaphosphate to reduce its swelling properties for use as a vehicle in 
oral delivery formulations. As a result of the crosslinking procedure guar 
gum lost its non-ionic nature and became negatively charged. This was 
demonstrated by methylene blue adsorption studies and swelling studies 
in sodium chloride solutions with increasing concentrations in which the 
hydrogels' network collapsed (Gliko-Kabir, et al., 2000a). 
Crosslinked guar gum products were analysed to check the efficacy as 
colon-specific drug carrier and it was found that the product which was 
crosslinked with 0.1 equivalent of trisodium trimetaphosphate was able to 
prevent the release of 80% of its hydrocortisone load for at least 6 h in 
PBS (pH 6.4).  
When a mixture of a -galactosidase and b-mannanase was added to the 
buffer solution, an enhanced release was observed. In vivo degradation 
studies in the rat caecum showed that despite the chemical modification 
of guar gum, it retained its enzyme-degrading properties in a crosslinker 
concentration dependent manner (Gliko-Kabir, et al., 2000b).  
 
1.4.1. Application of Guar gum for Colonic Drug Delivery Carrier: 
Guar gum is being used to deliver drug to colon due to its drug release 
retarding property and susceptibility to microbial degradation in the large 
intestine (Tomlin, et al., 1986; Macfarlane, et al., 1990; Momin and 
Pundarikakshudu, 2004). The anerobic bacteria that are responsible for 
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the degradation of guar gum in the colon are Bacteroides species (B. 
fragilis, B. ovatus, B. Variabilis, B. uniformis, B. distasonis and B. 
thetaiotaomicron).  
It is to be noted that the utility of guar gum as colon specific drug 
delivery carrier is based on  its degradation by colonic bacteria (Rama 
Prasad, et al., 1998; Krishnaiah, et al., 1998). The colon is rich in 
anerobic bacteria (Simon and Gorbach, 1984). It implies that guar gum 
in the form of either a matrix tablet or as a compression coat over the 
drug core might have been degraded to a large extent by the action of 
anerobic microbial population of the large intestine (Krishnaiah, et al., 
1998).  
A novel tablet formulation for oral administration using guar gum as the 
carrier and indomethacin as a model drug has been investigated for colon 
targeted drug delivery using in vitro methods. Drug release studies under 
conditions simulating the gastrointestinal transit have shown that guar 
gum protects the drug from being released completely in the 
physiological environment of stomach and small intestine. Studies in pH 
6.8 PBS containing rat caecal contents have demonstrated the 
susceptibility of guar gum to the colonic bacterial enzyme action with 
consequent drug release (Rama Prasad, et al., 1998).  
Gilko Kabir et al. have reduced the swelling properties of guar gum by 
crosslinking it with increasing amount of glutaraldehyde under acidic 
conditions and evaluated the degradation properties of modified guar 
gum. Reduction in the enormous swelling by crosslinking resulted in 
biodegradable hydrogel formation, which was able to retain poorly water-
soluble drug (Gilko Kabir et al., 1998). 
A novel colon-specific drug delivery system based on guar gum matrix 
tablets was evaluated by conducting gamma scintigraphy studies using 
technitium-99m-DTPA as a tracer, in six healthy male human volunteers. 
Scintigraphs taken at regular intervals showed that some amount of tracer 
present on the surface of the tablets was released in stomach and small 
intestine and the bulk of the tracer present in the tablet mass delivered to 
the colon (Krishnaiah et al., 1998).   
Krishnaiah et al. have studied the influence of metronidazole and 
tinidazole on the usefulness of guar gum, a colon-specific drug carrier 
based on the metabolic activity of colonic bacteria, using matrix tablets of 
albendazole (containing 20% of guar gum) as a model formulation. The 
guar gum matrix tablets of albendazole were degraded by colonic bacteria 
of rat caecal contents and released about 44% of albendazole in simulated 
colonic fluids (control study) at the end of 24 h indicating the 
susceptibility of the guar gum formulations to the rat caecal contents 
(Krishnaiah et al., 2001a) 
 21
Compression coated tablets of 5-ASA and matrix tablets of mebendazole 
have been prepared using guar gum as a carrier. Matrix tablets containing 
various proportions of guar gum were prepared by wet granulation 
technique using starch paste as a binder. The tablets were evaluated for 
drug content uniformity, and were subjected to in vitro drug release 
studies. The results of the study revealed that matrix tablets containing 
either 20% or 30% of guar gum are most likely to provide targeting of 
mebendazole for local action in the colon (Krishnaiah et al., 2001b).  
Matrix tablet containing various proportions of guar gum prepared by wet 
granulation technique using starch paste as binder has also been described 
in the literature. Momin and Pundarikakshudu investigated the general 
release pattern of sennosides as a model drug from such matrix tablet. 
Authors have found that the release of the drug in the physiological 
environment of gastrointestinal tract was dependent on the proportion of 
guar gum used in the formulation and matrix tablets containing 50% of 
guar gum released 43% and 96% of the loaded drug in colon with and 
without rat caecal fluids respectively. This suggests the susceptibility of 
the matrix to the colonic micro flora (Momin and Pundarikakshudu, 
2004).  
Guar gum is now becoming familiar as a sustained –release agent as it is 
significantly less expensive than hydroxypropyl methylcellulose and 
other cellulosic derivatives.    
 
1.5. Factorial Design and Formulation Development: 
Factorial design is one of the experimental designs to run formulations 
and when every setting of every factor appears with every setting of every 
other factor, it is termed as full factorial design. Full factorial designs are 
not recommended for 5 or more factors since the design under such 
condition requires a large number of runs and is not very efficient.  
 
1.5.1. Two-level Full Factorial Designs: 
Two-level designs are useful for investigating of the main effects and to 
some extent the quadratic interaction effects and it is written as a 2k 
factorial design. It means that k factors are considered, each at two levels. 
These are (usually) referred to as low and high levels. These levels are 
numerically expressed as -1 and +1. The reason that the two-level designs 
were proposed is to model possible upper and lower influential effect of 
specific variable on the desired response (Myers, 1990).  
 
1.6. Diclofenac Sodium: 
It is a benzene acetic acid derivative, 2-{(2,6-dichlorophenyl)amino}-, 
monosodium salt (C14 H10 Cl2 N Na O2) with molecular weight (mwt) of  
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318.13 (BP, 2003). The drug is a potent, relatively nonselective 
cyclooxygenase inhibitor and also decreases arachidonic acid 
bioavailability. It has the usual anti-inflammatory, analgesic and 
antipyretic properties.  
 
1.6.1. Diclofenac Sodium Uses: 
This medication is a nonsteroidal anti-inflammatory drug which relieves 
pain and reduces inflammation (swelling). It is used to treat headaches, 
muscle aches, dental pain, and athletic injuries. It is commonly used to 
treat the pain, swelling and stiffness associated with arthritis (Watts and 
lllum, 1997).  
 
1.6.2. Dosage and Administration: 
The drug is presented in different dosage form including conventional 
tablets (25 and 50mg/Tablet), conventional capsule (25mg/ capsule), 
sustained release tablets and capsules (each contains 100mg/unit dose), 
enteric coated tablets (25mg/ml) and intramuscular injection of 75mg/ml 
ampoule (Martindale, 2002). When administered in form of tablets, the 
drug should be taken with food, milk, or antacids to prevent stomach 
upset using 180-240ml of water. Moreover, tablets should be swallowed 
whole and not crushed or chewed. 
 
1.6.3. Adverse Effects of Diclofenac Sodium: 
Adverse effects occur in approximately 20% of patients and include 
gastrointestinal distress, occult gastrointestinal bleeding, and gastric 
ulceration, though ulceration may occur less frequently than with some 
other nonsteroidal anti-inflammatory drugs (NSAIDs) (Daniel, et al., 
2001).  
Stomach upset is the most common side effect. Nausea, vomiting, 
bloating, gas, dizziness, blurred vision, drowsiness, loss of appetite may 
also occur. In the unlikely event an allergic reaction to this drug might 
develop. Symptoms of an allergic reaction include rash, itching, swelling, 
sever dizziness and trouble breathing (Watts and lllum, 1997).  
 
1.6.4. Precautions with Diclofenac Sodium Usage: 
The drug should be used with caution in patients with or having history of 
asthma, bleeding tendencies, blood clotting disorders, blood disorders, 
Crohn’s disease, Current or previous heart failure, current or previous 
high blood pressure, stomach or intestinal disorders, decreased heart 
function, decreased kidney function, decreased liver function and in 
elderly people. Moreover, the drug should never be used in patients with 
bleeding from gastrointestinal tract or those in whom aspirin or other 
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medicines in this class (NSAIDs), causes attacks of asthma, itchy rash 
(urticaria) or nasal inflammation  (Net Doctors, 2004). 
Many attempts have been done to formulate the drug in non-conventional 
delivery system (Cheng, et al., 2004; Bravo, et al., 2002; Conte and 
Maggi, 2000; Gohel, et al., 1998). However, most of the cited reports 
were in the area of developing sustained release formulation capable to 
deliver the administered dose of the drug over prolonged period of time 
and very few reports were concerned with the development of colon-
specific delivery system for diclofenac sodium (Gang, et al., 2004).  
The drug was frequently used for treating rheumatoid arthritis, which had 
apparent circadian rhythms and peak symptoms in the early morning. 
When orally administering drug conventional formulation, it was difficult 
to achieve the desired clinical effect, because it elicited patients’ 
incompliance of administration in the early morning to coordinate the 
rhythm of rheumatoid arthritis, due to rapid absorption of the 
conventional formulation. It has been claimed that colon-specific DS 
delivery was not only effective, but also be more convenient for 
administration than the conventional formulation (Gang et al., 2004). 
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2. Scope of the Work 
 
Diclofenac sodium is a simple phenyl acetic acid derivative that possesses 
the usual anti-inflammatory, analgesic and antipyretic properties. The 
drug is frequently used for treating rheumatoid arthritis which had 
apparent circadian rhythm and peak symptoms in the early morning. The 
oral administration of diclofenac sodium conventional formulation makes 
it difficult to achieve the desired clinical effect, because it elicited 
patients’ incompliance of administration in the early morning to 
coordinate the rhythm of rheumatoid arthritis, due to rapid absorption of 
the conventional formulation. 
Guar gum is an inexpensive carrier for colonic delivery of drugs and this 
is due to its drug release retarding property and susceptibility to microbial 
degradation in the large intestine.  
The scope of the present study is to apply full factorial design in order to 
examine, in comparative manner, the impact of formulation type of guar 
gum as a processing variable (matrix tablets and compression coated 
tablets) on the colonic drug delivery using diclofenac sodium as a model 
drug.  Diclofenac sodium was selected as a model drug in this study since 
colon specific delivery of the drug is not only effective, but also more 
convenient for administration than conventional formulation.  
The susceptibility of guar gum to undergo biodegradation in colon is 
assessed by conducting in vitro drug release studies in the presence of rat 
caecal contents in pH 6.8 phosphate buffer saline (PBS). 
Moreover, the study is designed in away to explore the influence of 
different formulation variables on physical characters of the developed 
dosage form.        
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3. Materials and Methods 
 
 
3.1. Materials: 
The following materials have been used during the experimental part of 
the research: 
Diclofenac sodium (DS) reference standard and raw material, magnesium 
stearate, talc, microcrystalline cellulose (MCC 101), polyvinylpyrrilidone 
(PVP) and lactose were products of  Shinpoong Pharmaceuticals Co., 
Seoul, Korea which have been kindly supplied by General Medicine 
Company (GMC, Sudan) and used as received.  
Guar gum was donated by Wafra pharma laboratories (Sudan). 
Potassium dihydrogen phosphate, dipotassium hydrogen phosphate, 
sodium chloride and disodium hydrogen phosphate were analytical grade 
from different commercial sources. 
 
3.2. Instruments and Apparatus: 
The following instruments and equipment were used during the course of 
the work: 
Analytical balance (GOHI-KERN and Sohn, 72336 BP 400-3, Balingen, 
Germany). 
Tablet dissolution tester (Erweka GmbH DT-D6 Heusenstamm, 
Germany). 
Tablet compression machine (Single punch Erweka GmbH EK-0 
Heusenstamm, Germany). 
UV spectrophotometer device (PERKIN ELMER, UV/visible 
spectrophotometer. Lambda 2, England). 
Centrifuge (80-2 centrifuge, Shanghai Surgical Instruments Factory, 
China). 
Oven (Kizilary Kumrular Sk.26, Ankara Turkey). 
Friability tester, (Model FAT-1SER.NO 871204- Korea). 
 
3.3. Methods: 
 
3.3.1. Design of Dosage Form Formulations:  
The screening design selected for the development of the matrix and 
compression coated tablets was 23 full factorial experimental design, in 
which three variables, namely, drug: guar gum ratio (X1), 
microcryatalline cellulose (MCC) loading level (X2) and tablet hardness 
(X3), each investigated at two levels within the possible 8 iterations 
(formulation runs) for their main and interactive effects on physical and 
drug release characters of the developed formulations. The design is 
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described fully in the introduction section (under 1.5.1.) and presented, in 
along with the possible iterations, in Table I. 
  
3.3.2. Preparation of DS Matrix Tablets: 
According to different formulations  summarized in Table II, guar gum 
was mixed with diclofenac sodium and microcrystalline cellulose and the 
powder blend was wetted using 10% w/v PVP alcoholic solution. The 
wetted mass was forced through mesh-8 and granules thus obtained were 
dried for 2 hours in hot air oven set at 70 C˚. Dried granules were sized 
through mesh-14, lubricated (3% and 1% of talc and magnesium steratae, 
respectively) and compressed in to tablet using single punch tablet presser 
equipped with flat 12mm punch and die set. Within each formulation 
processing, different compression forces were applied in order to obtain 
tablets of different hardnesses on Monsanto hardness tester. The obtained 
tablets weighed 500mg and contained 100mg of the drug. 
Tablets of different formulations conceived were tested for their content 
uniformity, weight variation, friability, swelling and erosion at different 
time intervals and finally drug release in conditions mimicking mouth to 
colon transit. 
 
3.3.3. Preparation of DS Coated Tablets: 
In this case, core tablet containing only drug and lactose were prepared 
according to formulations presented in Table II. Diclofenac sodium and 
lactose were mixed and wet granulated using PVP in alcoholic 
solution(10%) and sieved at 8mesh, the granules were dried using hot air 
oven at 50C˚ for 2hours, dried granules were sieved at 14mesh and 
lubricated by 3% talc and 1% magnesium stearate. Core tablets 
containing 100mg diclofenac sodium were compressed using single 
punch tableting machine equipped with 8mm die set.  
Coating powders comprised of guar gum and MCC in the ratios shown in 
Table II were thoroughly mixed. Fraction of this powder equivalent to 
half its content per tablet was introduced manually into the compression 
hole of the tablet presser equipped with a larger die (12mm). Tablet core 
was then centered on the introduced coating powder. The second fraction 
of the powder was then added and the two fractions of the coating powder 
were compressed against the tablet core to obtain the compression coated 
tablets.  
Produced compression coated tablets were characterized with the same 
diameter, weight, drug content and hardness ranges as that of the matrix 
tablets.  
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3.3.4. Friability Testing: 
Friability of matrix and compression coated tablets was evaluated as the 
percentage weight loss of 20 tablets tumbled in the friabilator for 4 min at 
25 rpm. The tablets then were dedusted, and the loss in weight caused by 
fracture or abrasion was recorded as percentage friability. 
 
3.3.5. Gel formation Study: 
This test was run out on the granulated powder in the matrix system and 
the granulated powder for coating formula in the compression coated 
system. One gram granulated powder was mixed with 10 ml water. After 
5min, rigidity of the gel was checked by manually inverting the test tube 
three times. The results were then recorded as formation of uniform 
dispersion or intact gel (Gohel, et al., 2003). Results are summarized in 
Table III.  
 
3.3.5. Swelling and Erosion Studies: 
Tablets within different formulations were subjected to swelling and 
erosion studies where medium uptake in  tablet preparations and their 
initial weight gaining via swelling and consequent loss of weight via 
erosion were determined. Weighed tablet samples were placed in USP 
apparatus 1 (paddle) dissolution jars at 100 rpm, mounted in 500ml 
simulated gastric fluids (0.1M Hcl- enzyme free) and or/ phosphate buffer 
pH 6.8 maintained at 37C˚. After selected time intervals, each tablet was 
withdrawn and weighed. The wetted samples were then dried in an oven 
at 70C˚ for 24 hours, and finally weighed to a constant weight.  
The percentage increase in weight due to the absorbed media (Q) was 
estimated according to the equation: 
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Where Ww and Wf are the mass of the hydrated sample before drying and 
final mass of sample dried and partially eroded sample. 
The percentage of erosion (E) was estimated using the following 
equation: 
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Where Wi is the initial starting dry weight. The results were presented in 
in figures 5—9 and Tables IV and V. 
 
3.3.7. In vitro Drug Release Studies: 
In vitro release of the model drug, diclofenac sodium, from matrix and 
coating tablets within the selected formulations tested was determined in 
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0.1N HCl, phosphate buffer pH 7.4 and phosphate buffer saline pH 6.8 in 
the presence and absence of rat caecal contents. 
 
3.3.7.1. Drug Release Studies in 0.1N HCl and pH 7.4 Phosphate 
Buffer: 
Drug release studies were carried out using USP apparatus I basket 
dissolution tester set at 100rpm. The tablets were tested for drug release 
for 2hours in 900ml of 0.1N HCl kept at 37 ±0.5 ˚C as the average gastric 
emptying time is about 2hours. Then the dissolution medium was 
replaced with 900ml of pH 7.4 phosphate buffer solution and tested for 
drug release as the average small intestinal transit time is about 3hours. 
At the end of the time periods, two samples each of one ml were taken, 
the volumes were diluted to 10ml with respective dissolution fluids and 
assayed for the drug. 
 
3.3.7.2. Drug Release Studies in the Presence of Rat Caecal Contents: 
To assess the susceptility of guar gum to colonic bacteria, drug release 
studies were carried out in the presence of rat caecal contents because of 
the similarity with human intestinal micro flora. Disolution medium was 
pH 6.8 phosphate buffer saline (PBS) containing rat caecal content (4% 
w/v). 
 
3.3.7.2.1.  Preparation of  PBS Containing 4% Rat Caecal Content as 
Dissolution Medium: 
In order to induce enzymes specifically acting on guar gum in the caceum 
of male rats, 10 rats weighing 150-200 gram and maintained on normal 
diet were each administered 1ml of 2%w/v dispersion of guar gum in 
water directly into the stomach. This treatment was continued for 7days. 
Thirty minutes before the commencement of drug release studies, four 
rats were killed by spinal traction. The abdomen were opened, the caecia 
were isolated, cut loose and immediately transferred in to pH 6.8 
phosphate buffer saline (PBS), previously bubbled with CO2. The caecal 
bags were opened, their contents were individually weighed, pooled and 
then suspended in to PBS to give a final caecal dilution of 4% w/v. As the 
caucus is naturally anaerobic, all these operations were carried out under 
CO2. The method is well described by Sinha, et al. (2004).   
 
3.3.7.2.2. Drug Release Testing: 
The drug release studies were carried out using a USP apparatus 1 basket 
dissolution tester set at 100rpm and 37˚C with slight modifications. The 
experiments were carried out using 50ml of pH 6.8 PBS in 100ml beaker 
immersed in the water maintained in the jar which, in turn, is in the water 
path of the apparatus. The tablets were placed in the baskets of the 
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apparatus and immersed in the dissolution medium containing rat caecal 
matter. The experiment was carried out with continuous CO2 supply into 
the beakers. At different time intervals, 1ml sample was withdrawn with 
out a pre-filter and replaced with 1ml of fresh PBS bubbled with CO2 and 
the experiment was continued up to 24 h. The volume was made up to 
10ml with PBS and centrifuged for 15 min. The supernatant was filtered 
through a bacteria-proof filter and dilution was made (5ml to 50ml) and 
then analyzed for diclofenac sodium content.  
As a control, another dissolution run for the same formulations in PBS 
free of rat caecal content were carried out.  
 
3.3.7.3. Calibration Curve of Reference Standard Diclofenac Sodium: 
Diclofenac sodium dilution in 0.1N HCl, phosphate buffer pH 7.4 and 
phosphate buffer saline pH 6.8 were carried out to obtain different 
solutions of different concentrations. Absorbance of each solution was 
measured at 276 nm against the respective solution, as blank, is an 
indication of the concentration of diclofenac sodium in that solution. 
Using data thus obtained, calibration curves of the drug in each of the 
three solutions were generated and linear regression equations relating 
drug concentration to absorbance are calculated. Results are summarized 
in figures 10—12.  
 
3.3.7.4. Determination of Diclofenac Sodium in Dissolution Samples: 
Application of regression equations generated from calibration curves of 
the drug in the three solutions has enabled the determination of 
percentages of drug release at different time intervals. The absorbances of 
dissolution samples were converted to concentrations and ultimately to 
amount per time. Results of the in vitro diclofenac released from the 
formulations tested in different dissolution medium are shown in figures 
13—16. 
 
3.3.8. Statistical Analysis: 
For comparing the average values of the responses between the two types 
of formulations (matrix and compression coated), the independent student 
t’test was considered with confidence limit set at 95%. To compare 
between performances of specific formulation tested under two different 
conditions, paired t’test was applied at the same confidence limit. In both 
of the cases, results with probability ≤0.05 were considered significant. 
Moreover, statistical f2 was applied to detect the difference levels in drug 
release between different formulations under different conditions. Results 
are tabulated in Table VI.  
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Furthermore, statistical one-way ANOVA was selected for the analysis of 
the whole spectrum of the generated data in order to derive generalized 
conclusions. Results of ANOVA are summarized in Table VII.  
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4. Results and Discussion 
 
Table I and II show the complete layout of the experimental design 
adopted for this study and the respective formulation ingredients, 
respectively. 
 
Table I 
Lay out of the 23 full factorial design, with its coded and actual values, for 
development of colon-specific diclofenac sodium matrix tablets 
Formula code Drug: guar gum ratio 
(X1) 
MCC loading % 
(X2) 
Tablet hardness 
(kg/cm2) (X3) 
F1 -1 -1 -1 
F2 -1 -1 +1 
F3 -1 +1 -1 
F4 -1 +1 +1 
F5 +1 -1 -1 
F6 +1 -1 +1 
F7 +1 +1 -1 
F8 +1 +1 +1 
    
Coded values Actual values 
 X1 X2 X3 
-1 1:2 10% w/w 5kg/cm2 
+1 2:1 20% w/w 10kg/cm2 
 
Table II 
Formulations of Diclofenac sodium (DS) matrix and compression coated tablets in 
the 23 factorial design. Amounts of ingredients are equivalent to 100 tablets for each 
formulation 
Ingredients (g) Formulations 
 F1 F2 F3 F4 F5 F6 F7 F8 
DS 10 10 10 10 10 10 10 10 
Guar gum 20 20 20 20 5 5 5 5 
MCC 5 5 10 10 5 5 10 10 
Lactose  13 13 8 8 28 28 23 23 
Talc 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
Mg stearate 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
 
4.1  The Effect of Guar Gum and Microcrystalline Cellulose Loading 
Levels on Friability and Content Uniformity of Matrix Tablets: 
Figures 1 and 2 are surface plots illustrating the relation between guar 
gum (drug: guar gum ratio) and MCC loading levels on measured tablet 
friability assessed at hardness levels of 5 and 10kg/cm2, respectively. 
From the figures, it appears that the influence of loading level of MCC on 
tablet friability is more profound than that of drug: guar gum ratio (if 
any). Moreover, best matrix friability was associated with low loading 
level of MCC regardless of the drug: guar gum ratio. 
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Fig.1 
Surface plot for the relation between drug: guar gum ratio, MCC loading level and 
the attained friability of matrix tablets assessed at 5Kg/cm2 
 
The result could be explained in terms of the enhanced compressibility 
effect offered by MCC to the guar gum. One of the problems concerned 
with pharmaceutical application of guar gum in tablet technology is its 
inferior compaction character (Misra and Baweja, 1997; Gohel, et al., 
1998).  
When a powder is compressed, an increase in applied force of 
compression can induce elastic deformation, plastic deformation, or 
fragmentation and which of these alternatives predominates will depend 
on the properties of the material involved.  
When present in a particular low amount, MCC could possibly support 
the plastic deformation of guar gum upon application of compression 
force (stress), and that by lowering the stress limit for the elastic 
deformation of guar gum.  
It is obvious then that best matrix friability with less powder and matrix 
weight loss is associated with low MCC content as the results implies. 
Moreover, based on the stated compendial limitation of friability (< 1%), 
friability of matrix tablets compressed to 10kg/cm2 (0.27—0.76%) could 
be considered superior to those compressed to 5kg/cm2 (0.7—0.93%). 
However, the decision concerning the influence of MCC and guar gum 
loading levels on matrix friability at the two hardness levels remain the 
same. 
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Fig.2 
Surface plot for the relation between drug: guar gum ratio, MCC loading level and 
the attained friability of matrix tablets assessed at 10Kg/cm2 
 
Table III shows some of the physical characters of the produced matrix 
tablets. All of the formulations showed satisfactory values for drug 
content uniformity and weight variation, however, it appears that  low 
level of MCC loading favors an excellent drug content uniformity 
(100±5%) which could be visualized from the contour plot (Fig. 3). Once 
more, guar gum displayed no (or a little) effect on content uniformity of 
the loaded drug.  
 
Table III 
Drug content and weight variation characters of matrix tablet formulations in the 23 
factorial design 
Formulaa Guar gum 
(mg) 
MCC 
(mg) 
Hardness 
(kg/cm2) 
Drug content 
uniformity (%) 
Weight 
variationb 
Gel 
naturec 
F1 200 50 5 104 Pass + 
F2 200 50 10 95 Pass + 
F3 200 100 5 95 Pass + 
F4 200 100 10 99.5 Pass + 
F5 50 50 5 104.9 Pass - 
F6 50 50 10 95 Pass - 
F7 50 100 5 101.3 Pass - 
F8 50 100 10 104 pass - 
a each formulation contains diclofenac sodium 100mg/tablet. 
b all formulations showed weight variation of ±10% as RSD of the average tablet weight 
c the result of this test among matrix and compression coated tablets is the same. (+) indicates intact 
gel and (-) stand for formation of uniform dispersion.   
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Variables that negatively contribute to the content uniformity of drugs 
formulated into matrix tablets are particle size variation, over-mixing, 
inadequate mixing and inconsistence powder flow into the compression 
zone (Wu, et al., 2000). 
 
 
 
Fig. 3 
Surface contour plot for the relation between drug: guar gum ratio, MCC loading 
level and the drug content uniformity of matrix tablets assessed at 5Kg/cm2. Numbers 
within the contour measure the percentage content of the drug. 
 
In this study, neither the guar gum nor the MCC loading levels have 
contributed negatively on the drug content uniformity of the matrix 
formulation. This could easily be traced from the results associated with 
weight variation test where all tested matrix formulations were within the 
pharmacopeial limitations for weight variation and content uniformity 
(±5% for each). 
 
4.2. The Effect of Guar Gum and Microcrystalline Cellulose Loading 
Levels on Friability of Compression Coated Tablets: 
Results graphed in figure 4 indicate that with compression coated tablets, 
guar gum loading level in the coat formulation greatly influences 
friability of the produced tablets and accepted low tablet friability is 
associated with  low loading level of guar gum in the powder of coating 
formulation. Moreover, MCC loading level revealed no (or a little) effect 
on tablet friability. In fact, this is contrasting the situation with matrix 
tablets in which MCC rather than guar gum was found to affect tablet 
friability. 
Tablet friability is a surface attrition event and obviously with 
compression coated tablet, only the coat ingredients rather than the other 
tablet ingredients are responsible for this incident. On the other hand, 
most of formulation ingredients of matrix tablets could possibly 
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contribute with varying degree to the friability character of the finally 
compressed dosage form (Danckwerts and Vander Watt, 1995).   
When MCC and guar gum are the only constituents of the coating 
material as the case with compression coated tablets, the effect of MCC 
on guar gum compressibility could possibly be offset by the high load 
level of guar gum as the result implies. 
With matrix tablets, mixing guar gum and MCC present in loading levels 
similar to that of the compression coated formulation might result in 
some sort of dilution with other ingredients and allows influences of other 
formulation ingredients on binding capacity and compressibility of the 
powder blend be brought in effect.  
Accordingly, for a given formulation one might expect high values of 
friability with tablets processed as compression coated and this is actually 
what the results tell.  
Alternation of test conditions between tablet hardness 5 and 10kg/cm2 
revealed no difference in conclusion concerning the dependency of 
friability of compression coated tablets on the guar gum loading level. 
Although guar gum and MCC in compression coated tablets are not 
related to content uniformity criteria, yet, content uniformity and weight 
variation exhibited by tablets within all formulations were within the 
satisfactory acceptable limits of the pharmacopeia (±5% for each).  
 
 
 
Fig. 4 
Surface plot for the relation between drug: guar gum ratio, MCC loading level and 
the attained friability of compression coated tablets assessed at 5Kg/cm2 
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4.3. The Influence of Guar Gum Content on Gel Strength: 
In both matrix and compression coated tablets, powder of formulations 
containing 40% w/w guar gum (F1—F4) formed intact gel after 5 minutes 
according to the gel formation study whereas gels formed by formulations 
containing 10% w/w guar gum (F5—F8) were described as non intact 
uniform dispersions (Table III).  
Guar gum, like other hydrophilic polymers, relaxes and hydrates in the 
presence of dissolution medium to form a gel layer in and around the 
tablets. This viscous swollen (gel) layer forms a barrier that controls drug 
diffusion and can remain intact for many hours (Gohel, et al., 1998). The 
granulated powder samples of formulations F5—F8 formed a weak gel 
structure as determined by the gel formation study. The poor gel strength 
formation tendency of these formulations may be attributed to the low 
content of guar gum. 
It is apparent then that increasing the content of guar gum in these 
formulations is associated with formation of gel characterized by high 
strength and in general, the physical properties of polymers (viscosity, 
speed of gel formation, and compression behavior) can be used to balance 
the physicochemical properties of the active ingredient so as to control its 
release characteristics.  
In addition, dosage forms can be prepared from these polymers such that 
physiologic parameters like pH, gastrointestinal motility, and ionic 
strength or enzymatic composition of the gastric fluid have little influence 
on the release from the produced tablets (Gohel and Patel, 1997).   
 
4.4.  The Influence of Guar Gum Loading Level on Swelling and 
Erosion Behaviors of the Matrix Tablets Tested in 0.1N HCl: 
The general swelling and erosion patterns of matrix tablets formulations 
in the experimental design tested in 0.1N HCl are shown in figures 5 (a 
and b). Figures 6 (a and b) show how maximum swelling and erosion 
indices of the same matrix formulations is related to the guar gum loading 
level.  
It has been shown that formulations containing large amount of guar gum 
(F1—F4) revealed high swelling tendency (maximum of 160-220%) 
compared to those with small loading level of guar gum. The relative low 
swelling propensity shown by formulations F5—F8 (100—140%) may be 
attributed to the high erosion rates characterizing these formulations (Fig. 
5b). 
The characteristics of hydrophilic polymers and their ability to hydrate 
and form a gel layer are well known and are essential to sustain and 
control drug release from matrices. The hydrated gel layer thickness 
determines the diffusion path of the drug molecules through the polymer 
mass into the dissolution medium. 
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None the less, diffusion is not the only mechanism controlling drug 
release from these systems. The rate and extent of drug release are also 
dependent on the swelling and erosion of the hydrated polymer mass 
(Alderman, 1984; Hogan, 1989). 
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Fig.5 
General pattern of (a) swelling and (b) erosion behaviors of matrix tablet 
formulations tested in 0.1N HCl. Each data point represents the average of three 
determinations. Standard deviations of the mean values are not shown. 
 
When present in high loading level of 40% w/w (low drug:guar gum 
ratio), guar gum enhances the swelling capacity of the tablet formulation 
which could be easily traced from the contour plot of figure 6a.  
  
(a) (b) 
 
Fig. 6 
Surface contour plots that relate drug: guar gum ratio and MCC loading level to (a) 
the maximum % swelling at 6hours and (b) maximum erosion % after 6hours in 
matrix tablet formulations having hardness of 5kg/cm2 and tested in 0.1N HCl. 
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On the other hand, erosion tendency was shown to be under the influence 
of guar gum content and maximum erosion of these matrix tablets was 
found to be associated with low content of guar gum (high drug:guar gum 
ratio) as shown in figure 6b. 
In matrix preparations (monolithic systems) made of hydrophilic 
polymers the swelling rate of the polymer matrix governs the drug 
release. Moreover, constant release kinetics from these preparations can 
be maintained if the polymer swells at a constant rate, maintaining a 
constant surface area, and the diffusion of the drug is comparatively rapid 
(Nur, et al., 2005).  
Interestingly, the terminal segments of swelling profiles associated with 
formulations F1—F4 clearly indicate the resistance of these formulations 
to polymer erosion. Anyhow, the order of swelling observed in these 
tablet formulations indicates the rates at which the formulations are able 
to absorb aqueous medium and swell provided that time to reach 
maximum swelling and the attained maximum % swelling are direct 
measures for rate and extent of aqueous fluid uptake process.  
Accordingly, one can expect that among the 8 matrix formulations, only 
formulations F1—F4 are capable to control the release of the loaded drug.  
 
4.5.  The Influence of pH on Swelling and Erosion Behaviors of the 
Matrix Tablets Containing Guar Gum as Matrixing Agent:  
Swelling and erosion performances of different matrix formulations in the 
experimental design examined in phosphate buffer pH 6.8 are depicted in 
figures 7 and 8. 
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Fig. 7 
General pattern of (a) swelling and (b) erosion behaviors of matrix tablet 
formulations tested in phosphate buffer, pH 6.8. Each data point represents the 
average of three determinations. Standard deviations of the mean values are not 
shown. 
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By comparing the performances of the respective formulations in both 
0.1N HCl (pH 1.2) and phosphate buffer pH 6.8 it follows that the 
decision pertaining to the enhanced swelling and erosion behaviors of 
formulations F1—F4 and F5—F8, respectively is kept the same. 
  
(a) (b) 
 
Fig. 8 
Surface contour plots that relate drug: guar gum ratio and MCC loading level to (a) 
the maximum % swelling at 6hours and (b) maximum erosion % after 6hours in 
matrix tablet formulations having hardness of 5kg/cm2 and tested in phosphate buffer, 
pH 6.8. 
 
In other words and in spite of existence of variation among different 
formulations responses, changing the pH of testing solution has resulted 
in non significant differences in tablets swelling and erosion tendencies as 
supported by values of probability p associated with statistical one way-
ANOVA shown in Table VII.  
It is well documented that variation of pH could affect hydration, 
swelling, erosion and drug release profiles of ionic polymers (Perez-
Marcos, et al., 1996). However, it is not the case here where the non-
ionic nature of guar gum necessitates the obtained result.  
 
4.6.  The Influence of Guar Gum Loading Level on Swelling and 
Erosion Behavior of the Compression Coated Tablets Examined 
in 0.1N HCl: 
It is worth mentioning that among the eight compression coated tablets 
tested, only the first four batches (F1—F4) in which the coating formula 
contain 40% w/w guar gum were able to retain their integrity mass. 
Accordingly, swelling and erosion results associated with formulations 
F5—F8) were no longer considered in this discussion. Moreover, 
inadequacy of the data to be fitted to the full 23 design forbids the 
application of three-directional surface plots for data presentation.      
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The general swelling and erosion patterns of the four compression coated 
tablets formulations (F1—F4) tested in 0.1N HCl are shown in figures 9 (a 
and b). Table IV summarizes the attained levels of swelling and erosion 
% of the four formulations after 6hrs in relation to the actual values of 
hardness and MCC content.  
Two different swelling and erosion patterns could be distinguished. 
Tablets within formulations containing 10% MCC (F1 and F2) showed 
comparable swelling and erosion behavior irrespective what the tablet 
hardness was. The second pattern includes the performance of tablets 
within formulations that contain 20% MCC (F3 and F4). 
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Fig. 9 
General pattern of (a) swelling and (b) erosion behaviors of 4 compression coated 
tablet formulations tested in 0.1N HCl. Each data point represents the average of 
three determinations. Standard deviations of the mean values are not shown. 
 
It might be not possible to trace the influence of guar gum content on 
swelling and erosion among these four formulations since all of them 
contain the same content of guar gum in the coat. However, the retarding 
influence (enhancing erosion effect) of MCC on swelling and erosion in 
these tablet formulation is somewhat noticeable.  
The result could be explained in terms of the capability of MCC to form 
net structure that strengthen further the guar gum gel upon wetting and 
accordingly, obstruct the water uptake process resulting in limited 
swelling (Fig. 9a). On the other hand as rate of water uptake is delayed, 
the chance for polymer disentanglement and relaxation become great due 
to the propagated possibility for polymer-water interaction since 
diffusional path is kept constant. This could explain the accelerated rate 
of erosion in tablets containing large amount of MCC as the result implies 
(Fig. 9b and Table IV).  
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4.7.  The Influence of pH on Swelling and Erosion Behavior of the 
Compression Coated Tablets Containing Guar Gum as Coating 
Material: 
 
Concerning the average swelling profiles of the four formulations tested 
in 0.1N HCl and phosphate buffer pH 6.8, variation in pH revealed no 
significant difference in attained % swelling measured after 6hrs (t’ test, 
p≥ 0.05). On the contrary, maximum % erosion among these formulations 
is more sensitive to pH variation (Table IV and VII). 
 
Table IV 
Maximum % swelling and erosion of some compression coated formulations (F1—F4) 
tested at two different pH. 
Formulaa MCC (%w/w) Hardness Swelling %b Erosion %c 
   0.1N HCl Buffer pH 6.8 0.1N HCl Buffer pH 6.8 
F1 10 5 220 220 20 8 
F2 10 10 239 249 19 7 
F3 20 5 130 140 28 18 
F4 20 10 132 137 27 16 
a All formulations contain 200mg guar gum (40%) in the tablet coat 
band c Are the maximum % swelling and erosion attained after 6hrs.  
 
Once more, the obtained result with swelling study agreed with the non-
ionic nature of guar gum. However, in the light of this scenario, it might 
be difficult to interpret the existence of significant differences in erosion 
responses between the two testing medium as shown in Table VII (one-
way ANOVA, p= 0.0086). Moreover, limited setting level of guar gum 
with compression coated tablet formulations (only 40% w/w) has 
terminated the possibility of tracing the interactive effect of MCC and 
guar gum in determination of swelling and erosion responses.  
 
4.8.  The Impact of Hardness on Swelling Behavior of Guar Gum-
Based Matrix and Compression Coated Tablets: 
Since the expected effect of hardness on water uptake (swelling) criteria 
of tested tablet formulations would be more prominent during the initial 
2—3hrs, swelling capacity after 2hrs for all formulations tested in two 
different medium is considered as suitable response to assess the 
influence of hardness on swelling behavior of the tested formulations. 
Table V summarizes the change of swelling capacity among different 
formulations as a consequence of hardness and pH variations. 
With regard to matrix tablet formulations, formulations F1 and F2 contain 
the same content of guar gum and MCC (Table III) and any difference in 
swelling behaviors in a particular testing medium could possibly be 
attributed to variation in tablet hardness. The same is applicable with the 
paired formulations F3—F4, F5—F6 and F7—F8. Result has implied that at 
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high loading level of guar gum, compression of these matrices to a high 
hardness level (10kg/cm2) is associated with reduction in matrix swelling 
capacity.  
 
Table V 
Swelling indices after 2hrs for matrix and compression coated tablet formulations 
tested at two different pH levels. 
Formulationa MCC 
(mg) 
Hardness 
(kg/cm2) 
Matrix swelling 
at 2hrs (%) 
CC swelling at 
2hrs (%)b c 
   pH 1.2 pH 6.8 pH 1.2 pH 6.8 
F1 50 5 173 166 180 180 
F2 50 10 167 166 175 174 
F3 100 5 174 156 145 130 
F4 100 10 159 131 140 130 
F5 50 5 70 69 - - 
F6 50 10 72 70 - - 
F7 100 5 55 0 - - 
F8 100 10 60 50 - - 
a refer to Table III for loading levels of guar gum and MCC; b CC stands for compression coated 
tablets; cFormulations F5—F8 of compression coated tablets fail to retain their mass integrity after 
2hrs and so were excluded from the comparison.  
 
When guar gum is present in high amount, application of high 
compression force during production of matrix tablets can result in 
reduction in the numbers of available voids (porosity) and consequently, 
the ability of the matrix for water uptake would be retarded. Retardation 
level depends on matrix firmness as has been previously reported (Nur 
and Zhang, 2000).   
At low level of guar gum, variation in hardness revealed no significant 
differences in swelling character of investigated formulations (p≥0.05) 
regardless of the MCC loading level as evident by performance of 
formulations F5—F8 (Table V). 
Although 2hr-swelling % attained with matrix formulations tested in 0.1N 
HCl (pH 1.2) are greater than those related to the respective formulations 
tested in phosphate buffer pH 6.8, statistical analysis (student t’ test) 
showed no significant difference (p≥0.05) with regard to the influence of 
hardness in swelling capacity of matrix tablets when tested in medium 
with varying pH ranges. 
Only 4 out of the 8 compression coated formulations (F1—F4) were able 
to retain their swelling integrity and accordingly, were considered to 
assess the impact of hardness. However, and in spite of this limited 
number of formulation, the influence of hardness on the swelling capacity 
of the four formulations was found to be similar to its effect on the matrix 
tablets (Table V). Moreover, statistical decision concerning the influence 
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of hardness on the swelling capacity at different pH remains the same as 
that allied to the matrix tablets (p≥0.05). 
 
4.9. In vitro Drug Release Studies: 
Drug release profile of medicament from any delivery system is the most 
important criteria in the evaluation of the efficiency of that delivery 
system. All of the pre-discussed studies (gel formation, swelling, erosion 
and mass integrity) are indicators for the drug release rate and kinetics 
expectations. In this section, results concerned with the influence of 
different formulation and processing variables on the efficiency of the 
fabricated systems for colonic delivery of the loaded drug are presented 
and discussed. 
 
4.9.1.  Standard Calibration Curves of Reference Diclofenac 
Sodium:  
Following the method described under 3.3.7.3., calibration curves of 
reference standard diclofenac sodium were generated in 0.1N HCl and 
phosphate buffer, pH 7.4 (Fig. 10 and 11, respectively). Selection of those 
two solutions to generate calibration curves for the drug is based on two 
facts, first the specifications for colonic drug delivery system necessitate 
the drug release be tested in conditions similar to stomach—jejunum 
transition (USP, 1999) and secondly, difference in drug solubility in the 
two solutions is remarkable (Al-Taani and Tashtoush, 2003). Moreover, 
a third calibration curve for the drug in phosphate buffer saline was 
generated and applied to assess the drug delivery in a real pH condition of 
colonic content (Fig. 12).  
 
Fig. 10 
Calibration curve of DS in 0.1N HCl and measured at 276nm. Each data point is the 
average of 3 determinations 
 
Generated calibration curve of diclofenac sodium in 0.1 M HCL showed 
a linear relation in drug concentration range of 0.0001—0.1 mg/ml. Best-
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fit regression equation for such relation is y (absorbance) = 30.52 
(concentration) + 0.0548 with satisfactory high correlation (r) and 
determination (r2) coefficients (0.9995 and 0.999, respectively) (Fig. 10).  
With phosphate buffer pH 7.4, drug calibration curve showed linearity in 
concentration range of 0.00001—0.1 mg/ml with regression equation y = 
31.563x + 0.0486 associated with correlation (r) and determination (r2) 
coefficient of 0.9997 and 0.9995, respectively (Fig. 11)  
 
 
Fig. 11 
Calibration curve of DS in phosphate buffer pH 7.4 and measured at 276nm. Each 
data point is the average of 3 determinations 
 
In case of phosphate buffer saline pH 6.8, the best-fit regression equation 
that describe the linear relation between the drug concentration ranging 
from 0.002 to 0.08 mg/ml was y = 43.112 x +0.1934. The mathematical 
relation revealed high values of correlation and determination 
coefficients: 0.999 and 0.999, respectively (Fig. 12). 
 
 
Fig. 12 
Calibration curve of DS in phosphate buffer saline pH 6.8 and measured at 276nm. 
Each data point is the average of 3 determinations 
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High values of correlation and determination coefficients are direct 
measures for the precision and sensitivity of the considered analytical 
method. Accordingly, the three regression equations could be applied 
efficiently to determine diclofenac sodium concentration in the different 
dissolution media. 
 
4.9.2.  The Influence of Guar Gum on Drug Release from Matrix 
Tablets: 
The general DS release profiles of the different matrix formulations tested 
in 0.1N HCl (for two hours) and phosphate buffer pH 7.4 are graphed in 
figure 13. 
Obviously, formulations that showed inferior swelling capacity failed to 
deliver the drug over a considerable long duration of time (F5—F8). These 
formulations released up to 79—89% of the loaded drug by the end of the 
5 hr time interval. On the other hand, with formulations F1—F4 which 
showed resistance towards erosion, the cumulative amount of drug 
released only accounted for < 17% by the end of the same time interval 
(Fig. 13). It can be seen that as the amount of guar gum is increased, the 
ability of the matrix tablet to control the drug release is enhanced. 
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Fig. 13 
DS release profiles of different matrix tablet formulations tested in 0.1N HCl (for the 
first 2hrs) and pH 7.4 phosphate buffer solutions. Each data point is the average of 6 
determinations. 
 
Swellable matrices are also termed gel-forming matrices, as their drug-
delivery behaviour is characterized by the formation of an outer gel layer 
on the matrix surface, owing to the associated polymer transition. If the 
polymer gels slowly as in formulations F5—F8, the solvent can penetrate 
deep into the glassy matrix, thus dissolving the drug and disintegrating 
the matrix (Fig. 5 b). This gel layer acts as a ‘protective’ layer for the 
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matrix and its stability is as essential as its rapid formation as the case 
with formulations F1—F4) (Columbo, et al., 2000).  
In the matrix formulations that containing 40%of guar gum not more than 
25% of diclofenac sodium was released in the dissolution medium of 
0.1M HCl and pH 7.4 after 5 hours. This shows that guar gum is capable 
of protecting the drug from being released completely in the 
physiological pH of stomach and small intestine. On exposure to the 
dissolution fluids, the gum gets hydrates and forms a viscous gel layer 
that slows down further seeping-in of dissolution fluids towards the core 
of the tablets.  
The hydration of guar gum seems not to be affected by the pH of the 
dissolution medium. The initial drug release may be attributed to the 
dissolution of the drug present on the surface of the tablet and the lag 
time required for complete hydration of guar gum to form viscous gel 
layer around the tablet. 
The gel strength is important in the matrix performance and is controlled 
by the concentration, viscosity and chemical structure of the rubbery 
polymer. This restricts the suitability of the hydrophilic polymers for 
preparation of swellable matrices.  
Polymers such as carboxymethyl cellulose, hydroxypropyl cellulose or 
tragacanth gums do not form the gel layer quickly. Consequently, they 
are not suggested as excipients to be used alone in swellable matrices. 
However, with high content of guar gum (F1—F4), results revealed that 
the intact gel layer is quickly formed as a result of enhanced water uptake 
(Table III, Fig. 5 a and b) and accordingly, these formulations were 
capable to retain and control the drug release for more extended time 
period as compared to performance of other formulations. 
The gel-layer thickness as a function of time is determined by the relative 
position of the swelling and erosion moving fronts. In addition, a 
‘diffusion front’ located between the swelling and erosion fronts, and 
constituting the boundary that separates solid from dissolved drug, has 
been identified (Lee and Kim, 1991). During drug release, the diffusion 
front position in the gel phase is dependent on drug solubility and 
loading. The diffusion front movement is also related to drug dissolution 
rate in the gel (Colombo, et al., 2000).  
 
4.9.3.  The Effect of Guar Gum on Drug Release from Compression 
Coated Tablets: 
Results concerned with the in vitro drug release of the compression 
coated tablets revealed that the conclusion made before on the effect of 
guar gum on drug release from matrix formulations is also valid with 
compression coated tablet formulations.  
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Figure 14 shows the general DS release profiles of the different 
compression coated formulations tested in 0.1N HCl (for two hours) and 
phosphate buffer pH 7.4. and it is clear that only formulations that 
containing high load of guar gum in the coat (F1—F4) were able to control 
the drug release for the reasons mentioned before for matrix tablets. 
The importance of the gel layer in controlling drug diffusion and release 
in a controlled release hydrogel tablet is well documented (Misra and 
Baweja, 1997; Khullar, et al., 1998; Nur and Zhang, 2000).  
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Fig. 14 
DS release profiles of different compression coated tablet formulations tested in 0.1N 
HCl (for the first 2hrs) and pH 7.4 phosphate buffer solutions. Each data point is the 
average of 6 determinations. 
 
At the 5 hr time interval, it is apparent that cumulative percentages of 
drug released from compression coated formulations F1—F4 (5.2—7.8%) 
were less than the respective matrix formulations (13—17%). Statistical 
analysis, however, revealed that such differences are not significant as 
summarized in Table VII (one-way ANOVA, p=0.1033).  
This might be explained in terms of the gel strength formed by guar gum 
when present in sufficient amount in the outer layer surrounding the 
coated formulations whereas this effect could be reduced as a result of 
incorporation of other ingredients which lower the gel strength of guar 
gum when compounded as matrix tablets. The swelling behaviors of these 
formulations (Table V) support the derived assumption and probably it 
might be the first time to report this.  
As compression coated and/or matrix formulations F5—F8 failed to reveal 
satisfactory gel strength, swelling behavior and non-disintegrated 
coherent mass upon wetting, their drug release profiles were no longer 
considered and/or discussed in the context of this section. Moreover, only 
the drug release profiles of formulations F1—F4 (matrix or compression 
coated) would be of concern with regard to the evaluation processes.  
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4.9.4.  Effect of Adding Rat Caecal Content to Phosphate Buffer 
Saline on Drug Release Behavior of Guar Gum-Based Matrix 
Tablets: 
In this section, the matrix and compression coated formulations F1—F4 
were investigated for drug release profile in PBS pH 6.8 (as control) and 
in PBS containing 4% rat caecal content pH 6.8 to simulate the colonic 
fluid. The influence of adding rat caecal content on drug release profile 
was verified. 
Release profiles of DS from matrix formulations F1—F4 tested in PBS 
and simulated colonic fluid are shown in figure 15.  The results 
demonstrates that in presence of rat caecal content in the dissolution 
medium,drug release from the four formulations is significantly enhanced 
(Fig. 15b) as compared to those tested in absence of rat caecal content 
(Fig. 15a).  
In PBS, the four formulations revealed cumulative drug release after 24hr 
in the range of 40—52%, whereas the same formulations displayed 
significant increase (p≤0.05) in 24hr-cumulative drug release (70—80%) 
when tested in PBS containing 4% rat caecal content (simulated colonic 
fluid) (Table VII). The enhancing effect of rat caecal content on drug 
release from these matrices is prominent from the initial time of drug 
release to the end of the dissolution test (Fig. 15a and b). 
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Fig. 15 
DS release profiles of different matrix tablet formulations tested in (a) phosphate 
buffer saline pH 6.8 and (b) phosphate buffer saline pH 6.8 containing 4% rat caecal 
content. Each data point is the average of 6 determinations. 
 
This result indicates that the enhanced drug release of the drug in 
presence of rat caecal content is not due to mechanical erosion, but due to 
anaerobic microbial enzymatic action on swollen guar gum matrix tablets 
as has been reported (Rama Prasad. et al., 1998). This assumption is 
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based on the reports concerned with the responsibility of anaerobic 
bacteria in guar gum degradation in colon (Tomlin. et al., 1986; 
Macfarlane. et al., 1990).  
Moreover, it was reported earlier that matrix tablets of albendazole 
containing 20% guar gum were potential in targeting the drug to colon in 
the treatment of helminthiasis (Krishnaiah. et al., 2001).  
Due to the inadequacy of the individual time points (t25%, t75%….etc.) to 
characterize the overall drug release profile, similarity factor (f2) 
approach proposed by Moore and Flanner (1996) was used in this study 
to differentiate between drug release profiles of the matrix and/or 
compression coated tablets in PBS and simulated colonic fluid in order to 
evaluate the influence of rat caecal content on guar gum and 
consequently, on the drug release.  
Several reports concerned with the application of similarity factor (f2) to 
achieve different objectives have been cited (Williams et al., 2002; 
Gohel et al., 2003; Trapani et al., 2004). The following equation was 
used to calculate f2 value between reference and test formulations: 
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Where n is the number of sampling points, Rt is the reference profile at 
time point t, Tt is the test profile at the same time point and wt is an 
optional weight factor.  
Values of f2 between 50 and 100 indicate that the reference and test 
release profiles are comparable whereas value of 100 identifies the 
identical release profiles. Dissimilarities between release profiles are 
indicated by f2 values lesser than 50. Moreover, it has been suggested that 
the average difference between two release profiles corresponding to 
calculated f2 of 83, 65, 50, 41, or 36, is 2, 5, 10, 15, and 20%, respectively 
(Shah et al., 1998).  
 
Table VI 
Results of the similarity factor (f2) comparison in the drug release profiles of 
formulations F1—F4 matrix (M) and compression coated (C) tablets tested in 
phosphate buffer saline with and without rats’ caecal content. 
Reference formulationa Test formulationb f2 Average difference 
F1 (M) F1 (M) 34 >20% 
F2 (M) F2 (M) 30 >20% 
F3 (M) F3 (M) 39 20% 
F4 (M) F4 (M) 36 20% 
F1 (C) F1 (C) 29 >20% 
F2 (C) F2 (C) 31 >20% 
F3 (C) F3 (C) 30 >20% 
F4 (C) F4 (C) 30 >20% 
a Drug release was tested in PBS without caecal rats content. 
bDrug release was investigated in simulated colonic fluid (PBS containing 4% w/v caecal rats content). 
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Based on data presented in Table VI, drug release profiles of the four 
matrix formulations F1(M)—F4(M) investigated in both dissolution 
medium showed similarity factor (f2) (30—39) corresponding to average 
difference of ≥20, indicating the dissimilarity of drug release of these 
formulations in the two dissolution medium.  This result support the 
finding that DS release from these matrices is significantly enhanced 
when tested in simulated colonic fluid.  
 
4.9.5.  Effect of Adding Rat Caecal Content to Phosphate Buffer 
Saline on Drug Release Behavior of Guar Gum-Based 
Compression Coated Tablets: 
Figure 16(a and b) show drug release profiles of compression coated 
formulations F1—F4 tested in PBS and simulated colonic fluid, 
respectively. As with the case of matrix formulations, presence of rat 
caecal content in the dissolution medium greatly influences the release 
profiles of these compression coated tablets.  
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Fig. 16 
DS release profiles of compression coated tablet formulations tested in (a) phosphate 
buffer saline pH 6.8 and (b) phosphate buffer saline pH 6.8 containing 4% rat caecal 
content. Each data point is the average of 6 determinations. 
 
Upon examination for drug release in PBS, the four compression coated 
tablet formulations displayed cumulative drug release after 24hr ranging 
from 14—25% (Fig. 16 a) whereas the same formulations presented 
significant increase (p≤0.05) in 24hr-cumulative drug release (75—90%) 
when tested in PBS containing 4% rat caecal content (simulated colonic 
fluid) (Fig. 16 b).  
It is apparent that the enhanced effect of rat caecal content on drug 
release from guar gum based compression coated formulations is more 
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prominent than with matrix formulations. This can be traced from figures 
15 and 16 or from Table VI in which the four compression coated tablets 
showed average difference of >20% when their release profiles in both 
dissolution medium were computationally compared.  
Rama Prasad. et al. (1998) have found that the rat caecal contents at 
4%w/v level in the dissolution medium after 7days of enzyme induction 
provide the best conditions for assessing the susceptibility of guar gum to 
colonic bacterial degradation. Thus, the results clearly demonstrate that 
guar gum is a potential colon-specific drug delivery carrier. The obtained 
results agreed with a recent published relevant work (Momin and 
Pundarikakshudu, 2004). 
The first four formulations in both matrix and coated system which 
contain 200mg of guar gum (40%) give the best results in swelling and 
erosion studies and form contact gel in the gel formation study. 
The results of the in vitro release study clearly reveal that when guar gum 
is formulated as matrix tablet formulation, there exists a chance for 27% 
of the loaded drug to be released within the physiological environment of 
stomach and small intestine before reaching the colon with maximum 
cumulative drug release of 78% by the end of 24hrs.  
On the other hand, formulation of guar gum as coating biodegradable 
material has limited the amount of drug release before reaching colon to 
only  11% with maximum drug delivery of 89%.  
Consequently, concerning the drug release profile in colonic condition, 
guar gum in form of coating material is confirmed to be more effective 
than when present as matrixing agent for colonic drug delivery. 
 
4.10. Statistical Analysis: 
Table VII summarizes the outcomes of statistical analysis conducted on 
the results of swelling, erosion and drug release studies. In these analyses, 
one way analysis of variance (one way-ANOVA) was selected with 
confidence limit of 95% and probability values ≤0.05 were considered as 
significant results. One way-ANOVA was selected since compared units 
were more than two or even three formulations (8—16 formulations were 
compared). In simplified form where average of performances was the 
target, independent or paired student t’test (depending on the case) was 
conducted and the results of these types of statistical analyses were not 
included in Table VII but referred to within the context.   
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Table VII 
Summary of statistical one-way ANOVA on the comparative physical performances of 
guar gum based matrix and compression coated tablet formulations. 
  
Parameters HCl Phosphate 
buffer (pH 7.4) 
PBS (pH 6.8) Simulated 
colonic fluid 
Total 
df 
p-valuea 
Swelling       
 Matrix    27 0.0876 
  Matrix   24 0.1504 
 Matrix Matrix   52 0.0622 
 Coated    19 0.2477 
  Coated   19 0.2614 
 Coated Coated   39 0.2916 
 Matrix/Coated    39 0.7856 
  Matrix/Coated   39 0.5883 
Erosion       
 Matrix    33 0.0525 
  Matrix   30 0.0035 
 Matrix Matrix   64 0.0206 
 Coated    19 0.1881 
  Coated   19 0.4413 
 Coated Coated   39 0.0086 
 Matrix/Coated    39 0.4245 
  Matrix/Coated   39 0.0041 
Drug release       
 Matrix   23 0.2009 
 Coated   23 0.1188 
 Matrix/Coated   47 0.1033 
   Matrix Matrix 39 0.0419 
   Coated Coated 39 0.0063 
   Matrix/Coated  39 0.2852 
    Matrix/Coated 39 0.9395 
a Only values of p ≤0.05 were considered significant. 
 53
5. Conclusions 
In order to obtain tablet formulation with satisfactory gel strength, 
swelling, erosion and drug release characters, loading level of guar gum 
was shown to be a limiting factor. Guar gum loading level of 40% w/w 
was shown to be effective to obtain the desired characters previously 
mentioned. Most of variations in performance of guar gum can possibly 
be explained in terms of the wetted macrostructure of the polymer.  
The possible influences of most formulation variables (additives) are 
mainly offset by high content of guar gum in the formulations series 
tested in this study, at least under the conditions of the study. 
Processing variables of (matrix or coated forms) have profound effects on 
the physical performance of the produced tablets, and such effects are 
triggered at high loading levels of guar gum in the formulations. 
The study shows that when guar gum is formulated as a matrix tablet 
formulation, there exists a chance for 27% of the loaded drug to be 
released before reaching the colon whereas formulation of the polymer as 
coating biodegradable material limits the amount of drug release before 
reaching the colon to only  11%.  
Although in the form of coating material guar gum was confirmed to be 
more effective for colonic drug delivery than when present as matrixing 
agent, other variables as formulation simplicity, inexpensiveness, 
versatility and ease of processing are to be considered before deriving 
final conclusions.  
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CHAPTER ONE 
INTRODUCTION 
1.1 General introduction 
Crude oil is a naturally occurring material, which is composed principally of 
hydrocarbons. It varies from a light liquid to a highly viscous liquid. Crude oil needs 
to be transported from the fields to sea ports and refineries. The commercial methods 
for transportation of crude oil, used nowadays, are: land trucks, railways, sea barges 
and pipelines; pipelines being the major means of transportation.  
The crude oil, especially the waxy one, faces many problems while it flows through 
the pipeline. The oil is subjected to cooling which can lead to increase in viscosity, 
gel formation and wax deposition on the walls of the pipeline. Many methods are now 
in use to overcome these difficulties. Some of these methods are: thermal treatment 
while the oil is flowing, addition of additives, blending with light petroleum products, 
mechanical (scraping and pigging) and visbreaking treatments are all in application. 
Another treatment process which can be applied to the waxy crude oil is de-waxing. It 
is usually performed at the oil fields before pumping the crude through pipelines, it is 
proved to be suitable but it is expensive.  
 
1.2 Muglad basin field facilities 
The majority of Muglad basin crude oils (Nile Blend) are paraffinic in nature and 
have a lower pour point above the minimum ground temperature, 27○C. Muglad basin 
consists of eight major oil fields (Heglig, Unity, El Toor, El Nar, Toma South, 
Bamboo, Munga, and Diffra) located at central Southern Sudan. These fields produce 
up 150,000 bbd pumped to Fields Processing Facilities (F.P.F) and then to the Central 
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Processing Facility (C.P.F) in Heglig, where it is heated to 105○C for final 
conditioning. The oil is then cooled to 70○C, temporarily held in storage, then 
transported through a 1,500 km pipeline to Bashayer Marine Export Terminal near 
Port Sudan, Appendix, A1.shows the map thereof. Two off-take points are located at 
El Obeid refinery (10,000 bbd, 400 km) and Khartoum refinery (50,000 bbd, 817 km).  
 
1.3 Nile Blend properties and problems 
Nile Blend crude oils are paraffinic (waxy) in nature based on long hydrocarbon 
series of macro crystal, non-Newtonian fluid (Pseudo plastic, Bingham plastic, 
Thixotropic, Rheopoxy). Its properties vary due to the various production fields. The 
main features of the blend mixture are: medium density, low sulphur content (sweet), 
low metal content, viscous and relatively lower pour point (Appendix, A2). 
Nile Blend may experience wax deposition problems throughout the pipeline system. 
Wax is very sensitive to temperature, duration of shutdown, shear rate, pressure, and 
history. As the wax deposition thickness increases, pressure drop across the pipeline 
increases; as a result, the power requirement for the crude transport will increase. 
Since the solubility of the wax decreases rapidly with decrease in temperature, the 
arterial blockage problems of the waxy crude can be efficiently reduced by insulation 
and heating. Sludging may occur in the storage tanks and the high levels of insoluble 
wax also indicate potential for pipeline pumpability problems. However, pumpability 
pressure effect must be determined by viscosity measurements, as the crude oil 
rheology is very sensitive to temperature, time of shear. For Nile Blend crude, both, 
heat and chemical treatment are used (wax crystal modifiers). These are more 
effective and economical and thereby influence the rheology of crude. 
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1.4 Nature of wells and fields 
The crude specification and classification depends on its well’s properties. Some of 
the crude produced from the wells give high viscosity and others give low viscosity. 
In addition, some have high water content while others are found with low water 
content. These fields crude contain different wax and water content and gas ratio; 
therefore field-processing facilities are made for each field. 
 
1.5 Nile Blend field treatments 
1.5.1 Well treatment 
1.5.1.1 Addition of pour point depressant 
The pour point depressant (PPD) is pumped from storage tanks (near the wells), to the 
pipeline. Determining of the pour point depressant dosage depends on crude 
properties. This procedure is carried out in Toma South, El Toor & El Nar fields 
because these fields have high wax content. 
1.5.1.2 Water treatment 
Some fields have high water content, so demulsifier are added to remove the water, in 
Heglig field.  
1.5.2 Field Processing Facilities 
At the F.P.F the crude is heated to 85°C and a treatment dosage of pour point 
depressant is added to decrease the viscosity and pour point. All these treatments are 
used to improve the crude properties and to ensure its flow to the Central Processing 
Facilities. 
1.5.3 Central Processing Facility treatment 
In this unit, the production of each field is collected, water and gases are separated 
and pour point depressants are then added, these treatments are:  
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1.5.3.1 Electrostatic treaters 
It is a horizontal vessels containing two electrodes. The designed temperature and 
pressure are 115°C and 1034 Kpa respectively. After injection of demulsifier at 85°C 
the crude distributed through pipe to electrostatic treaters. With the action of 
electrostatic field and specific gravity, molecules of water are separated from the 
crude and settle in the lower part of the vessel.  
1.5.3.2 Gas Boot 
This is a vertical cylinder of 7.5 m height and 3 m diameter that is used to remove 
gases. 
1.5.4 Oil Recycling Pumps 
After leaving gas boots the crude is pumped to oil heaters. Oil heaters are cross heat 
exchangers, which raise the temperature of the crude to 105°C. The crude is then 
pumped to the treaters for heat exchange with crude from other fields, and then the 
crude temperature is reduced to (65-70°C). 
1.5.5 Crude Storage Tanks 
The maximum capacity of storage tanks is (300,000 b). The tank bottom and walls are 
coated with an oil resistant paint to prevent corrosion; each tank is supplied with a 
heating coil to sustain a temperature of (40-60°C). 
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1.6 Objectives 
1.6.1 Main Objectives 
The main objectives of this study are to investigate the following on Nile Blend crude 
oil: 
1. Effect of cooling rate (High, Medium, and Slow) on dynamic viscosity.  
2. Effect of different preheats temperatures on yield stress. 
3. Effect of temperatures on starting up pressure. 
4. Development of hydraulic correlations incorporating the physical properties 
and dimensionless groups that can represent the system. 
5. Verification of the hydraulic correlation against the actual data. 
 
1.6.2 Specific objectives 
1. Determinations of the design restart pressure according to the relevant pipeline 
length. 
2. Follow-up of the rheological and physical properties of the crude along the 
pipeline, to help operators to take appropriate action. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Previous Studies 
The rheological behaviour of waxy oils is considered to be of crucial importance in 
the design of a pipeline. Pipeline transportation of waxy crude oil is subjected to 
cooling which affects their flow properties. According to (Kennedy, 1993), pipelines 
provide an efficient way to transport oil and gas. Using this transportation medium 
with maximum efficiency becomes interesting to the oil industry. However, the 
operational decision-making in pipeline systems is still based on experience. 
(Ford et al., 1965) mentioned that ambient temperatures condition is a major influence 
factors on the design of the pipeline, and whether it is buried or above the ground.  
(Chandrasekharan and Sikdar, 1970) stated that due to gelling tendency and the high 
viscosity of the crude at the low temperatures encountered in the Indian winter. The 
crude which contains a high percentage of wax precipitates on cooling. This leads to 
the formation of a structure, which, if allowed to develop in pipeline, leads to 
excessive break-through and pumping pressures. The development of a new process 
to solve this problem resulted in the construction of the crude oil conditioning plants. 
The wax in the raw crude oil has a tendency to form an interlacing structure on 
separation when the oil is cooled, resulting in a gel structure entrapping the oil. On 
conditioning, the structure of wax crystals changes and they remain in suspension in 
the oil without forming agglomeration with considerable reduction in viscosity even 
at low temperatures much below the pour point of the crude oil. Sub-soil temperature 
survey of a pipeline route, showed that the minimum temperature attained in winter at 
the pipeline depth of about 4 to 6 ft was only 18○C. This temperature is well below 
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the pour points of the crude investigated which ranges from 29○ to 34○C. Due to the 
sharp rise in viscosity of the oil below the pour point, excessive pumping pressure 
would be required to transport the crude. Also, due to high yield value of the crude 
below the pour point, the break-through pressure, while restarting pumping after a 
temporary shutdown of the line, would be so large that the safety limits of the line 
would be exceeded. 
(Barry, 1971) mentioned that discoveries of large quantities of waxy crude oil in 
North Africa have brought about a change in pipeline operation economics. It has now 
become desirable to ship large quantities of waxy North African crude oil through 
unheated pipelines. Due to the expected low ground temperatures, this pumped crude 
oil may be chilled to a temperature wherein the wax and asphaltenes come out of 
solution. If this occurs, the fluids flow changes from Newtonian to non-Newtonian 
fluid. The problem that industry has been facing in planning to maximize shipments 
of the oils has been to determine which tests and methods accurately predict their flow 
when such changes occur. This is necessary to insure that accurate flow rates can be 
predicted and that the pipeline is adequately protected against physical damage. 
(Weingarten and Euchner, 1986) stated that the disintergration of large wax 
agglomerates appears to be the primary cause due to lower viscosity. Paraffins tend to 
precipitate when the temperature of the crude falls below the cloud point or the wax 
appearance temperature. As the crude flows up the well bore, its pressure drops 
causing solution gas to liberate. This leads to a fall in temperature, increase in 
viscosity and a change in oil composition.  
(Caranhan, 1989) mentioned that solids deposition in production tubing, the most 
common example of the paraffin problem observed in production, is primarily a result 
of decreasing temperature, which causes a certain portion of the high-molecular 
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weight fraction to precipitate. A line exposed to severely cold climatic condition 
remains an expensive aspect of gelling oil to the market place, especially when 
pipelines are on the ocean floor. 
(Al Fariss and Zahrani, 1990) mentioned that at an elevated temperature (e.g., 40°C.), 
wax dissolves in the crude oil to form a homogeneous fluid. When the temperature is 
decreased, wax crystals separate out with adsorbed resin, and the rheological 
behaviour of Saudi oils is changed from a Newtonian fluid into pesudoplastic and 
yield- pseudoplastic successively. This change in rheological behaviour, due to the 
thermal and shear histories and weight percentage of wax, strongly affects the design 
calculations of a pipeline handling such Saudi oils. 
(Farina, 1996) mentioned that the crude oils in many reservoirs throughout the world 
contain significant quantities of wax which can crystallize during production, 
transportation, and storage. This can cause severe difficulties in pipelining and 
storage. At sufficiently high temperatures, the waxy crude oils, although chemically 
very complex, are simple Newtonian fluids. As the temperature is reduced, the flow 
properties of this crude oil can radically change from the simple Newtonian flow to a 
very complex behaviour due to the crystallization of waxes.  
(Nenniger, 1997) mentioned that the rheology results were extremely sensitive to 
preheat temperature and static versus dynamic cooling. 
(Chandaa et al., 1998) mentioned that the rheological behaviour of a crude oil is 
highly influenced by its chemical composition, temperature circulation, as well as 
previous thermal history. High waxy crude oil exhibits a non-Newtonian character, 
often with a yield stress at and below their pour point temperature. At a sufficiently 
high temperature the crude oil, although chemically very complex, is a simple 
Newtonian liquid. If the waxy crude oil is allowed to cool, wax will crystallize, 
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agglomerate and entrap the oil into its structure. This phenomenon often happens if 
the ambient temperature of the place is below the pour point of the crude oil. Pre-
treatment of the crude oil is necessary for transportation of this waxy crude oil 
through the pipeline. Pre-treatment of the crude oil with flow improver is one method 
by which the rheological character of the gelled waxy crude is changed for easier 
transportation. The viscosity of waxy crude oil is highly complex due to the transition 
from Newtonian to non- Newtonian pseudoplastic with thixotropic character below 
the pour point. It is more realistic to use the apparent viscosity for testing, since the 
breakdown in apparent viscosity reflects the break- down effect on both yield stress 
and equilibrium viscosity. Yield value is also an important parameter, characterizing 
the cold flow behaviour of waxy crude oil. However, the rate of shear while cooling 
has only a minor influence on values obtained. Evaluation of flow via pour point test 
is inadequate for pipelining since it is performed at too small undefined shear effect, 
far below that applied under field conditions. However, it is utilized for screening 
flow improvers in waxy crude oil in particular. On pipeline transportation of waxy 
crude oil they are subjected to a cooling effect, which adversely affects their flow 
properties. They are additionally influenced by the shear effect that tends to 
ameliorate their flow behaviour. The final flow character is designated according to 
the net result of the two opposing parameters. Few studies are published in this 
respect. (Davenport and Somper, 1971) pointed out that yield stress and plastic 
viscosity resulting from viscometric measurements showed inconsistent trends with 
shear rate during cooling. Plots of viscosity versus cooling temperature have been 
published by (Sifferman and Withers and Mowll, 1979) who used the data directly in 
Newtonian design equations. (Wardhaugh and Boger, 1991) studied the viscosity 
temperature relationship at different shear rates and showed that the viscosity remains 
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constant above the wax crystallization point, and then increases substantially with 
reduction in the shear rate below this point. They found inverse results of shear stress 
with the reduction in shear rate. 
A report of (Champion Technology, 2001) mentioned that seasonal ground 
temperature variation will have an effect on the temperature of the fluids in the 
pipeline, given that there is between 12-15○C variation in sub surface ground 
temperature between winter and summer conditions. The majority of the cooling in 
the pipeline occurs between Central Processing Facility (C.P.F.) and pump station #2; 
there is a temperature drop of 35○C during the first two days of transit (236km). The 
temperature of the crude in the line relatively stable thereafter, the cooling rate 
reducing significantly to give a net temperature drop of 10○C during the remainder of 
the transit time. 
(Da Silva and Coutinho, 2003) stated that the waxy crude oils, which contain 
significant proportions of heavy paraffin compounds, are known to produce a gel-like 
structure when the crude oils are cooled below their pour point. Wax precipitation and 
deposition occurring due to oil cooling during production, transportation, and storage 
of crude oil, cause detrimental effects in several aspects of crude oil processing.  
(Hong and Zhang, 2003) mentioned that above the wax appearance temperature, waxy 
crude although chemically very complex is a simple Newtonian fluid. The 
temperature dependence in the Newtonian regime is adequately expressed by an 
exponential Arrhenius type equation. If waxy crude is allowed to cool to the 
temperatures below the wax appearance temperature, wax will precipitate, 
agglomerate and entrap the liquid oil into its structure, and the crude will become a 
two-phase dispersion with wax solid particles dispersed in the liquid hydrocarbons. 
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Precipitation of wax significantly increases crude viscosity and will gradually change 
the flow properties of the crude from Newtonian to non-Newtonian behaviour.  
(Hong and Tohidi, 2003) mentioned that the Petroleum fluids contain heavy paraffins 
that may form solid wax phases at low temperatures. Problems caused by wax 
precipitation, such as decreased production rates, increased power requirements, and 
failure of facilities, are a major concern in the production and transportation of 
hydrocarbon fluids. Techniques such as thermal treatment of pipelines, addition of 
chemical inhibitors, and/or pigging are commonly used to prevent wax accumulation. 
The costs associated with such measures could be reduced significantly if accurate 
means to predict the wax precipitation region were available 
(Ford et al., 1965) stated that the rate of shear whilst cooling has only a minor 
influence on the yield stress. The oil, which has been cooled under shear, has a much 
lower yield value than oil cooled statically. 
In studying the viscosity temperature relationship at different shear rates, (Wardhaugh 
and Boger, 1991) studied showed that the viscosity remains constant above the wax 
crystallization point, and then increases substantially with reduction in the shear rate 
below this point. They found inverse results of shear stress with the reduction in shear 
rate. Cooling under flow leads to different states, which are non-Newtonian fluids, 
with a very rapid increase in viscosity below the wax appearance temperature. The 
following statements can be made from the literature on waxy crude oils:  
Experimental work on the rheology of crude oils cooled at rest is principally devoted 
to the determination of yield stresses, for the selection of pumping restarting 
procedures for pipelines filled with the gelled oil.  The effect of the shear applied 
during cooling was systematically investigated. 
The rheological properties for crude oils cooled at a given test temperature depend on 
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shear rate, thermal history and time. For a fixed shear rate, after an increase of the 
shear stress during the cooling stage, with the temperature kept constant, the stress 
decreased and finally reached a constant value after several hours, depending on the 
cooling rate. For low shear rates (below 1 (s-1)) the crude oils gelled.  Time evolution 
after the shear is stopped, is another aspect of the rheology of waxy crude oils. 
(Remizov et al., 1995) stated that it was found that the character of the highly 
paraffinaceous oil flow curve depends on the mechanical history of a sample. A 
comparison of the flow curves obtained at increasing   and decreasing shear rate 
demonstrates clearly the hysteresis phenomenon. 
(E1-Gamal, 1998) mentioned that the low temperature non-Newtonian flow behaviour 
of paraffinic crude oil is strongly affected by shear strength, time of shear, cooling 
temperature, rate of cooling and composition of the crude oil matrix. In addition, the 
shear and thermal history play an essential role in identifying this flow behaviour. 
Difficulties encountered through cold handling of waxy crude oil are concentrated in 
the high pour point that impedes the start of flow at relatively low temperatures. 
In another work, (Hong and Tohidi, 2003) mentioned that Experimental studies 
conducted in this laboratory show that wax appearance temperature is commonly a 
strong function of cooling rate; faster cooling rates often leading to a lower measured 
wax appearance temperature. 
In another investigation, (Da Silva and Coutinho, 2003) mentioned that the presence 
of wax crystals imparts particular rheological behaviour to the oil, including yield 
stress, shear thinning behaviour and time dependency under steady shear flow, and the 
formation of strong thermo-reversible gels, a behaviour that is highly dependent on 
the shear and thermal histories of the sample. 
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(Altmanna et al., 2004) concluded that the properties of physical gels are highly 
dependent on their preparation procedure. Under quiescent conditions, a strong 
physical gel, whose elastic module is essentially independent of strain up to a critical 
strain when it breaks, is formed. Under the effect of high enough shear rates, a 
particulate gel which is capable of sustaining mechanical deformation at small enough 
strains or stresses, but which flows at larger deformations, is obtained. The current 
understanding of particulate gel formation is that during gelation, which proceeds 
through a nucleation and growth mechanism, the flow field imposed on the system 
restricts the size of the gelled domains. Thus, the higher the shear rate the smaller the 
particle size. These particles are held together by weak inter-particle connectivity 
forming a gel capable of holding its structure at very small deformations but which 
flows if subject to larger deformations, similar to colloidal suspensions. The 
underlying mechanism, however, of precisely how shear is capable of limiting or 
controlling the particle size within particulate gel systems is not well understood, nor 
how and why complex-shape particles, particles with one or many tails, are formed 
under simple shear. With one or many tails, are formed under simple shear. In order to 
gain insight into the formation of particulate gels using shear, we should first 
recognise that altering the properties of materials using shear is not unique to 
biopolymer solutions undergoing chain association. Shear is known to cause 
alterations in the structural arrangement and solution morphology of a number of 
other systems including biopolymer solutions, emulsions, particulate suspensions, 
associative polymers, polymer–surfactant mixtures, and simple linear non associative 
polymer solutions. Various mechanistic models have been proposed by researchers 
investigating such materials to explain the observed shear induced structural changes. 
For example, one mechanism through which shear is capable of bringing about drastic 
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changes in the structural and rheological properties of polymeric solutions is shear 
induced mixing, an event which is usually associated with increasing temperatures 
under quiescent conditions. Theory suggests that when the shear rate exceeds the rate 
of relaxation of the concentration fluctuations, a material that would phase separate at 
rest may become homogeneous. However, the opposite effect, that is, shear induced 
phase separation is also often observed, which is an event usually associated with 
decreasing temperatures under quiescent conditions. In semi-dilute polymer solutions 
phase separation events have been explained in terms of the intrinsic existence of 
lower and higher concentrations of entanglements even in quiescent conditions. When 
shear flow is imposed on the material, stress is higher at the entangled regions due to 
the coupling between concentration fluctuations and stress. If the relaxation time for 
entanglement is higher than the inverse of the shear rate, then the higher stress levels 
cause solvent squeezing, which enhances concentration differences and induces phase 
separation. This duality in behaviour (i.e. shear induced mixing versus separation) for 
even simple, linear polymer solutions has historically complicated the possibility of 
predicting the effect of shear on complex formulations and has intrigued the scientific 
community in the recent years. However, perhaps the lack of predictability of the 
effect of shear in complex formulations has its roots in the figurative interpretations 
often used to explain the observed solution behaviour. The use of such explanations 
make the correlation between events that happen in one system with events that 
happen in another quite difficult. In this paper it is report that the rheological 
properties of biopolymer gels produced under oscillatory shear during and post-
gelation, probing in particular the effects of applied frequency and strain. From this 
insight it is proposed a single mechanism for the formation of shear gels that can 
begin to elucidate the effect of shear on many other complex formulations.  
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(Davidsona et al., 2004) mentioned that a waxy crude oil contains paraffins, which 
can cause it to form a gel, consisting of wax crystals in a viscous matrix, when the oil 
is cooled. This circumstance can occur when the pipeline carrying the crude oil is 
being shutdown for operational or emergency reasons in locations with low ambient 
temperature. The gelled oil exhibits a complex time-dependent rheology with a yield 
stress and viscosity, which depend on the time of shearing. 
In another investigation (Ford et al., 1965) mentioned that the most important 
question in the design of pipelines for handling waxy crude is whether the line is 
restarted easily after shutdown during which the waxy crude may have cooled 
sufficiently to gel to determine the yield value. Next in importance is the 
determination of the correct pressure drop profile along the line for various flow rate 
of oil. 
Further, (Dafan and Zeming, 1987) mentioned that for a pipeline operating under 
condition of temperature, the oil temperature is lower than the wax appearance 
temperature of crude in quite along segment between two stations of the pipeline, this 
results in wax deposition on the pipe wall, which in turn raises the pressure drop of 
pipelining, in order to resolve this problem, asset of pipeline pigging technology was 
developed, including designing and manufacturing of various kinds of pigs, as well as 
determination of the economical period of pigging for various states of operation. 
Continuing his investigation, (E1-Gamal, 1998) mentioned that difficulties 
encountered through cold handling of waxy crude oil are concentrated in the high 
pour point that impede the start of flow at relatively low temperatures, the high yield 
stress and high viscosity on restart ability after prolonged shut-down and progressive 
wax deposition at the pipeline downstream. Waxy crude oils place specific constraints 
on pipeline design because the oil temperature usually drops along the pipeline, 
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causing increasing quantities of wax crystals to be formed in the crude oil phase. This 
results in the formation of a gel structure with much higher viscosity levels. Under 
these circumstances, viscosity is strongly dependent in the shear effect and its 
duration. Consequently, greater pumping power expressed in shear effect is required 
for easy pipeline transportation. 
(Henaut et al., 1999) mentioned that in case of prolonged shutdown and an 
inopportune cooling, the crystallization of waxy components of a crude oil takes place 
and clogs up the pipeline. The restarting pressure required to start up flow is difficult 
to evaluate. The flow properties were found to deeply depend on the thermal 
treatment and on the shear history of the crude.  
In studying the applied pressure, (Davidsona et al., 2004) mentioned that to the restart 
flow in the pipeline, the gelled oil is displaced by another fluid under pressure. The 
pressure, which must be applied exceeds the usual operating pressure and must be 
sufficiently large to overcome the strength of the gelled oil plug. As flow begins, 
shearing causes a progressive breakdown in the gel structure leading to further 
increases in the flow rate. However, the formation of a solid-like gel after shutdown 
presents the serious risk that restarting the pipeline may not be possible if the static 
yield stress of the gel is too great for the available applied pressure. 
(Petronas Research and Scientific services, 2004) reported that the Greater Nile 
Petroleum Operation Company (GNPOC) 28- in pipeline, located in Sudan, is 
approximately 1500km in length and transports a high viscosity crude oil. The initial 
500-km of the pipeline undergoes dynamic cooling, whereas the last 1000-km 
undergoes static cooling to reach the ambient soil temperature. During winter 
operation, shutdown of the pipeline for extended time period poses considerable risk 
for gelling of the fluid in the line. During pipeline restart, the gel strength may be 
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sufficient to exceed the maximum allowable operation pressure of the line. The lowest 
winter soil temperature that is seen is 24°C at 1m depths along the pipeline. 
In studding the effect of temperature  (Ford et al., 1965) mentioned that methods 
which have been used for handling waxy crude oil in locations, where the minimum 
ground temperature is an appreciably below the pour point of the crude include, 
mixing with water to give an emulsion, dilution with other hydrocarbons, Pre-heating 
the crude with subsequent heating of the line, pre-heating the crude and then pumping 
the hot crude through a buried pipeline, subjecting the crude initially to a special 
heating/cooling treatment cycle designed to change the wax crystal structure in a 
waxy, which reduces both the pour point and the pumping viscosity and injection of a 
divinities to modify the wax structure of the crude oil. 
(Chong, 1985) mentioned that to reduce energy consumption in pipelining waxy 
crude, beginning from the 1960's a technique called heat treatment or thermal 
conditioning, which reduces the pour point and improves flow ability of a waxy 
crude, was studied and applied to some pipeline in China, the crude were generally 
heated to 85-90○C (the optimum heat treatment temperature), and then quickly cooled 
through heat exchangers to 65○C, the crude were then pumped into the buried 
pipelines and cooled naturally during flowing, this is called the simple heat treatment, 
for pipelines operating at a low throughput, this heat treatment could reduce the 
consumption of fuel oil and electricity per unit throughput to 1/3-1/2 of that before the 
treatment. 
(El Emam et al., 1993) mentioned that some crude oils are so waxy that their 
transportation by ordinary pipelines is difficult and sometimes impossible. Several 
techniques have been proposed for improving the flow properties of such waxy crude 
oils to make their transportation by pipelines easier. These techniques include, heating 
 18
the crude in the pipeline, diluting with light hydrocarbon distillates, blending with low 
wax content crude’s, using water either as an emulsifier or as a layer between the 
crude and the in side wall of pipeline, using chemical additives (pour point 
depressants, flow improvers, paraffin inhibitors, wax crystal modifiers), and using 
certain heating/ cooling cycles to modify wax crystal growth and thus lower the pour 
point.  
 
2.2 Mathematical Correlations 
Forced convection and natural convection are two basic mechanisms by which fluid 
motion can be made. Forced convection represents fluid flow that is caused by pumps. 
Natural convection refers to fluid motion that is caused by temperature induced 
density gradients within the fluid. In practice, many convection heat transfer systems 
involve both the forced and natural convections mechanisms, that is combined natural 
and forced convection, (Thomas, 1978).  
It is important to note that the velocity and temperature distributions are generally 
functions of axial location in internal flow areas. Such areas are said to be hydro-
dynamically and thermally developing. However, under certain conditions associated 
with internal flow systems with constant cross-section area, the form of the velocity 
and temperature distributions become independent of axial location. And flow areas 
are known as hydro-dynamically and thermally fully developed. (Figure. 2.1) shows 
representative distribution of axial velocity for pipe flow. The velocity distributions 
are seen to be developing in the entrance region and are fully developed distributions 
in temperature also occurring. 
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Figure.2.1 Typical axial velocity distribution for laminar flow 
The performance of convection heat transfer processes is a strong function of the 
properties of the fluid involved. The more important properties associated with both 
forced and natural convection heat transfer includes density, viscosity, specific heat 
and thermal conductivity. 
In regard to the properties of viscosity and thermal conductivity, many of the fluid in 
practice can be classified as being Newtonian and isotropic; such fluids satisfy the 
conduction and heat transfer laws, (Thomas, 1978). 
In flow of crude oil through the pipeline both natural and forced convection are 
involved. The rheological and physical properties are continuously changing along the 
line because the temperature profile is changing from 70 - 40°C. All these factors are 
incorporated in a set of dimensionless equations as will be illustrated below: 
2.2.1 Pressure drop in pipeline 
The differential pressure required to pump a fluid through a pipeline is the sum of 
frictional pressure drop, which is a function of Reynolds Number, and hence of 
viscosity, density, and pipe diameter. Viscosity is a function of temperature, it is very 
important to know the exact viscosity values at different temperatures, along the 
pipeline, it worth mentioning here that waxy crude behaves like non-Newtonian fluid 
and the effect of temperature on viscosity is more pronounced for waxy crude oil. To 
calculate pressure at any arbitrary station equation (3.4) can be used. 
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Pipeline frictional loss is the difference between the upstream discharge pressure and 
downstream suction pressure at the next pumping station. The amount of frictional 
loss (energy lost) between stations depends on the distance between the upstream and 
downstream stations, the flow rate, pipe size, and fluid characteristics of the pipeline. 
As crude oil flows in a pipeline, energy is lost because of the friction between the 
crude oil and the wall of the pipeline. This lost energy is referred to as pipeline 
frictional loss (Skelland, 1996). 
For different flow behaviours and regimes, mathematical models are needed to 
describe variation of friction factor with temperature, i.e. with distance from the 
pipeline inlet. All the equations that are used to calculate the friction factor have been 
based on the relationship f = f (NRe), where NRe is the Reynolds number. The 
relationship that used to calculate Friction factor are (equation 3.13) for laminar flow 
regime. For turbulent flow regime (Colebrook equation) (equation 3.14) and (equation 
3.5) (Swamee equation). This equation is based upon the range of values for Reynolds 
number and surface roughness, which are shown below: 
8
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3
6
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(The errors % is not greater than 2). 
Reynolds number defined as the ratio of the inertia force to the viscous force of a 
flowing fluid. The Reynolds number actually represents the ratio between the inertial 
and viscous forces, which act upon the fluid. The Reynolds number provides useful 
information pertaining to the nature of the flow, with the fact, the flow is generally 
laminar if Reynolds number is less than about 2,000, and the flow is turbulent if 
Reynolds number greater than 10,000 and transitional for Reynolds number between 
2,000 and 10,000:  
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2.2.2 Temperature distribution along the pipeline 
Deposition during oil production and processing is a very serious problem in many 
areas throughout the world. Paraffin wax may cause deposition due to lowering of the 
crude oil temperature. Seasonal temperature variation has an impact on the sub-
surface ground temperature throughout the year. The pipeline is buried to a depth of 
around 1metre throughout its length; as such, it will enjoy some insulation, which will 
reduce the effect of seasonal temperature effects. The minimum ground temperature at 
a depth of 1 meter is between approximately 27○C to 29○C, depending on ground 
elevation, among other factors. Clearly the low ground temperature has implications 
for the rate of cooling in the pipeline and potential temperature of pipeline fluids 
should a shutdown occurs. (Craig, 2000). 
During its operation, different points along Sudan pipeline have different 
temperatures; this temperature variation is due to the rate of heat transfer from the hot 
crude to the surroundings, leading to a continuous temperature declination. This 
temperature distribution, on the other hand, is affected by the heat generation resulting 
from the friction resistance. The temperature at any length along the pipeline can be 
calculated from equations (3.8). 
2.2.3 Heat loss from pipes 
Heat lost from piped fluids is energy wasted. Even a fluid temperature drop of 1 ○C or 
less from the pipe inlet to its outlet is a sign of heat loss. In general, heat loss is 
determined by the properties of the fluid inside and outside of the pipe, and energy 
saving is provided by insulation. However, when the temperature drop within the pipe 
turbulent000,10
transition000,102000
laminar000,2
Re
Re
Re
≡>
≡≤≤
≡<
N
N
N
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(between its up stream and down stream ends) is small, and when the pipe is of metal 
or another material of high heat conductivity, the heat loss can be assumed to depend 
very strongly on the external conditions, and the engineer needs to focus only on the 
external flow. In this situation, the temperature of the pipe outer wall is assumed to be 
the same as the bulk temperature of the fluid within the pipe. The heat loss from pipes 
is often calculated as the Hilpert correlation: (Konak, 1993). 
Equations (3.9, 3.10) are used to calculate, heat losses in pipes where the internal fluid 
temperature does not change appreciably from the inlet to the outlet. In these pipes, 
the heat loss is determined only by the velocity and properties of the fluid surrounding 
the pipe. When the internal fluid temperature changes significantly, its properties 
must be included in the heat loss calculations. This is because a film of internal fluid 
at the inner pipe wall resists heat transfer just as a film of external fluid resists heat 
transfer at the outer wall. The heat transfer coefficients of these films are combined to 
give an overall heat transfer coefficient. This value and the temperature difference 
between internal and external fluids are plugged into an energy balance equation to 
determine the fluid temperature at any distance from the inlet.  
The friction loss through the pipeline is calculated based on viscosity and yield stress 
at a specific temperature, further, in pipeline there is a difference between the inlet oil 
temperature and the sub-soil temperature, the temperature of crude oil falls gradually 
while moving along the pipeline and reaches a temperature, very close to the sub-soil 
temperature. 
Hence in the pipeline the temperature varies from one point to the other both in the Y 
and X directions. 
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Figure.2.2 Variation of temperature in Y and X axes 
 For a buried pipeline, the overall heat-transfer coefficient depends on the type of soil, 
its moisture content and the depth at which the pipeline is buried. (Konak, 1993). 
The temperature of soil is resulting from the insulation and heat flowing from the 
interior of the earth towards the surface. Insulation has a daily and a yearly period. 
There are several methods to determine the thermal conductivity of the undisturbed 
soil. Transient needle probe method after Makowski and Mochlinski (1956) can be 
successfully used to do so (Szilas, 1986). The transient needle probe is a device 
inserted into a 20-30mm hole in the soil and heated electrically. In order to determine 
the thermal conductivity accurately, the humidity of the soil, the bulk density of the 
dry substance, the clay to sand ratio, and the specific heat of the sand sample have to 
be determined before the measurement. 
For a pipeline engineering practice, the measured soil conductivity is used to calculate 
the thermal resistance of the soil surrounding a buried pipeline; approximately the 
thermal resistance can be calculated as follows in equations (3.15), the thermal 
conductivity of the insulator depends on its material and pore volume, which is filled 
by air, and pore distribution. The thermal conductivity coefficient of air at room 
temperature is less than 0.023 W/ (mk) (Szilas, 1986). Pipe wall heat transfer 
coefficient calculated as follows in equations (3.18). 
The internal convective thermal resistance of transported oil can be described by its 
internal convective factor ∝Oil (Skelland, 1996) equations (3.16 and 3.17). If Reynolds 
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Number is less than 2000, there is laminar flow inside the pipe, the Nusselt Number is 
a constant (3.66) (Konak, 1993). 
In order to, accurately, evaluate the overall friction pressure of the pipeline the total 
length of the pipeline was divided into 5-kilometers segments. The temperature, and 
hence, density, viscosity, friction factor and heat transfer are assumed to be constants 
within every segment. Then equations describing the variation of density and friction 
factor with temperature were introduced to calculate the friction pressure difference 
within every 5-kilometers length along the pipeline. The temperature at any length is 
the value that calculated by applying equations above.   
2.2.4 Gelled crude 
Nile blend is solidified and making a very high resistance force, below its gel point.  
Pressure force = ∆ P (π/4) D2   ----------------- (2.1) 
 
The resistance shear force = π D L Ty----------------- (2.2) 
 
The minimum force required to yield the gelled crude should be greater than the 
resistance force, ∆ P (π/4) D2   > π D L Ty. Thus, considering the variation of the 
yield stress with temperature in the axial direction, the start-up pressure required to 
overcome the resistance force of any kilometre length is related to the yield stress of 
the crude contained in that length by the 
∆P = 4 L Ty / D----------------- (2.3) 
 
For the line inlet at time t after shutdown. The value of yield stress is calculated from the 
equation describe the variation of yield stress with temperature which obtained from the 
experimental works,  Yield is defined by the following coefficients in the 6th order 
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polynomial. Ensure that the correlation complies with the experimental data in the graph. 
The polynomial regression technique has higher coefficient of correlation (R, 99.7%) 
than the other types of regression. 
    y = -3E-07x6 + 9E-05x5 - 0.0112x4 + 0.7248x3 - 25.756x2 + 474.16x - 3495.2 
Ty [Pa] =Σ6ι=1 Ai Ti----------------- (2.4) 
 
In light of the literature reviewed on rheological and physical properties, such as 
dynamic viscosity, yield stress, and restart pressure, and pipeline design an 
investigation of Nile Blend behaviour will be studied and investigated. 
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CHAPTER THREE 
MATERIAL AND METHODS 
3.1 Experimental 
Some of the important properties of the Nile Blend are to be measured. These 
properties are density, dynamic viscosity, yield stress and restart pressure. 
The sample, equipment and methods used to measure these properties are described 
below: 
3.2 Sample of crude oil 
A sample of one barrel (150 litters) of Nile Blend crude oil was obtained from Central 
Processing Facility (C.P.F) in Heglig, on 20th-May-2004. The sample was a blend 
from different fields with different ratios as shown in table (3.1) below:  
Table (3.1) Nile Blend composition ratio: 
Fields Heglig Unity El Toor El Nar Toma South Bamboo Munga  Diffra  
Ratio (vol %) 12.85 20.03 4.31 19.05 24.48 4.79 7.37 7.12 
 
The experiments were performed using these samples. 
3.3 Apparatus 
3.3.1 Viscometer 
Brookfield viscometer (model DV111 + Programmable (Rheocalk Software)) with a 
small sample adapter connected to a water bath using spindle 41 (plate cylinder 
spindle) was used to measure viscosity. A photograph of the apparatus is shown in 
Figure .3.1. 
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Figure.3.1 Brookfield viscometer 
3.3.2 Density 
The apparatus consists of a hydrometer, a thermometer, a hydrometer cylinder and a 
water bath a photograph of the rig is show in Figure. 3.2. 
 
 
 
 
 
 
Figure.3.2 Density apparatus 
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3.4 Test Methods 
3.4.1 Viscosity determination 
The dynamic viscosity was measured against decreasing temperature for three types 
of process modes:  
3.4.1.1 Rapid cooling method 
A sample of 100 ml was heated to 105°C for 30 minutes to start a new history of the 
sample. It was then cooled to 70°C over one hour. The temperature was maintained at 
70°C for 1 hour to ensure that the sample temperature was stabilized. The sample was 
then transferred to the viscometer cup, which was maintained at 70°C by the water 
bath. The bath was cooled at a rate of 1°Cmin-1 while applying a constant stirring 
equivalent to a shear rate of 10s-1. The temperature was kept constant at 25°C to 
measure the equilibrium viscosity. Figure. 3.3. shows the rapid cooling process 
against time (Appendix, A3). 
The same procedure outline in rapid cooling method was repeated with cooling rate of 
0.5°Cmin-1 for medium cooling, and 0.01°Cmin-1 for slow cooling. Figures. 3.4 and 
3.5 show the behaviour of each mode (Appendix A4 and A5). 
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Figure (3.3) Rapid cooling process
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Figure (3.4)Medium cooling process
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Figure (3.5) Slow cooling process
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3.4.1.2 Cycle cooling method 
A sample of 100 ml was heated to 105°C for 30 minutes to start a new history of the 
sample. It was then cooled to 70°C over one hour. The temperature was maintained at 
70°C for 1 hour to ensure the sample temperature was stabilized. The sample was then 
transferred to the viscometer cup, which was maintained at 70°C by the water bath. 
The bath was cooled at a rate of 0.1° Cmin-1 while applying a constant stirring 
equivalent to a shear rate of 10s-1. When the temperature reached 25°C, the sample 
was reheated to 70°C and cooled as described above. 
3.4.1.3 Variation of shear rates method (upward, downward) 
A sample of 100 ml was heated to 105 °C for 30 minutes to start a new history of the 
sample. It was then cooled to 70°C. A shear rate of 5s-1 was applied to the sample for 
3 minutes. The viscosity was then measured. The experiment was repeated at a 
temperature of 70°C and applying shear rates of (10, 20, 30, 50, 100, 200, 300, 500) s-
1 upward, for 3 minutes. The experiments were, then, repeated at 70°C, but decreasing 
the shear rates from (500, 300, 200, 100, 50, 30, 20, and 10s-1), downward. The same 
procedure was repeated at different temperatures of 65, 60, 55, 50, 45, 40, 35, and 
30°C.  
3.4.2 Density determination 
A sample of 1000ml was transferred to a hydrometer cylinder, which was then 
immersed in a water heating bath at 70°C.When the temperature of the sample 
reached 70°C, the hydrometer was dipped into the sample. The level of the oil on the 
hydrometer was recorded. The reading was then transferred to the corresponding 
density using Table 53A, correlating the relevant temperature versus density. The 
same procedure was repeated using different samples at temperatures of 65, 60, 55, 
50, 45, 40, 35, 30 and 25°C. 
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3.4.3 Yield stress test 
A sample of 100 ml was transferred to Brookfield viscometer cup, heated to 
70°C, a shear rate of 5s-1 was applied to the sample. The corresponding shear 
stress was tabulated from the screen. The same procedure was repeated for 
different temperatures of 65, 60, 55, 50, 45, 40, 35, and 30 °C under shear 
rates of (10, 20, 30, 50, 100, 200, 300) s-1.  
3.5 Mathematical model 
3.5 .1 Descriptions 
The pipeline is segmented to differential length over a distance from Central 
Processing Facility (C.P.F) to Bashayer Marine Export Terminal. 
3.5 .2 Assumptions 
1. Length of each segment is 5 km along the pipeline. 
The following are considered constant over each segment: 
2. Physical properties of crude oil. 
3. Temperature. 
4. Heat losses. 
5. Friction losses. 
6. Ambient air temperature. 
7. Thermal conductivity, depth, and roughness of the pipeline. 
8. The flow is at steady state. 
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3.5.3 Mathematical Correlations 
1. Dynamic viscosity versus temperature relationship was obtained through 
curve fitting of the experimental data, for Slow, Medium, and High cooling 
rate respectively, in the form of the following equation: 
                                                                                  
  µ =Σ ι=0  Ai Ti                  …………………………………………………………………………… (3.1)  
 
2. Density at various temperatures was correlated by linear regression from 
the experimental data and the following correlation was obtained  
 ρ = -0.07(T) + 860                 …………………………………………. (3.2) 
3. Velocity was calculated by the following equation: 
V = Q/A……………………………………………..…………………... (3.3) 
4. Pressure, temperature variation along the pipeline as well as important 
parameters and dimensionless groups relevant to the calculations are 
determined using the set of equations presented below: 
 Pi+1 =Pi - 0.5. ρi.fi.Vi2.Li/Dpipe- ρi.g. (Yi+1-Yi)……………………..….... (3.4) 
 fi  = [1.14-2Log10[ε/Dpipe+21.25/ NRe0.9]]-2……………………...……….(3.5) 
 NRe=Vi. Dpipe. ρi……………………………………………………...…..(3.6) 
    µi 
Vi =       Mi                        ………………………………………….…….(3.7)         
     ρi. π/4. D2pipe 
Ti+1=Ti – hi.π. Dpipe.Li   . (Ti-Tair)…………………………………..………(3.8) 
       (Mi.cpi)  
 
hi= [1/hinner+Σι=1 1/ (Dpipe/2.k.Ln(Di+1/Di)) +1/(houter. Douter/Dpipe)]-1.........(3.9)                 
 
6
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hinner = 0.023 NRe0.8Pr0.3 ………………………………………………...(3.10)  
Pri= (µi. cpi/K)........................................................................................(3.11) 
houter= 2.ksoil/ Douter.cosh-1 (2. Depth/ Douter)………………………….…(3.12) 
Re
64
N
f =     ……………………………………………….….….…......(3.13) 
⎥⎥⎦
⎤
⎢⎢⎣
⎡ +∈−=
fNdf i Re
51.2
7.3
ln86.01 ………………………...……………(3.14) 
⎟⎟⎠
⎞
⎜⎜⎝
⎛=
inssoil
soil d
hK 4ln
2
1
λ …………………………………..…..........(3.15) 
oil
oilK ∝=
1
……………………………………………..……..…………….......(3.16) 
∝Oil = (NNU) (λf) ………………………………………………………......(3.17) 
)ln(
2
1)ln(
2
1
do
d
di
doK ins
inspipe
pipe λλ += ………………………….…….......(3.18) 
Ty =Σ6ι=1 Ai Ti ..................................................................................(3.19) 
∆P = 4 L Ty / D..........................................................................................(3.20) 
 
 
3.5.4 Calculations 
A software program P- HYDROTHERM was developed to solve the above 
mathematical equations for crude oil velocity, pressure, temperature variation, crude 
oil viscosity, crude oil density, Reynolds number, friction loss, yield stress, and restart 
up pressure along the pipeline, (Appendix, A6). 
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3.5.5 Verification of the model 
3.5.5.1 Input data 
1. Pipeline specification, outside diameter, wall thickness, and surface 
roughness. 
2. Overall fluid properties (density, thermal conductivity, specific heat). 
3. Soil conditions (depth, thermal conductivity) 
4. Operating pressure. 
5. Operating temperature. 
6. Flow rates. 
3.5.5.2 Calculated data 
The program determes the flow regimes, friction losses, yield stress and restart 
pressure for every segment along the pipeline. The actual parameters of pressure, 
temperature, viscosity, and density are used to verify the model. Table (3.2) is used 
for such comparison: 
Table (3.2): Comparison between calculated and actual data: 
Parameters Calculated Value 
 
Experimental 
Value 
Deviation % 
Temperature (°C)    
Pressure (bar)    
Viscosity (mpa.s)    
Density (kg/m3)    
 
The software program of the mathematical model written in Visual Basic is 
shown in (Appendix, A7); the computer logic flow diagram is shown in 
Figure. 3.6. 
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Figure.3.6 the computer logic flow diagram 
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CHAPTER FOUR 
RESULTS AND DISCUSSION 
4.1 Results 
The following figures show various results of the experimental work; the 
tables thereof are shown in the (appendices A8, A9, A10, A11, A12, A13, 
A14, A15, A16, A17, and A18) for Nile Blend sample. 
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4.1.1 Type of cooling results 
 Figure (4.1) Viscosities of Nile Blend at different temperatures 
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Figure 4.1: Viscosities at different temperatures with and without stirring cooling, (dynamic & static). 
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4.1.2 Cooling rate results 
Figure (4.2) Viscosities of Nile Blend at different temperatures and  type of cooling
0
50
100
150
200
250
20304050607080
Temperature (°C)
V
i
s
c
o
s
i
t
y
 
(
m
p
a
.
s
)
High cooling
Meduim cooling
Slow cooling
 
Figure 4.2: Dynamic viscosities at different temperatures and type of cooling (High, Medium, and Slow). 
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Figure (4.3) Viscosities of Nile Blend at different temperatures and different shear 
rates
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Figure 4.3: Dynamic viscosities at different temperatures and different shear rates. 
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4.1.3 Thermal cycle cooling process results 
Figure (4.4) Viscosities of Nile Blend at different temperatures and thermal cycles
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Figure 4.4: Dynamic viscosities at different temperatures and thermal cycles. 
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4.1.4 Heating results 
Figure (4.5) Viscosities of Nile Blend at different temperatures and shear rates 
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Figure 4.5: Dynamic viscosities at different temperatures and different shear rates. 
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4.1.5 Different rates of cooling at different preheat temperatures results 
Figure (4.6) Viscosities of Nile Blend at different temperatures and different preheat 
temperatures
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Figure 4.6: Dynamic viscosities at different temperatures and different preheat temperatures. 
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4.1.6 Variation of shear rates method (upward, downward) results 
Figure (4.7) Viscosities of Nile Blend at different temperatures and different shear rates
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Figure 4.7: Dynamic viscosities at different temperatures and different shear rates. 
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Figure (4.8) Viscosities of Nile Blend at different temperatures and decreasing shear rates 
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Figure 4.8: Dynamic viscosities at different temperatures and decreasing shear rates. 
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Figure (4.9) Viscosities of Nile Blend at different temperatures and increasing shear 
rates 
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Figure 4.9: Dynamic viscosities at different temperatures and increasing shear rates. 
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Figure (4.10) Viscosities of Nile Blend at different shear rates ( Increasing & 
decreasing) and different temperatures  
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Figure 4.10: Dynamic viscosities at different shear rates (increasing & decreasing) and different temperatures. 
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4.1.7 Yield stress & restart pressure results 
Figure (4.11)  Yield stress at different temperatures and different shear rates (increasing & 
decreasing)
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Figure 4.11: Yield stress at different temperatures and different shear rates (increasing & decreasing). 
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Figure (4.12)  Restart pressure at different temperatures and different shear rates (increasing & 
decreasing)
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Figure 4.12: Restart pressure at different temperatures and different shear rates (increasing & decreasing). 
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Figure (4.13)  Yield stress & restart pressure at different temperatures and different shear rates 
(increasing & decreasing)
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Figure 4.13: Yield stress and restart pressure at different temperatures and different shear rates. 
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4.1.8 Density results 
 Figure (4.14) Densities of Nile Blend at different temperatures 
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Figure 4.14: Density at different temperatures 
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4.1.9 Comparison between calculated and actual results 
Table 4.1. Shows the comparison between calculated and actual data. 
Pump Station #1 (0Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 70.5 70 0.71 
Pressure (bar) 94.5 96.4 -2.01 
Viscosity (mpa.s) 8.8 - - 
Density (kg/m3) 0.813 - - 
 
Pump Station #2 (236.12Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 45 44 2.2 
Pressure (bar) 71.5 77.2 -7.97 
Viscosity (mpa.s) 19.2 - - 
Density (kg/m3) 0.831 - - 
 
Pump Station #3 (547.6Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 34.2 37.5 -9.7 
Pressure (bar) 87.6 90.6 -3.4 
Viscosity (mpa.s) 35.7 - - 
Density (kg/m3) 0.839 - - 
 
Pump Station #4 (817Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 31.7 36 -13.6 
Pressure (bar) 62.1 62.5 -0.64 
Viscosity (mpa.s) 47 - - 
Density (kg/m3) 0.841 - - 
 
Pump Station #5 (1085.7Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 30.8 39 -26.6 
Pressure (bar) 79.3 72.8 8.2 
Viscosity (mpa.s) 53 - - 
Density (kg/m3) 0.842 - - 
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Pump Station #6 (1313Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 31 37 -19.4 
Pressure (bar) 46.5 42.7 8.17 
Viscosity (mpa.s) 53.8 - - 
Density (kg/m3) 0.843 - - 
 
B.M.T. (1504Km) 
Parameters Calculated
Value 
Experimental
Value 
Deviation % 
Temperature (°C) 30.3 37 -22.11 
Pressure (bar) 52.3 51 2.49 
Viscosity (mpa.s) 56.79 51.03 10.14 
Density (kg/m3) 0.842 0.845 -0.36 
 
4.2 Discussion 
4.2.1 Viscosity 
4.2.1.1 Cooling process analysis (static and dynamic) 
The experiments were made statically (without shear) and were repeated for samples 
subjected to shear during their cooling with a rate of (10 s-1). It is observed that the 
sample subjected to shear have much lower viscosity than the statically cooled 
sample, as shown in (Figure4.1). This is due to the fact that the growth of the 
paraffinic particles is disturbed by the applied shear rate, and confirmed that shearing 
during cooling diminishes the shear modulus of gelled waxy crude oils. This result is 
in agreement with that stated by (Henaut et al., 1999) who noted that, cooling under 
shear has more significant effect on crude oil rheological properties at a temperature 
higher than the pour point and with no effect below it. Moreover, Pipeline operation 
training program it is reported that increasing the temperature of a liquid increases the 
spacing between molecules and this reduces the viscosity. Hence, a change in 
temperature, will affect the flow rate of a liquid moving through a pipeline, (Pipeline 
operation training program, 1998). 
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The results are in agreement with Remizov et al. who recommended that the cooling 
under flow leads to different states, for non-Newtonian fluids, with a very rapid 
increase in viscosity below the wax appearance temperature, (Remizov et al., 1995). 
Further (Figure4.1) demonstrates the relation between sample viscosity and 
temperature, when crude sample were subjected to different cooling process (dynamic 
and static). It is clearly observed that the process of cooling and shearing results in 
decreasing the viscosity at entering range of temperatures. The figure confirmed that 
shearing during cooling diminishes the shear modulus of gelled waxy crude oils, 
especially at temperatures below 55°C. Wax crystallisation and formation of the 
networks of wax crystals is known to be the main cause of the viscosity increase and 
eventual gelation in crude oils at low temperatures. This is in a greement with Al-
Fariss and Zahrani who reported that when the temperature is decreased, wax crystals 
separate out with adsorbed resin, and the rheological behaviour of crude oils is 
changed from a Newtonian fluid into pesudoplastic and yield- pseudoplastic 
successively, (Al-Fariss and Zahrani, 1990). This change in rheological behaviour, 
due to the thermal and shear histories and weight percentage of wax, strongly affects 
the design calculations of a pipeline handling. Precipitation of waxy crude oil on 
cooling below the pour point leads to the formation of a structure which, if allowed to 
develop in pipeline, leads to excessive break-through and pumping pressures. This 
was due to the gelling tendency and the high viscosity of the crude at the low 
temperatures encountered in the winter seasons.  
Experiments were carried out on statically cooled samples; they were repeated on 
samples sheared during their cooling with different rates. It is observed that sheared 
sample have much lower viscosity than the statically cooled one. This indicates that 
 56
the growth of the paraffinic particles is disturbed by the applied shear rate. It can be 
concluded that shearing induces the orientation of the particles.  
 In agreement with E1-Gamal stated   that the low temperature non-Newtonian flow 
behaviour of paraffinic crude is strongly affected by shear strength, time of shear, 
cooling temperature, rate of cooling and composition of the crude oil matrix, (E1-
Gamal, 1998). This also in agreement with Remizov et al, who mentioned that the 
rheological properties for oils cooled at a given test temperature depend on shear rate, 
thermal history and time. Remizov et al. also stated that at high temperatures, the 
crude oils containing linear paraffins behave like Newtonian liquids, the paraffins 
being in the molten state. Below the wax appearance temperature wax apparent 
temperature which corresponds to incipient crystallisation of the paraffins during 
cooling in static conditions, where oils turn into gels, (Remizov et al., 1995).  
4.2.1.2 Analysis of type of cooling 
(Figure 4.2) shows that the viscosity for Nile Blend crude oil sample, without any 
chemical treatment undergoing a cooling process at rates of 1, 0.5, and 0.01 °Cmin-1, 
respectively. The Figure indicates that, the type of cooling only has slight effect on 
the viscosity over the entering range of temperatures. Then the viscosity increased in 
clear manner between high, medium, and slow rate of cooling and there is minimal 
change in crude viscosity at (55 up to 70 °C), the reason for that is the Newtonian 
behaviour of crude at this range of temperature. The viscosity decreased when 
temperature exceeded wax apparent temperature (whose value depend on the 
composition of the crude), and the shear rate effect disappeared. The declining point 
on the curve starts when the temperature is less than wax apparent temperature, the 
viscosity increased and the crude oil start to behave as a Non- Newtonian fluid. The 
viscosity decreases with increasing shear rate until the agglomerate is completely 
 57
broken down into the basic particles, so the waxy crude system shows Non-
Newtonian pseudo-plastic characteristic. 
At temperature above 55°C, the shear rate has minimal effect on the viscosity. At 
temperature below 55°C, the viscosity of the crude at slow cooling increases sharply 
as the temperature decreases from 40°C to 30°C.The viscometer was not able to 
accurately measure the viscosity of the crude at temperature below 30°C due to the 
solidification of the crude sample. The viscosity of the crude at those low 
temperatures is (253.22mpa.s). High wax content and slow cooling rate tend to form 
small crystals that gel quickly which lead to solid gel at the pour point. 
It is shown from (Figure4.2) that the slow static cooling rates resulted in higher 
apparent viscosities, this is due to the agglomeration of wax particles at slow cooling 
rate (In case of slow cooling, the crystallization of the wax crude oil takes place and 
hinders the production of the crude oil, due to the gel-like network formed by the 
crystals entrapping the oil). 
Difference appears between the viscosities of the oils cooled; in (Figure 4.3) due to 
shear rate change, at low shear rate, the viscosity increase, significantly at temperature 
below 45°C. However at high shear rate, the temperatures have minimal effect on the 
viscosity of the crude. At high shear rate the temperature effect become not observed 
on viscosity; this might be due to the crude is in Newtonian region. The viscosity 
decreases with increasing shear rate until the agglomerate is completely broken down 
into the basic particles, so the waxy crude system shows Non-Newtonian pseudo-
plastic characteristic. Moreover, this term was used to describe the transit changes in 
the apparent viscosity after exposure to different shear rate. The transit could occur 
due to passage through a pump exposed to high shear, which breaks the gel down. 
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(Figure 4.3) also indicates that the shear rate has an appreciable effect in decreasing 
viscosity particularly at temperatures below the pour point and that the viscosity tends 
to stabilize at higher shear rates when approaching the equilibrium steady state. This 
result is in agreement with (Davenport and Somper, 1971) who mentioned that the 
viscosity temperature relationship at different shear rates showed that the viscosity 
remains constant above the wax crystallization point, and then increases substantially 
with reduction in the shear rate below this point. They found opposite results of shear 
stress with the reduction in shear rate. Moreover, (Hong and Tohidi, 2003) mentioned 
that the experimental studies show that wax apparent temperature (WAT) is 
commonly a strong function of cooling rate; faster cooling rates often leading to a 
lower measured WAT.  
This is in line with (Agrawal et al., 1990) who mentioned that the low temperature 
non-Newtonian flow behaviour of paraffinic crude is strongly affected by shear rate, 
time of shear, cooling temperature, rate of cooling and composition of the crude oil 
matrix. Moreover, (Remizov et al., 1995) studied the viscosity temperature 
relationship at different shear rates and showed that the viscosity remains constant 
above the wax crystallization point, and then increases substantially with reduction in 
the shear rate below this point. They found inverse results of shear stress with the 
reduction in shear rate. 
(Sherman, 1970) mentioned that the shear effect act for improving the cold flow 
properties of waxy crude, the shear rate acts through the breakdown of the secondary 
inter particle bonds formed among flocculated wax crystals during cooling. However, 
(Chandrasekharan and Sikdar, 1970) mentioned that the wax in the raw crude oil has a 
tendency to form an interlacing structure on separation when the oil is cooled, 
resulting in a gel structure entrapping the oil. On conditioning, the structure of wax 
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crystals changes and they remain in suspension in the oil without forming 
agglomeration with considerable reduction in viscosity even at low temperatures 
much below the pour point of the crude oil. 
4.2.1.3 Thermal cycle cooling process 
(Figure 4.4), illustrates in detail the distribution of the viscosity and temperature 
experienced within the thermal cycles process. It should be emphasized that the 
hysteresis phenomenon may often be observed in the rheological investigation of 
thixotropic systems, which leads to differences in the viscosity values. The process of 
heating and shearing results in volatile components loss, and this increases the 
viscosity. This result is in agreement with (Ford et al., 1965) who reported that the 
heating/cooling treatment cycle changes the wax crystal structure in a waxy crude oil. 
The dramatic increase of dynamic viscosity may be explained by quenching of new 
wax structures formed in the pre-heated samples. By cooling a crude oil below its 
pour point, some newly- acquired properties of the paraffin/ wax sub phase may be 
temporarily conserved in this temperature range. (E1-Gamal, 1998) mentioned that 
the viscosity of waxy crude is highly complex due to the transition from Newtonian to 
non- Newtonian pseudoplastic with thixotropic character below the pour point. In 
conditions of a decreased thermal movement wax aggregates, mediated by paraffin’s, 
may form extended networks, which increases the viscosity. At low ambient 
temperatures such “sub cooled” state of the crude oil is certainly unstable but rather 
long lived, the order structures are only partially broken in shear flow. However, this 
non-equilibrium oil phase is easily destroyed by re-heating the sample to temperatures 
above the wax apparent temperature. These characterizations helped assessing 
whether or not crude thermal treatment (heat to 70-60 °C) are sufficient options for 
reducing viscosity to recommended specification allowing pipeline transportation.  
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In conformation to the above analysis of the results (Ford et al., 1965) mentioned that 
the pre-heating the crude with subsequent heating of the line, subjected the crude 
initially to a special heating/cooling treatment cycle. This changes the wax crystal 
structure in a waxy crude and reduces both the pour point and the pumping viscosity. 
An injection of additive to modify the wax structure of the crude oil is essential. 
However, (Agrawal et al., 1990) stated that the waxy crude oils add specific 
constraints on pipeline design, because the oil temperature usually drops along the 
pipeline, causing increasing quantities of wax crystals to be formed in the crude oil 
phase. This results in the formation of a gel structure with much higher viscosity 
levels. This result is in agreement with (Hongy and Tohidi, 2003) who reported that 
precipitation of wax significantly increases crude viscosity and will gradually change 
the flow properties of the crude from Newtonian to non-Newtonian behavior. The 
crude begins to show non-Newtonian flow behavior at temperatures called the 
abnormal point, which is generally a few degree Celsius below the wax apparent 
temperature. On further cooling, more and more wax crystals precipitate out and 
interlock to form a wax crystal lattice. This results in gelation of the crude and loss of 
flow ability. 
(Chandaa et al., 1998) reported that if the waxy crude oil is allowed to cool, wax will 
crystallize, agglomerate and entrap the oil into its structure. This phenomenon often 
happens if the ambient temperature is below the pour point of the crude oil. Pre-
treatment of the crude oil is necessary for transportation of these waxy crudes through 
the pipeline. However, (El Emam et al., 1993) stated that some crude oils are so waxy 
that their transportation by ordinary pipelines is difficult and sometimes impossible. 
Several techniques have been proposed for improving the flow properties of such 
waxy crude oils to make their transportation by pipelines easier. These techniques 
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include, heating the crude in the pipeline and using certain heating/ cooling cycles to 
modify wax crystal growth and thus lower the pour point. 
4.2.1.4 Heating process 
It is clear from (Figure 4.5) that, the blend viscosity behaves in Newtonian manner 
until wax crystals begin to from, which temperature decrease. The rapid rise in 
viscosity near the pour point of the crude was a commonly observed phenomenon for 
high paraffin content systems. The crude behaves as non- Newtonian fluids at 
temperature below their pour point, Newtonian characteristics begin to appear at just 
above the pour point of the crude because, higher temperature destroys the nucleus in 
the oil and allow the wax to precipitate as a discrete particle size rather than 
homogeneous gel. Wax crystals dissolve at high temperatures. For many waxy crude 
oils, Newtonian behaviour is almost certain at temperatures greater than pour point. 
Most petroleum waxes melt and are in solution at temperatures greater than pour 
point. Temperature is the major factor affecting wax precipitation. This result is in 
agreement with that reported in (Pipeline operation training program, 1998) which 
recommends that heat can be imparted to the liquid from both the ground and the 
main line pumps. Friction which accompanies an increase in the flow rate also 
generates heat which raises the liquid temperature. 
Figure 4.5 also shows that viscosity below the wax apparent temperature deviates 
from the extrapolated line due to wax crystallization. Considering the fact that wax 
has a pronounced effect on the flow behaviour of waxy crude oil. above the wax 
apparent temperature wax has little effect on oil viscosity, as shown in the (Figure 
4.5), the pronounced increase in viscosity with decreasing temperature for most crude 
oil are closely related to the amount of precipitated wax. (Ji et al., 2004) found that 
the hydrocarbon fluids contain heavy paraffins that may form solid phases of wax at 
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low temperatures. Problems associated with wax formation and depositions are a 
major concern in production and transportation of hydrocarbon fluids. The industry 
has directed considerable efforts towards generating reliable experimental data and 
developing models for estimating the wax phase boundary. 
(Figure 4.5) shows that a higher proportion of the wax accumulates on the pipeline 
wall at slow shear rates. This result is consistent with the observation that higher shear 
rates lead to less deposit accumulation due to deposit formation. Figure 4.5 shows that 
a faster deposit growth rate at slow shear rate and temperature below 45 °C (below 
wax apparent temperature) is dominant. One would also expect harder deposits at 
slow shear rate. 
(Dafan and Zeming, 1987) mentioned that for a pipeline operating under condition of 
temperature, the oil temperature is lower than the wax apparent temperature of crude 
in quite along segment between two stations of the pipeline. These result in wax 
deposition on the pipe wall. (Ji et al., 2004) mentioned that to reduce energy 
consumption in pipelining waxy crude, a technique called heat treatment or thermal 
conditioning, which reduces the pour point and improves flow ability of a waxy 
crude, was studied and applied to some pipeline in China. The crude were generally 
heated and then quickly cooled through heat exchangers, the crude were then pumped 
into the buried pipelines and cooled naturally during flowing, this is called the simple 
heat treatment. 
4.2.1.5 Different rate of cooling for different preheat temperatures 
(Figure 4.6) shows that in samples, pre-heated at “moderately warm conditions” 
viscosity remains fairly constant. Whereas in samples, pre-heated to temperatures, 
exceeding the wax apparent temperature viscosity decreased. The variations of 
viscosity are indicative of the formation /destruction of wax. 
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Crude oil temperatures have been measured during a certain period and depicted as 
shows in (Figure 4.6) these characterizations helped in assessing whether or not crude 
thermal history of (70, 65, 60, 55, 50, 45, 40, 35 °C) is sufficient for reducing 
viscosity to the recommended specification allowing pipeline transportation 
From the same figure it is clear that in the samples, pre-heated to temperatures 
exceeding the wax apparent temperature, viscosity decreased. The observed variations 
of viscosity are indicative of the formation /destruction of wax. The final heating 
temperatures have noticeable effect on viscosity of the blend. (Figure 4.6) shows that 
the character of highly paraffinaceous oil flow curve depends on the thermal history 
of the sample. 
When final heating temperatures was higher than the wax precipitation temperature of 
the oil (55°C), more molecular wax was dissolved and the crude is in Newtonian 
region. It is clear that most of the wax was dissolved in the high range of 
temperatures. However when the final heating temperatures were lower than the wax 
precipitation temperature of the oil (50°C), more molecular wax was precipitated 
from the oil and formed into particles. It is clear that most of the wax was deposited. 
(Mingyuan et al., 1997) mentioned that when oil was heated to 70°C and then cooled 
to the final cooling temperature of 47, 45 or 42°C while the oil flowed in the glass and 
steel tubes, respectively, the wax fraction in oil deposited on the wall of the glass and 
steel tubes was increased from 8.0 to 24.5% and from 6.2 to 16.1%. Because the final 
cooling temperatures was lower than the wax precipitation temperature of the oil 
(50°C), more molecular wax was precipitated from the oil and formed into particles. It 
is clear that most of the wax was deposited on the wall of the tube by shear dispersion, 
i.e. the wax particles were transported laterally by shearing. It is obvious that the 
mechanisms of wax deposition on the wall of the tubes in this investigation are 
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molecular diffusion, when the temperature was higher. The shear dispersion occurred 
when the temperature was below the wax precipitation temperature of the oil. 
Moreover, (Henaut et al., 1999) mentioned that the flow properties of wax crude oils 
were found to depend on the thermal treatment and on the shear history of the sample.  
(Nenniger, 1997) mentioned that the rheology results were extremely sensitive to 
preheat temperature and static versus dynamic cooling. 
4.2.1.6 Variation of Shear rates method (upward, downward) 
A study of the dependence of the apparent viscosity on shear rate was made on the 
crude. It was measured for different temperatures over an increasing followed by a 
decreasing shear stress. The flow curves are presented in (Figure 4.7). When the 
temperature is higher than 40°C, the waxy crude oil is Newtonian and no shear history 
effect is noticed (the shear rate effect disappeared). 
(Figure 4.7) illustrate the viscosity profile of the crude at shear rate of (5, 10, 20, 30, 
50, 100, 200, 300, 500 (1 s-1) respectively. At low shear rate, the viscosity increases, 
significantly at temperature below 40°C. However at high shear rate, the temperatures 
have minimal effect on the viscosity of the crude. At high shear rate the temperature 
effect on viscosity becomes not observed; this might be due to the fact that crude is 
being in Newtonian region. The viscosity decreased when temperature exceeded wax 
apparent temperature. The turning declining point on the curve starts when the 
temperature is less than wax apparent temperature, the viscosity increased and crude 
oil start to imitate non- Newtonian behaviour. Based on previous tests, at below 40 
°C, the viscosity of the blended crude increases drastically, and varies with shear 
rates. This could suggest that the crude is non-Newtonian.  
(Henaut et al., 1999) mentioned that on the contrary, when temperature is lower than 
36°C, the crude exhibits a pseudo-plastic behavior. A hysteresis is also observed. The 
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apparent viscosity is smaller on the way back to the starting value. The hysteresis is 
more pronounced at low temperature, which means that the paraffinic particles are 
responsible for this phenomenon. When paraffinic particles precipitate, the crude oil 
changes from a low viscous Newtonian fluid to a high viscous shear thinning and 
thixotropic product.  
(Figure 4.8,9, &10) illustrate that the rate of shear whilst cooling, has only a minor 
influence on the viscosity values obtained at a range of temperature above the pour 
point. When the temperature is decreased, wax crystals separate out with adsorbed 
resin, and the rheological behaviour of crude is changed from a Newtonian fluid to 
Non- Newtonian. This change in rheological behaviour, which is due to the 
temperature strongly affect by shear rate. The shear has clear effect at range of 
temperature below the pour point (Figure 4.10).  
4.2.2 Yield stress 
The yield stress showed a non linear curve with temperature, it increases very quickly 
when temperature is at a lower range, that is to say when more solid particles are 
present. When the maximum amount of crystals is obtained, the yield stress does not 
rise any more even if the temperature decreases. The effect of shear rate (increasing 
and decreasing) observed in yield stress at temperatures at and below the pour point 
(Figure 4.11). The experiments showed the complex rheology of waxy crude oil with 
the appearance of a yield stress, the flow properties were found to depend on the 
thermal treatment and on the shear history of the sample, especially at temperatures 
below the pour point. 
It was noticed that slow cooling rate lead to higher yield stress. This phenomenon 
comes from the different morphology developed by the crude during its more or less 
slow cooling. When slow cooled, the wax crystals are much smaller and more 
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numerous than when rapidly cooled. The particular morphology of small and 
numerous crystals favours their intermingling and their surface contact which explains 
the upper yields stress. As a conclusion, the yield stress of waxy crude oil depends on 
the amount of precipitated particles and on the size of the crystals.  
(E1-Gamal, 1998) reported that the high yield stress and high viscosity affect the 
restart ability after prolonged shutdown and progressive wax deposition at the 
pipeline downstream. Waxy crude oils place specific constraints on pipeline design 
because the oil temperature usually drops along the pipeline, causing increasing 
quantities of wax crystals to be formed in the crude oil phase. This results in the 
formation of a gel structure with much higher viscosity levels. Under these 
circumstances, viscosity is strongly dependent on the shear effect and its duration. 
Consequently, greater pumping power expressed in shear effect is required for easy 
pipeline transportation. 
(Henaut et al., 1999) concluded that the yield stress of a waxy crude oil depends on 
the amount of precipitated particles and the size of the crystals that is the applied 
thermal treatment. 
(Ford et al., 1965) mentioned that the oil which has been cooled under shear has a 
much lower yield value than oil which has been cooled statically. 
(Silva & Coutinho, 2003) mentioned that the presence of wax crystals imparts 
particular rheological behaviour to the oil, including yield stress, shear thinning 
behaviour and time dependency under steady shear flow, and the formation of strong 
thermo-reversible gels, a behaviour that is highly dependent on the shear and thermal 
histories of the sample.  
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4.2.3 Restart pressure 
The restart pressure obtained from the restart procedure was converted to yield 
pressure using the force balance. (Figure 4.12) shows the experimental restart 
pressure of the dynamic cooling tests for various temperatures. A graphical 
illustration of the experimental restart pressure of the dynamic cooling test is shown 
in (Figure 4.12), the maximum allowable yield pressure of each section of the pipeline 
when the gel strength in the pipeline exceeds the maximum allowable yield pressure, 
the pipeline will not be able to be restarted instantaneously .If the crude temperature 
drops below 33°C (this is the gelling temperature) the pipeline encounters some 
difficulties in restarting.  
(Petronas Research and Scientific services, 2004) reported that during winter 
operation, shutdown of the pipeline for extended time periods poses considerable risk 
for gelling of the fluid in the line. The lowest winter temperature that is normally seen 
is 20 °C. Therefore, during pipeline restart, the gel strength may exceed the maximum 
allowable operating pressure of the pipeline and causes difficulty in start up. 
(Ford et al., 1965) mentioned that the procedure to determine the start up pressure 
required is best illustrated by the equilibrium temperature distribution for the line, as 
well as flow rate, inlet temperature and the ground at its coldest condition and time of 
shut-down. 
(Henaut et al., 1999) reported that the restarting pressure required to start up flow is 
difficult to evaluate. The flow properties were found to depend on the thermal 
treatment and on the shear history of the crude.  
(Petronas Research and Scientific services, 2004) reported that the pipeline restart is 
only possible if the created pressure drop is high enough to push the gelled fluid. 
Temperature and elevation has effects on calculations of pipeline pressure drop. 
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(Henaut et al., 1999) mentioned that in case of a prolonged shutdown and an 
appropriate cooling, the crystallization of the waxy components of a crude oil takes 
place and clogs up the pipeline. The restarting pressure required to start-up flow is 
difficult to evaluate. In order to predict it precisely, the restart process and the 
corresponding mechanical behavior of the gelled oil must be assessed (mechanical 
and rheological properties). 
(Figure 4.13) shows that the experimental restart pressure and yield stress depend on 
the temperature in the same way, they shown a nonlinear curve with temperature; they 
increase rapidly when the temperature decrease to lower range, that is to say more 
solid particles are present. 
This result is in agreement with (Pipeline operation training program, 1998) which 
stated that a change in temperature means a change in viscosity; and that the operating 
parameters in the pipelines have to be adjusted when seasonal temperature changes 
occur. In addition, there will probably be lower flow rates and higher discharge 
pressures upstream, greater friction losses between stations and lower downstream 
suction pressures. Higher viscosity means more energy is required to keep the liquid 
moving, and the flow will slow down much more rapidly. 
4.2.4 Density 
It is clear from (Figure 4.14) that the blend density increases when the temperature 
decreases, the density at 70°C is about 0.815(kg/m3) and is about 0.8602 (kg/m3) at 25°C. 
The linear regression technique has higher coefficient of correlation (R, 97.77%) than the 
other types of regression. 
ρ = -0.07(T) + 860 
Density [kg/m3] = -0.07(Temperature) [°C]  + 860 ----------------- (2.34) 
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4.2.5 Comparison between calculated and actual results 
As shown in (Table4.1), the results predicted by the model through the program were 
compared with the actual data and showed good agreement. The deviation between 
actual and program results for temperatures at Ps#1, Ps#2, Ps#3, Ps#4, Ps#5, Ps#6 and 
B.M.T. are (0.71, 2.22, -9.65, 13.56, -26.62, -19.35 & -22.11 % respectively) where 
for pressure are (-2.01, -7.97, -3.42, -0.64, 8.2, 8.17 & 2.49 % respectively) 
(Appendix A31 & A32). Comparison between actual and program results for density 
and viscosity was not done for all pump station due to unavailability of data. 
However, actual data for density and viscosity at B.M.T shows good agreement as 
shown by deviation values (10.14 & -0.36 respectively). 
 
4.3 Conclusion 
Rapid cooling rate increases the viscosity in a shorter time than the slow cooling. The 
result is attributed to the formation of brittle macro-crystal of wax, by the rapid 
cooling rate, whereas, slow cooling rate forms hard micro-crystals of wax which are 
not easy to remove from the internal surface of the pipeline at temperature below the 
wax apparent temperature.  
The software developed during this study incorporating the Nile Blend properties with 
pipeline specifications, proved to be quite useful for research and development (R and 
D), follow-up and investigation of various conditions that can not be experimentally 
determined, a case that has been verification against the actual data. 
The restart pressure can be predicted for any distance desired. 
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4.4 Recommendations 
1. To study the effect of heating at different intervals along the first 
200km of the pipeline instead of preheating to 105°C at C.P.F. 
2. The software can be developed using other program language, i.e., 
Pascal and C++. 
3. A complete control system must be developed to control any 
possible disturbance in temperature, pressure and properties along 
the pipeline. 
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APPENDICES 
 
 
 
 
 
Appendix A1: Pipeline profile  
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A2: Nile Blend crude assay 
 
Test Method Unit Results 
Density at 15 0C ASTM D4052 Kg/m3 855.0 
API Gravity IP table 51 Degree 33.91 
Bottom Sediment & Water ASTM D4007 Vol. % 0.05 
Water ASTM D4006 Vol. % 0.05 
Reid Vapour Pressure ASTM D 5191 kPa <7 
Total Acid Number ASTM IP 213 mgKOH/g 0.27 
Flash Point IP 170 0C <30 
Pour Point ASTM D97 0C +33 
ASTM colour ASTM 1500 ─ >8 
Total sulphur ASTM D4294 Wt % 0.056 
Salt Content IP 265 Mg/l <5 
Nitrogen Content ASTM D4629 Mg/kg 1030 
Ash Content ASTM D482 % m/m 0.005 
Wax Content BP 237 Wt % 34.3 
Gross calorific value ASTM D240 MJ/kg 45.635 
Mercury ICP ppb <250 
Asphaltenes IP143 Wt % 0.06 
Metals    
Sodium (Na) Ash and ICP Mg/kg <1 
Potassium (K) Ash and ICP Mg/kg 0.2 
Copper (Cu) Ash and ICP Mg/kg <1 
Lead (Pb) Ash and ICP Mg/kg <0.1 
Iron (Fe) Ash and ICP Mg/kg 0.3 
Nickel (Ni) Ash and ICP Mg/kg 5.8 
Vanadium (V) Ash and ICP Mg/kg 0.2 
Arsenic (As) Ash and ICP Mg/kg <1 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A3: Rapid cooling method 
Time(min) 
Temp. 
(°C) Time(min) 
Temp. 
(°C) Time(min) 
Temp. 
(°C) Time(min) 
Temp. 
(°C) 
1 105 50 93.33 99 70 148 70 
2 105 51 92.75 100 70 149 70 
3 105 52 92.17 101 70 150 70 
4 105 53 91.58 102 70 151 69 
5 105 54 91 103 70 152 68 
6 105 55 90.42 104 70 153 67 
7 105 56 89.83 105 70 154 66 
8 105 57 89.25 106 70 155 65 
9 105 58 88.67 107 70 156 64 
10 105 59 88.1 108 70 157 63 
11 105 60 87.5 109 70 158 62 
12 105 61 86.92 110 70 159 61 
13 105 62 86.33 111 70 160 60 
14 105 63 85.75 112 70 161 59 
15 105 64 85.17 113 70 162 58 
16 105 65 84.58 114 70 163 57 
17 105 66 84 115 70 164 56 
18 105 67 83.42 116 70 165 55 
19 105 68 82.83 117 70 166 54 
20 105 69 82.25 118 70 167 53 
21 105 70 81.67 119 70 168 52 
22 105 71 81.2 120 70 169 51 
23 105 72 80.5 121 70 170 50 
24 105 73 79.92 122 70 171 49 
25 105 74 79.33 123 70 172 48 
26 105 75 78.75 124 70 173 47 
27 105 76 78.17 125 70 174 46 
28 105 77 77.58 126 70 175 45 
29 105 78 77 127 70 176 44 
30 105 79 76.42 128 70 177 43 
31 104.42 80 75.83 129 70 178 42 
32 103.83 81 75.25 130 70 179 41 
33 103.25 82 74.67 131 70 180 40 
34 102.67 83 74.08 132 70 181 39 
35 102.2 84 73.5 133 70 182 38 
36 101.5 85 72.92 134 70 183 37 
37 100.92 86 72.33 135 70 184 36 
38 100.3 87 71.75 136 70 185 35 
39 99.75 88 71.17 137 70 186 34 
40 99.17 89 70.58 138 70 187 33 
41 98.58 90 70 139 70 188 32 
42 98 91 70 140 70 189 31 
43 97.42 92 70 141 70 190 30 
44 96.83 93 70 142 70 191 29 
45 96.25 94 70 143 70 192 28 
46 95.67 95 70 144 70 193 27 
47 95.1 96 70 145 70 194 26 
48 94.5 97 70 146 70 195 25 
49 93.92 98 70 147 70     
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Appendix A4: Medium cooling method 
 
Time  
(min) 
Temp. 
 (°C) 
Time 
 (min) 
Temp. 
(°C) 
Time 
 (min) 
Temp. 
(°C) 
Time 
(min) 
Temp. 
(°C) 
Time  
(min) 
Temp.  
(°C) 
1 105 49 93.92 97 70 145 70 193 48.5 
2 105 50 93.33 98 70 146 70 194 48 
3 105 51 92.75 99 70 147 70 195 47.5 
4 105 52 92.17 100 70 148 70 196 47 
5 105 53 91.58 101 70 149 70 197 46.5 
6 105 54 91 102 70 150 70 198 46 
7 105 55 90.42 103 70 151 69.5 199 45.5 
8 105 56 89.83 104 70 152 69 200 45 
9 105 57 89.25 105 70 153 68.5 201 44.5 
10 105 58 88.67 106 70 154 68 202 44 
11 105 59 88.1 107 70 155 67.5 203 43.5 
12 105 60 87.5 108 70 156 67 204 43 
13 105 61 86.92 109 70 157 66.5 205 42.5 
14 105 62 86.33 110 70 158 66 206 42 
15 105 63 85.75 111 70 159 65.5 207 41.5 
16 105 64 85.17 112 70 160 65 208 41 
17 105 65 84.58 113 70 161 64.5 209 40.5 
18 105 66 84 114 70 162 64 210 40 
19 105 67 83.42 115 70 163 63.5 211 39.5 
20 105 68 82.83 116 70 164 63 212 39 
21 105 69 82.25 117 70 165 62.5 213 38.5 
22 105 70 81.67 118 70 166 62 214 38 
23 105 71 81.2 119 70 167 61.5 215 37.5 
24 105 72 80.5 120 70 168 61 216 37 
25 105 73 79.92 121 70 169 60.5 217 36.5 
26 105 74 79.33 122 70 170 60 218 36 
27 105 75 78.75 123 70 171 59.5 219 35.5 
28 105 76 78.17 124 70 172 59 220 35 
29 105 77 77.58 125 70 173 58.5 221 34.5 
30 105 78 77 126 70 174 58 222 34 
31 104.42 79 76.42 127 70 175 57.5 223 33.5 
32 103.83 80 75.83 128 70 176 57 224 33 
33 103.25 81 75.25 129 70 177 56.5 225 32.5 
34 102.67 82 74.67 130 70 178 56 226 32 
35 102.1 83 74.1 131 70 179 55.5 227 31.5 
36 101.5 84 73.5 132 70 180 55 228 31 
37 100.92 85 72.92 133 70 181 54.5 229 30.5 
38 100.33 86 72.33 134 70 182 54 230 30 
39 99.75 87 71.75 135 70 183 53.5 231 29.5 
40 99.17 88 71.17 136 70 184 53 232 29 
41 98.58 89 70.58 137 70 185 52.5 233 28.5 
42 98 90 70 138 70 186 52 234 28 
43 97.42 91 70 139 70 187 51.5 235 27.5 
44 96.83 92 70 140 70 188 51 236 27 
45 96.25 93 70 141 70 189 50.5 237 26.5 
46 95.67 94 70 142 70 190 50 238 26 
47 95.1 95 70 143 70 191 49.5 239 25.5 
48 94.5 96 70 144 70 192 49 240 25 
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Appendix A5: Slow cooling method 
 
Time(min) Temp. (°C) Time(min) Temp. (°C) 
1 105 2821 43.29 
61 86.92 2881 42.69 
121 70 2941 42.09 
181 69.69 3001 41.49 
241 69.09 3061 40.89 
301 68.49 3121 40.29 
361 67.89 3181 39.69 
421 67.29 3241 39.09 
481 66.69 3301 38.49 
541 66.09 3361 37.89 
601 65.49 3421 37.29 
661 64.89 3481 36.69 
721 64.29 3541 36.09 
781 63.69 3601 35.49 
841 63.09 3661 34.89 
901 62.49 3721 34.29 
961 61.89 3781 33.69 
1021 61.29 3841 33.09 
1081 60.69 3901 32.49 
1141 60.09 3961 31.89 
1201 59.49 4021 31.29 
1261 58.89 4081 30.69 
1321 58.29 4141 30.09 
1381 57.69 4201 29.49 
1441 57.09 4261 28.89 
1501 56.49 4321 28.29 
1561 55.89 4381 27.69 
1621 55.29 4441 27.09 
1681 54.69 4501 26.49 
1741 54.09 4561 25.89 
1801 53.49 4621 25.29 
1861 52.89 4650 25 
1921 52.29     
1981 51.69     
2041 51.09     
2101 50.49     
2161 49.89     
2221 49.29     
2281 48.69     
2341 48.09     
2401 47.49     
2461 46.89     
2521 46.29     
2581 45.69     
2641 45.09     
2701 44.49     
2761 43.89     
 
 81
Appendix A6: Display the output calculation 
 
KP                            The distance the pipeline covered 
Elevation  Pipeline elevation 
Velocity  Is calculated by one of these 3 formulas according to the location:- 
Flow_Take-off rate of CPF / 3600 * Density / A1 / Density  
Flow_Take-off rate of (CPF-Obeid) / 3600 * Density / A1 / Density  
Flow_Take-off rate of (CPF-Obeid-Khartoum) / 3600  
* Density / A1 / Density  
Pressure  The initial value is obtained from specific pump table (PS1 to PS6)  
Calculated discharge pressure   
Rest of the values are calculated according to the following:- 
 prevPressure-0.5* prevDensity* prevfriction loss sowame  
*prevVelocity^2*( KP-prevKP)/( ID1)*1000/10^5-9.81* prevDensity 
*( Elevation-prev Elevation)/10^5 
Temperature The initial values are obtained from 
prevTemperature+Temperature increase across pump   
Rest values are calculated as follows: - 
prevT_air+(prevTemperature-prevT_air)*EXP(-prevKt totat heat 
transfer 
*(KP-prevKP)*1000*3.14*ID1/(prevVelocity*'prevDensity*A1*cp)) 
Density  (-0.0007*Temperature)+0.8602 
Viscosity  (A0+A1*Temperature+A2*Temperature^2+A3 
*Temperature^3+A4*Temperature^4+A5*Temperature^5+A6 
*Temperature^6) 
Re  Velocity*ID1*Density*10^3/Viscosity 
Friction_ 
Loss_Sowame  
 (1.14-2*LOG(Surface roughness/1000/ID1+21.25/ Re ^0.9))^(-2) 
Kt_Total 
_Heat_Transfer  
(1/H_inner+1/(H_outer*OD/1000/'ID1))^-1 
T_air  Ambient temperature 
H_inner  0.023*Re^0.8*(Viscosity*10^-3*cp /kf)^0.3 
H_outer  2*k_soil/(OD/1000)/LN(1+2*Trench 
/(OD/1000)+SQRT((1+2*Trench/(OD/1000))^2-1)) 
Amb_Temp 
_Winter  
= 25 (Obtained from the table) 
Flow_Zone  If (dtaPumps_Stations.Recordset.Fields("Re") < 2100) Then 
      dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Laminar" 
   ElseIf (dtaPumps_Stations.Recordset.Fields("Re") < 4000) Then 
      dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Transition" 
   Else 
      dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Turbulent" 
   End If 
Max_Yield_Stress  ((mTemp_Tmp - mTemp_Y) / (mTemp_Y - mTemp_Y_Next))  
* ((mYield - mYield_Next)) + (mYield) 
Max_Allow 
_Restart_Pressure 
4 * dtaPumps_Stations.Recordset.Fields("Elevation") / mID1 * 
dtaPumps_Stations.Recordset.Fields("Max_Yield_Stress") 
MAOP 9750 
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Appendix A7: The software program of the mathematical model written in 
Visual Basic 
Main Form 
 
Public mA0_A6_PS As String 
Public mPumpStation As String 
Public mPump As String 
Public mPumpAlarm As String 
Public mPAlarmTemp As String 
Public mprevPAlarmTemp As String 
Public prePressure, preDensity, preFriction_Loss_Swamee, preElevation, 
preVelocity, preKP, preT_air, PreTemperature, preKt_Total_Heat_Transfer, 
PreAmbTempWinter 
Public mID1, mID2, mA1, mA2 
Private Sub Form_Load() 
    
   optA0_A6(0).Value = True 
   optA0_A6_PS(0).Value = True 
   optCity(0).Value = True 
   optPAlarmTemp(0).Value = True 
   optPStation(0).Value = True 
   optPump(0).Value = True 
   optPumpAlarm(0).Value = True 
   optTemp(0).Value = True 
   optYield(0).Value = True 
    
End Sub 
Private Sub cmdExit_Click() 
    
   End 
    
End Sub 
Private Sub cmdPumpStations_Click() 
    
   SSTab1.Tab = 4 
    
End Sub 
Private Sub cmdFlowRates_Click() 
    
   SSTab1.Tab = 0 
    
End Sub 
Private Sub cmdReport1_Click() 
    
   Set rptOutput1.DataSource = dtaPumps_Stations 
   rptOutput1.Show 
    
End Sub 
Private Sub cmdReport2_Click() 
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   Set rptOutput2.DataSource = dtaPumps_Stations 
   rptOutput2.Show 
    
End Sub 
Private Sub cmdUnits_Click() 
    
   frmUnits.Show 
    
End Sub 
Private Sub cmdCharts_Click() 
    
   frmMSChart.Show 
    
End Sub 
Private Sub Image2_Click() 
    
   frmMSChart.Show 
    
End Sub 
Private Sub optA0_A6_Click(Index As Integer) 
    
   Select Case optA0_A6(Index).Caption 
          Case "High" 
               dtaA0_A6.RecordSource = "A_High" 
          Case "Medium" 
               dtaA0_A6.RecordSource = "A_Medium" 
          Case "Slow" 
               dtaA0_A6.RecordSource = "A_Slow" 
   End Select 
    
   dtaA0_A6.Refresh 
    
End Sub 
Private Sub optYield_Click(Index As Integer) 
    
   Select Case optYield(Index).Caption 
          Case "High" 
               dtaYield.RecordSource = "Yield_High" 
          Case "Medium" 
               dtaYield.RecordSource = "Yield_Medium" 
          Case "Slow" 
               dtaYield.RecordSource = "Yield_Slow" 
   End Select 
    
   dtaYield.Refresh 
    
End Sub 
Private Sub Image1_Click() 
    
   cmdCalculate_Click 
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   End Sub 
'Start Calculations 
Private Sub cmdCalculate_Click() 
 
   Dim mIndex 
   Dim mTemp 
      
   Select Case SSTab1.Caption 
          Case "City" 
               City_Calc 
          
          Case "A0 - A6" 
               A0_A6_Calc 'Calculate A0_A6 
          
          Case "Temperature" 
               'Calculate Temperature 
          
          Case "Pumps" 
               If optPump(0).Value = True Then PS1_Calc 
               If optPump(1).Value = True Then PS2_Calc 
               If optPump(2).Value = True Then PS3_Calc 
               If optPump(3).Value = True Then PS4_Calc 
               If optPump(4).Value = True Then PS5_Calc 
               If optPump(5).Value = True Then PS6_Calc 
               
          Case "Pump Stations" 
               If optA0_A6_PS(0).Value = True Then mA0_A6_PS = "A_High" 
               If optA0_A6_PS(1).Value = True Then mA0_A6_PS = "A_Medium" 
               If optA0_A6_PS(2).Value = True Then mA0_A6_PS = "A_Slow" 
                
               If optPStation(0).Value = True Then 
                  mPumpStation = "PS1_PS2" 
                  mprevPAlarmTemp = "" 
               End If 
                   
               If optPStation(1).Value = True Then 
                  mPumpStation = "PS2_PS3" 
                  mprevPAlarmTemp = "PS1_PS2" 
               End If 
                
               If optPStation(2).Value = True Then 
                  mPumpStation = "PS3_PS4" 
                  mprevPAlarmTemp = "PS2_PS3" 
               End If 
               If optPStation(3).Value = True Then 
                  mPumpStation = "PS4_PS5" 
                  mprevPAlarmTemp = "PS3_PS4" 
               End If 
                
               If optPStation(4).Value = True Then 
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                  mPumpStation = "PS5_PS6" 
                  mprevPAlarmTemp = "PS4_PS5" 
               End If 
                
               If optPStation(5).Value = True Then 
                  mPumpStation = "PS6_MT" 
                  mprevPAlarmTemp = "PS5_PS6" 
               End If 
                
               'Check Alarm Tables 
               'dtaPump_Alarm.RecordSource = Mid(mPumpStation, 1, 3) & "_Alarm_" & 
Mid(mA0_A6_PS, 3, Len(mA0_A6_PS) - 2) 
               'dtaPump_Alarm.Refresh 
                
               'Calculate Value 
               PS_PS_Calc 
                
          Case "Pump Alarm" 
               If optPumpAlarm(0).Value = True Then mIndex = 1 
               If optPumpAlarm(1).Value = True Then mIndex = 2 
               If optPumpAlarm(2).Value = True Then mIndex = 3 
               If optPumpAlarm(3).Value = True Then mIndex = 4 
               If optPumpAlarm(4).Value = True Then mIndex = 5 
               If optPumpAlarm(5).Value = True Then mIndex = 6 
                
               If optPAlarmTemp(0).Value = True Then mTemp = "High" 
               If optPAlarmTemp(1).Value = True Then mTemp = "Medium" 
               If optPAlarmTemp(2).Value = True Then mTemp = "Slow" 
                
               dtaPumps.RecordSource = "PS" & mIndex 
               dtaPumps.Refresh 
               dtaPump_Alarm.RecordSource = "PS" & mIndex & "_Alarm_" & mTemp 
               dtaPump_Alarm.Refresh 
               PS_Alarm_Calc 
                
          Case "Others" 
               'Case "Temperature" 
               'Temperature_Calc 
               'Case "Pressure" 
               'Pressure_Calc 
   End Select 
      
End Sub 
Private Sub optCity_Click(Index As Integer) 
    
   Select Case optCity(Index).Caption 
          Case "CPF" 
               dtaCity.RecordSource = "CPF" 
          Case "ElObeid" 
               dtaCity.RecordSource = "ElObeid" 
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          Case "Khartoum" 
               dtaCity.RecordSource = "Khartoum" 
   End Select 
    
   dtaCity.Refresh 
           
End Sub 
Private Sub City_Calc() 
       
   dtaCity.Refresh 
   Do While Not dtaCity.Recordset.EOF 
      dtaCity.Recordset.Fields("Flow_Take_Off_Rate_KSTBD") = 
dtaCity.Recordset.Fields("Flow_Take_Off_Rate_SM") / 0.159 * 24 / 1000 
      dtaCity.Recordset.Update 
      dtaCity.Recordset.MoveNext 
   Loop 
   dtaCity.Recordset.UpdateBatch adAffectAll 
    
End Sub 
Private Sub A0_A6_Calc() 
    
   Dim mRecNo, mANo 
   Dim A0_A6(6) 
   Dim Atemp, mOption 
 
   'declare and start a new excel application 
   Dim MyXLApp As New Excel.Application 
   Dim oTrendline As Object 
   Dim oSeries As Object 
    
   'Open an Excel workbook 
   MyXLApp.Workbooks.Open "C:\PipeLine System\Charts.xls" 'FileName:= 
       
   'Select the sheet that has the input cells 
   MyXLApp.Sheets("Sheet1").Select 
 
   'Substitute your cell for the 'B2' and your textbox name for 'txtFirstTextbox' 
   'MyXLApp.Range("B2").value = "Carl's Inputbox title" 
   'MyXLApp.Cells(1, 7) = "Carl's Inputbox title" 
    
   'Write Temperature/Viscosity 
   mOption = MsgBox("Data From Table " & dtaTemperature.RecordSource & " Will 
Be Used to Create New Value For A0-A6 in Table " & dtaA0_A6.RecordSource, 
vbYesNo) 
   If mOption = vbYes Then 
      mRecNo = 2 
      dtaTemperature.Refresh 
      Do While Not dtaTemperature.Recordset.EOF 
         MyXLApp.Cells(mRecNo, 1) = 
dtaTemperature.Recordset.Fields("Temperature") 
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         MyXLApp.Cells(mRecNo, 2) = dtaTemperature.Recordset.Fields("Viscosity") 
         dtaTemperature.Recordset.MoveNext 
         mRecNo = mRecNo + 1 
      Loop 
    
      'Write A0-A6 Formulas 
      For mANo = 1 To 6 
          MyXLApp.Cells(mANo, 6) = "=INDEX(LINEST(B2:B" & mRecNo - 1 & 
",A2:A" & mRecNo - 1 & "^{1,2,3,4,5,6}),1," & 8 - mANo & ")" 
      Next 
    
      'Read A0-A6 Value 
      dtaA0_A6.Refresh 
      For X = 0 To 6 
          Atemp = "A" & X 
          dtaA0_A6.Recordset.Fields(Atemp) = MyXLApp.Cells(X + 1, 6) 
          dtaA0_A6.Recordset.Update 
      Next 
      dtaA0_A6.Recordset.UpdateBatch adAffectAll 
       
      'MyXLApp.Charts("Chart1").Select 
       
      'Save File 
      MyXLApp.Workbooks(1).SaveAs "C:\PipeLine System\Charts2.xls" 
 
      'You MUST always do this in order to free up your memory 
      MyXLApp.Quit 
      Set MyXLApp = Nothing 
       
   End If 
    
End Sub 
Private Sub optTemp_Click(Index As Integer) 
    
   Select Case optTemp(Index).Caption 
          Case "High" 
               dtaTemperature.RecordSource = "High" 
          Case "Medium" 
               dtaTemperature.RecordSource = "Medium" 
          Case "Slow" 
               dtaTemperature.RecordSource = "Slow" 
   End Select 
    
   dtaTemperature.Refresh 
    
End Sub 
Private Sub High_Calc() 
 
End Sub 
Private Sub Slow_Calc() 
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End Sub 
Private Sub Medium_Calc() 
 
End Sub 
Private Sub optPump_Click(Index As Integer) 
    
   Select Case optPump(Index).Caption 
          Case "Pump 1" 
               dtaPumps.RecordSource = "PS1" 
          Case "Pump 2" 
               dtaPumps.RecordSource = "PS2" 
          Case "Pump 3" 
               dtaPumps.RecordSource = "PS3" 
          Case "Pump 4" 
               dtaPumps.RecordSource = "PS4" 
          Case "Pump 5" 
               dtaPumps.RecordSource = "PS5" 
          Case "Pump 6" 
               dtaPumps.RecordSource = "PS6" 
   End Select 
    
   dtaPumps.Refresh 
    
End Sub 
Private Sub PS1_Calc() 
      
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaDataTable.Refresh 
          
   dtaPumps.RecordSource = "PS1" 
   dtaPumps.Refresh 
   Do While Not dtaPumps.Recordset.EOF 
      dtaPumps.Recordset.Fields("Oil_Temperature") = 
dtaCalcTable1.Recordset.Fields("Export_Temperature_PS1") 
      dtaPumps.Recordset.Fields("Suction_Pressure") = 
dtaCalcTable1.Recordset.Fields("Suction_Pressure_PS1") 
       
      dtaPumps.Recordset.Fields("Rate") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") 
      'GNPOC 
      dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7218 * dtaPumps.Recordset.Fields("Oil_Temperature") + 864) 
      'Khadiga 
      'dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7 * dtaPumps.Recordset.Fields("Oil_Temperature") + 860) 
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            dtaPumps.Recordset.Fields("Volume_pr_Pump") = 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") 
      dtaPumps.Recordset.Fields("Motor_rpm") = 
dtaPumps.Recordset.Fields("Pump_rpm") / 4.8367 
       
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Discharge_Head") = 0 
      Else 
         dtaPumps.Recordset.Fields("Discharge_Head") = -0.000387 * 
(dtaPumps.Recordset.Fields("Volume_pr_Pump") ^ 2) + (0.000057 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 0.000785) * 
dtaPumps.Recordset.Fields("Volume_pr_Pump") + 0.0000854 * 
(dtaPumps.Recordset.Fields("Pump_rpm") ^ 2) - 0.0013088 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 1.9600463 
      End If 
       
      dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaPumps.Recordset.Fields("Discharge_Head") * 9.81 * 0.85 / 100 + 
dtaPumps.Recordset.Fields("Suction_Pressure") 
      'dtaPumps.Recordset.Fields("Calculated_Oulet_Pressure") = 
                   
      dtaPumps.Recordset.Update 
      dtaPumps.Recordset.MoveNext 
   Loop 
   dtaPumps.Recordset.UpdateBatch adAffectAll 
    
End Sub 
Private Sub PS2_Calc() 
    
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaCalcTable3.RecordSource = "PS1_PS2" 
   dtaCalcTable3.Refresh 
   dtaCalcTable3.Recordset.MoveLast 
    
   dtaPumps.RecordSource = "PS2" 
   dtaPumps.Refresh 
   Do While Not dtaPumps.Recordset.EOF 
      dtaPumps.Recordset.Fields("Oil_Temperature") = 
dtaCalcTable3.Recordset.Fields("Temperature") 
      'dtaPumps.Recordset.Fields("Suction_Pressure") = 
dtaCalcTable1.Recordset.Fields("Suction_Pressure_PS1") 
       
      dtaPumps.Recordset.Fields("Rate") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") 
      'GNPOC 
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      dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7218 * dtaPumps.Recordset.Fields("Oil_Temperature") + 864) 
      'Khadiga 
      'dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7 * dtaPumps.Recordset.Fields("Oil_Temperature") + 860) 
       
      dtaPumps.Recordset.Fields("Volume_pr_Pump") = 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") 
      dtaPumps.Recordset.Fields("Motor_rpm") = 
dtaPumps.Recordset.Fields("Pump_rpm") / 4.8378 
       
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Discharge_Head") = 0 
      Else 
         dtaPumps.Recordset.Fields("Discharge_Head") = -0.000387 * 
(dtaPumps.Recordset.Fields("Volume_pr_Pump") ^ 2) + (0.000057 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 0.000785) * 
dtaPumps.Recordset.Fields("Volume_pr_Pump") + 0.0000854 * 
(dtaPumps.Recordset.Fields("Pump_rpm") ^ 2) - 0.0013088 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 1.9600463 
      End If 
       
      dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaPumps.Recordset.Fields("Discharge_Head") * 9.81 * 0.85 / 100 + 
dtaPumps.Recordset.Fields("Suction_Pressure") 
      dtaPumps.Recordset.Fields("Calculated_Oulet_Pressure") = 
dtaCalcTable3.Recordset.Fields("Pressure") 
       
      dtaPumps.Recordset.Update 
      dtaPumps.Recordset.MoveNext 
   Loop 
   dtaPumps.Recordset.UpdateBatch adAffectAll 
    
End Sub 
Private Sub PS3_Calc() 
    
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaCalcTable3.RecordSource = "PS2_PS3" 
   dtaCalcTable3.Refresh 
   dtaCalcTable3.Recordset.MoveLast 
   dtaCalcTable4.RecordSource = "ElObeid" 
   dtaCalcTable4.Refresh 
          
   dtaPumps.RecordSource = "PS3" 
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   dtaPumps.Refresh 
   Do While Not dtaPumps.Recordset.EOF 
      dtaPumps.Recordset.Fields("Oil_Temperature") = 
dtaCalcTable3.Recordset.Fields("Temperature") 
      'dtapumps.Recordset.Fields("Suction_Pressure") = 
dtaCalcTable1.Recordset.Fields("Suction_Pressure_PS1") 
       
      dtaPumps.Recordset.Fields("Rate") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable4.Recordset.Fields("Flow_Take_Off_Rate_SM") 
      'GNPOC 
      dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7218 * dtaPumps.Recordset.Fields("Oil_Temperature") + 864) 
      'Khadiga 
      'dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7 * dtaPumps.Recordset.Fields("Oil_Temperature") + 860) 
       
      dtaPumps.Recordset.Fields("Volume_pr_Pump") = 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") 
      dtaPumps.Recordset.Fields("Motor_rpm") = 
dtaPumps.Recordset.Fields("Pump_rpm") / 4.6533 
                  
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Discharge_Head") = 0 
      Else 
         dtaPumps.Recordset.Fields("Discharge_Head") = -0.00135 * 
((dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No")) ^ 2) + (0.00000015857 * 
(dtaPumps.Recordset.Fields("Pump_rpm") ^ 2) - 0.00068382 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 1.1274) * 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") + 0.52278 * 
dtaPumps.Recordset.Fields("Pump_rpm") - 683.079 
      End If 
       
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaCalcTable3.Recordset.Fields("Pressure") 
      Else 
         dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaPumps.Recordset.Fields("Discharge_Head") * 9.81 * 0.85 / 100 + 
dtaPumps.Recordset.Fields("Suction_Pressure") 
      End If 
                
      'dtapumps.Recordset.Fields("Calculated_Oulet_Pressure") = 
dtaCalcTable3.Recordset.Fields("Pressure") 
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      dtaPumps.Recordset.Update 
      dtaPumps.Recordset.MoveNext 
   Loop 
   dtaPumps.Recordset.UpdateBatch adAffectAll 
         
End Sub 
Private Sub PS4_Calc() 
    
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaCalcTable3.RecordSource = "PS3_PS4" 
   dtaCalcTable3.Refresh 
   dtaCalcTable3.Recordset.MoveLast 
   dtaCalcTable4.RecordSource = "ElObeid" 
   dtaCalcTable4.Refresh 
   dtaCalcTable5.RecordSource = "Khartoum" 
   dtaCalcTable5.Refresh 
       
   dtaPumps.RecordSource = "PS4" 
   dtaPumps.Refresh 
   Do While Not dtaPumps.Recordset.EOF 
      dtaPumps.Recordset.Fields("Oil_Temperature") = 
dtaCalcTable3.Recordset.Fields("Temperature") 
      'dtapumps.Recordset.Fields("Suction_Pressure") = 
dtaCalcTable1.Recordset.Fields("Suction_Pressure_PS1") 
       
      dtaPumps.Recordset.Fields("Rate") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable4.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable5.Recordset.Fields("Flow_Take_Off_Rate_SM") 
      'GNPOC 
      dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7218 * dtaPumps.Recordset.Fields("Oil_Temperature") + 864) 
      'Khadiga 
      'dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7 * dtaPumps.Recordset.Fields("Oil_Temperature") + 860) 
       
      dtaPumps.Recordset.Fields("Volume_pr_Pump") = 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") 
      dtaPumps.Recordset.Fields("Motor_rpm") = 
dtaPumps.Recordset.Fields("Pump_rpm") / 4.8367 
                  
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Discharge_Head") = 0 
      Else 
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         dtaPumps.Recordset.Fields("Discharge_Head") = -0.000387 * 
(dtaPumps.Recordset.Fields("Volume_pr_Pump") ^ 2) + (0.000057 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 0.000785) * 
dtaPumps.Recordset.Fields("Volume_pr_Pump") + 0.0000854 * 
(dtaPumps.Recordset.Fields("Pump_rpm") ^ 2) - 0.0013088 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 1.9600463 
      End If 
       
      dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaPumps.Recordset.Fields("Discharge_Head") * 9.81 * 0.85 / 100 + 
dtaPumps.Recordset.Fields("Suction_Pressure") 
                
      dtaPumps.Recordset.Fields("Calculated_Oulet_Pressure") = 
dtaCalcTable3.Recordset.Fields("Pressure") 
                   
      dtaPumps.Recordset.Update 
      dtaPumps.Recordset.MoveNext 
   Loop 
   dtaPumps.Recordset.UpdateBatch adAffectAll 
    
End Sub 
Private Sub PS5_Calc() 
    
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaCalcTable3.RecordSource = "PS4_PS5" 
   dtaCalcTable3.Refresh 
   dtaCalcTable3.Recordset.MoveLast 
   dtaCalcTable4.RecordSource = "ElObeid" 
   dtaCalcTable4.Refresh 
   dtaCalcTable5.RecordSource = "Khartoum" 
   dtaCalcTable5.Refresh 
       
   dtaPumps.RecordSource = "PS5" 
   dtaPumps.Refresh 
   Do While Not dtaPumps.Recordset.EOF 
      dtaPumps.Recordset.Fields("Oil_Temperature") = 
dtaCalcTable3.Recordset.Fields("Temperature") 
      'dtapumps.Recordset.Fields("Suction_Pressure") = 
dtaCalcTable1.Recordset.Fields("Suction_Pressure_PS1") 
       
      dtaPumps.Recordset.Fields("Rate") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable4.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable5.Recordset.Fields("Flow_Take_Off_Rate_SM") 
      'GNPOC 
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      dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7218 * dtaPumps.Recordset.Fields("Oil_Temperature") + 864) 
      'Khadiga 
      'dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7 * dtaPumps.Recordset.Fields("Oil_Temperature") + 860) 
       
      dtaPumps.Recordset.Fields("Volume_pr_Pump") = 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") 
      dtaPumps.Recordset.Fields("Motor_rpm") = 
dtaPumps.Recordset.Fields("Pump_rpm") / 4.6533 
       
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Discharge_Head") = 0 
      Else 
         dtaPumps.Recordset.Fields("Discharge_Head") = -0.00135 * 
((dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No")) ^ 2) + (0.00000015857 * 
(dtaPumps.Recordset.Fields("Pump_rpm") ^ 2) - 0.00068382 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 1.1274) * 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") + 0.52278 * 
dtaPumps.Recordset.Fields("Pump_rpm") - 683.079 
      End If 
       
      dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaPumps.Recordset.Fields("Discharge_Head") * 9.81 * 0.85 / 100 + 
dtaPumps.Recordset.Fields("Suction_Pressure") 
                
      dtaPumps.Recordset.Fields("Calculated_Oulet_Pressure") = 
dtaCalcTable3.Recordset.Fields("Pressure") 
                   
      dtaPumps.Recordset.Update 
      dtaPumps.Recordset.MoveNext 
   Loop 
   dtaPumps.Recordset.UpdateBatch adAffectAll 
      
End Sub 
Private Sub PS6_Calc() 
    
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaCalcTable3.RecordSource = "PS5_PS6" 
   dtaCalcTable3.Refresh 
   dtaCalcTable3.Recordset.MoveLast 
   dtaCalcTable4.RecordSource = "ElObeid" 
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   dtaCalcTable4.Refresh 
   dtaCalcTable5.RecordSource = "Khartoum" 
   dtaCalcTable5.Refresh 
       
   dtaPumps.RecordSource = "PS6" 
   dtaPumps.Refresh 
   Do While Not dtaPumps.Recordset.EOF 
      dtaPumps.Recordset.Fields("Oil_Temperature") = 
dtaCalcTable3.Recordset.Fields("Temperature") 
      'dtapumps.Recordset.Fields("Suction_Pressure") = 
dtaCalcTable1.Recordset.Fields("Suction_Pressure_PS1") 
       
      dtaPumps.Recordset.Fields("Rate") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable4.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable5.Recordset.Fields("Flow_Take_Off_Rate_SM") 
      'GNPOC 
      dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7218 * dtaPumps.Recordset.Fields("Oil_Temperature") + 864) 
      'Khadiga 
      'dtaPumps.Recordset.Fields("Actual_Volume_Rate") = 
dtaPumps.Recordset.Fields("Rate") * dtaCalcTable2.Recordset.Fields("Density") / (-
0.7 * dtaPumps.Recordset.Fields("Oil_Temperature") + 860) 
       
      dtaPumps.Recordset.Fields("Volume_pr_Pump") = 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") 
      dtaPumps.Recordset.Fields("Motor_rpm") = 
dtaPumps.Recordset.Fields("Pump_rpm") / 4.6533 
       
      If dtaPumps.Recordset.Fields("Pumps_No") = 0 Then 
         dtaPumps.Recordset.Fields("Discharge_Head") = 0 
      Else 
         dtaPumps.Recordset.Fields("Discharge_Head") = -0.00135 * 
((dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No")) ^ 2) + (0.00000015857 * 
(dtaPumps.Recordset.Fields("Pump_rpm") ^ 2) - 0.00068382 * 
dtaPumps.Recordset.Fields("Pump_rpm") + 1.1274) * 
dtaPumps.Recordset.Fields("Actual_Volume_Rate") / 
dtaPumps.Recordset.Fields("Pumps_No") + 0.52278 * 
dtaPumps.Recordset.Fields("Pump_rpm") - 683.079 
      End If 
       
      dtaPumps.Recordset.Fields("Calculated_Discharge_Pressure") = 
dtaPumps.Recordset.Fields("Discharge_Head") * 9.81 * 0.85 / 100 + 
dtaPumps.Recordset.Fields("Suction_Pressure") 
                
      dtaPumps.Recordset.Fields("Calculated_Oulet_Pressure") = 
dtaCalcTable3.Recordset.Fields("Pressure") 
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      dtaPumps.Recordset.Update 
      dtaPumps.Recordset.MoveNext 
   Loop 
   dtaPumps.Recordset.UpdateBatch adAffectAll 
    
End Sub 
Private Sub optPumpAlarm_Click(Index As Integer) 
    
   Select Case optPumpAlarm(Index).Caption 
          Case "Pump 1" 
               mPumpAlarm = "PS1_Alarm" 
          Case "Pump 2" 
               mPumpAlarm = "PS2_Alarm" 
          Case "Pump 3" 
               mPumpAlarm = "PS3_Alarm" 
          Case "Pump 4" 
               mPumpAlarm = "PS4_Alarm" 
          Case "Pump 5" 
               mPumpAlarm = "PS5_Alarm" 
          Case "Pump 6" 
               mPumpAlarm = "PS6_Alarm" 
   End Select 
    
   If ((mPumpAlarm <> "") And (mPAlarmTemp <> "")) Then Display_Pump_Alarm 
    
End Sub 
Private Sub optPAlarmTemp_Click(Index As Integer) 
    
   Select Case optPAlarmTemp(Index).Caption 
          Case "High" 
               mPAlarmTemp = "_High" 
          Case "Medium" 
               mPAlarmTemp = "_Medium" 
          Case "Slow" 
               mPAlarmTemp = "_Slow" 
   End Select 
    
   If ((mPumpAlarm <> "") And (mPAlarmTemp <> "")) Then Display_Pump_Alarm 
         
End Sub 
Private Sub Display_Pump_Alarm() 
    
   dtaPump_Alarm.RecordSource = "PS_Alarm" 'mPumpAlarm & mPAlarmTemp 
   dtaPump_Alarm.Refresh 
    
End Sub 
Private Sub PS_Alarm_Calc() 
       dtaPump_Alarm.Recordset.Fields("Discharge_Presure_Alarm_High") = 
dtaPumps.Recordset.Fields("PH") - Calculated_Discharge_Pressure 
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   dtaPump_Alarm.Recordset.Fields("Suction_Pressure_Alarm") = 
dtaPumps.Recordset.Fields("Suction_Pressure") - dtaPumps.Recordset.Fields("PL") 
   dtaPump_Alarm.Recordset.Fields("RPM_Alarm") = 
dtaPumps.Recordset.Fields("Max_RPM") - dtaPumps.Recordset.Fields("Pump_rpm") 
    
   dtaPump_Alarm.Recordset.Update 
   dtaPump_Alarm.Recordset.UpdateBatch adAffectAll 
    
End Sub 
Private Sub optPStation_Click(Index As Integer) 
    
   Select Case optPStation(Index).Caption 
          Case "PS1_PS2" 
               dtaPumps_Stations.RecordSource = "PS1_PS2" 
          Case "PS2_PS3" 
               dtaPumps_Stations.RecordSource = "PS2_PS3" 
          Case "PS3_PS4" 
               dtaPumps_Stations.RecordSource = "PS3_PS4" 
          Case "PS4_PS5" 
               dtaPumps_Stations.RecordSource = "PS4_PS5" 
          Case "PS5_PS6" 
               dtaPumps_Stations.RecordSource = "PS5_PS6" 
          Case "PS6_MT" 
               dtaPumps_Stations.RecordSource = "PS6_MT" 
   End Select 
    
   dtaPumps_Stations.Refresh 
    
End Sub 
Private Sub Check_Alarm() 
        
   'If dtaPumps_Stations.Recordset.Fields("Pressure") >= 
dtaPump_Alarm.Recordset.Fields("Discharge_Presure_Alarm_High") Then MsgBox 
"Discharge Presure High" 
   'If dtaPumps_Stations.Recordset.Fields("Pressure") >= 
dtaPump_Alarm.Recordset.Fields("Suction_Pressure_Alarm") Then MsgBox 
"Suction Pressure Alarm" 
   'If dtaPumps.Recordset.Fields("Pump_rpm") >= 
dtaPump_Alarm.Recordset.Fields("RPM_Alarm") Then MsgBox "RPM Alarm" 
        
End Sub 
Private Sub Yield_Calculate() 
      
   Dim mTemp_Tmp, mTemp_Y, mTemp_Y_Next, mYield, mYield_Next 
   Dim mMax_Allow_Yield_Stress 
    
   dtaYield.RecordSource = "Yield_" & Mid(mA0_A6_PS, 3, Len(mA0_A6_PS) - 2) 
   dtaYield.Refresh 
      'Locate Range 
   '**** Revise <= >= 
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   Do While Not dtaYield.Recordset.EOF 
      If ((dtaPumps_Stations.Recordset.Fields("Temperature") >= 
dtaYield.Recordset.Fields("Min_Temp")) And 
(dtaPumps_Stations.Recordset.Fields("Temperature") < 
dtaYield.Recordset.Fields("Max_Temp"))) Then 
         Exit Do 
      Else 
         dtaYield.Recordset.MoveNext 
      End If 
   Loop 
      
   mTemp_Tmp = dtaPumps_Stations.Recordset.Fields("Temperature") 
   mTemp_Y = dtaYield.Recordset.Fields("Temperature") 
   mYield = dtaYield.Recordset.Fields("Max_Yield") 
   dtaYield.Recordset.MoveNext 
   mYield_Next = dtaYield.Recordset.Fields("Max_Yield") 
   mTemp_Y_Next = dtaYield.Recordset.Fields("Temperature") 
         
   dtaPumps_Stations.Recordset.Fields("Yield_Stress") = ((mTemp_Tmp - 
mTemp_Y) / (mTemp_Y - mTemp_Y_Next)) * ((mYield - mYield_Next)) + 
(mYield) 
   dtaPumps_Stations.Recordset.Fields("Allow_Restart_Pressure") = 4 * 
dtaPumps_Stations.Recordset.Fields("Elevation") / mID1 * 
dtaPumps_Stations.Recordset.Fields("Yield_Stress") 
   dtaPumps_Stations.Recordset.Fields("MAOP") = 9750 
    
End Sub 
Private Sub EspEquations() 
    
   Dim mRecSource 
    
   'Pressure 
   '-------- 
   If dtaPumps_Stations.Recordset.AbsolutePosition = 1 Then 
      'Use Equations 1-6 
      dtaPumps_Stations.Recordset.Fields("Pressure") = 
dtaCalcTable4.Recordset.Fields("Calculated_Discharge_Pressure") 
   Else 
      'MsgBox "Pressure ESP"  & Chr(13) & Chr(10) & prePressure & "-" & 0.5 & "*" 
& preDensity & "*" & preFriction_Loss_Swamee & "* (" & preVelocity & "^ 2) * (" 
& dtaPumps_Stations.Recordset.Fields("KP") & " - " & preKP & ") / (" & mID1 & ") 
* 1000 / 10 ^ 5 - 9.81 *" & preDensity & "* (" & 
dtaPumps_Stations.Recordset.Fields("Elevation") & " - " & preElevation & ") / 10 ^ 
5" 
      'Use Equation 7 
      dtaPumps_Stations.Recordset.Fields("Pressure") = prePressure - 0.5 * preDensity 
* preFriction_Loss_Swamee * (preVelocity ^ 2) * 
(dtaPumps_Stations.Recordset.Fields("KP") - preKP) / (mID1) * 1000 / 10 ^ 5 - 9.81 
* preDensity * (dtaPumps_Stations.Recordset.Fields("Elevation") - preElevation) / 10 
^ 5 
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   End If 
       
   'Temperature 
   '----------- 
   If dtaPumps_Stations.Recordset.AbsolutePosition = 1 Then 
      If dtaPumps_Stations.RecordSource = "PS1_PS2" Then 
         'MsgBox "Temperature ESP1" & Chr(13) & Chr(10) & 
dtaCalcTable4.Recordset.Fields("Oil_Temperature") & "+" & 
dtaCalcTable4.Recordset.Fields("Temperature_Incr_Across_Pump") 
         'Use Equations 1 (Oil Temperature in PS1) 
         dtaPumps_Stations.Recordset.Fields("Temperature") = 
dtaCalcTable4.Recordset.Fields("Oil_Temperature") + 
dtaCalcTable4.Recordset.Fields("Temperature_Incr_Across_Pump") 
      Else 
         'Use Equations 2,4,5,6 (Temperature of last rec in PS-1_PS-1) 
         If Val(Mid(dtaPumps_Stations.RecordSource, 3, 1) - 1) <> 5 Then 
            mRecSource = "PS" & Val(Mid(dtaPumps_Stations.RecordSource, 3, 1) - 1) 
& "_PS" & Val(Mid(dtaPumps_Stations.RecordSource, 7, 1) - 1) 
         Else 
            mRecSource = "PS" & Val(Mid(dtaPumps_Stations.RecordSource, 3, 1) - 1) 
& "_PS6" 
         End If 
         dtaCalcTable7.RecordSource = mRecSource 
         dtaCalcTable7.Refresh 
         dtaCalcTable7.Recordset.MoveLast 
         'MsgBox "Temperature ESP 2,3,4,5,6" & Chr(13) & Chr(10) & 
dtaCalcTable7.Recordset.Fields("Temperature") & "+" & 
dtaCalcTable4.Recordset.Fields("Temperature_Incr_Across_Pump") 
         dtaPumps_Stations.Recordset.Fields("Temperature") = 
dtaCalcTable7.Recordset.Fields("Temperature") + 
dtaCalcTable4.Recordset.Fields("Temperature_Incr_Across_Pump") 
      End If 
   Else 
      'MsgBox "Temperature ESP 7" & Chr(13) & Chr(10) & preT_air & "+ (" & 
PreTemperature & "-" & preT_air & ") * Exp(-" & preKt_Total_Heat_Transfer & "* 
(" & dtaPumps_Stations.Recordset.Fields("KP") & " -" & preKP & ") * 1000 * 3.14 
*" & mID1 & "/ (" & preVelocity & "*" & preDensity & "*" & mA1 & "*" & 
dtaCalcTable2.Recordset.Fields("CP") & "))&" 
      'Use Equation 7 
      dtaPumps_Stations.Recordset.Fields("Temperature") = preT_air + 
(PreTemperature - preT_air) * Exp(-preKt_Total_Heat_Transfer * 
(dtaPumps_Stations.Recordset.Fields("KP") - preKP) * 1000 * 3.14 * mID1 / 
(preVelocity * preDensity * mA1 * dtaCalcTable2.Recordset.Fields("CP"))) 
   End If 
    
   'Density 
   '------- 
   'MsgBox "Density ESP" & Chr(13) & Chr(10) & "(-0.7218 * " & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "+ 864)" 
   'GNPOC 
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   dtaPumps_Stations.Recordset.Fields("Density") = (-0.7218 * 
dtaPumps_Stations.Recordset.Fields("Temperature") + 864) 
   'Khadiga 
   'dtaPumps_Stations.Recordset.Fields("Density") = (-0.7 * 
dtaPumps_Stations.Recordset.Fields("Temperature") + 860) 
           
   'Velocity 
   '-------- 
   'Use Equation 1 (CPF) 
   If dtaPumps_Stations.Recordset.Fields("KP") < 400 Then 
      'MsgBox "Velocity ESP" & Chr(13) & Chr(10) & 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") & "/ 3600 *" & 
dtaCalcTable2.Recordset.Fields("Density") & "/" & mA1 & "/" & 
dtaPumps_Stations.Recordset.Fields("Density") 
      dtaPumps_Stations.Recordset.Fields("Velocity") = 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") / 3600 * 
dtaCalcTable2.Recordset.Fields("Density") / mA1 / 
dtaPumps_Stations.Recordset.Fields("Density") 
   End If 
   'Use Equation 2 (CPF-Obeid) 
   If ((dtaPumps_Stations.Recordset.Fields("KP") >= 400) And 
((dtaPumps_Stations.RecordSource = "PS2_PS3") Or 
(dtaPumps_Stations.RecordSource = "PS3_PS4"))) Then 
      'MsgBox "Velocity ESP" & Chr(13) & Chr(10) & "(" & 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") & "-" & 
dtaCalcTable8.Recordset.Fields("Flow_Take_Off_Rate_SM") & ") / 3600 *" & 
dtaCalcTable2.Recordset.Fields("Density") & "/" & mA1 & "/" & 
dtaPumps_Stations.Recordset.Fields("Density") 
      dtaPumps_Stations.Recordset.Fields("Velocity") = 
(dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable8.Recordset.Fields("Flow_Take_Off_Rate_SM")) / 3600 * 
dtaCalcTable2.Recordset.Fields("Density") / mA1 / 
dtaPumps_Stations.Recordset.Fields("Density") 
   End If 
   'Use Equation 3 (CPF-Obeid-Khartoum) 
   If ((dtaPumps_Stations.RecordSource = "PS4_PS5") Or 
(dtaPumps_Stations.RecordSource = "PS5_PS6") Or 
(dtaPumps_Stations.RecordSource = "PS6_MT")) Then 
      'MsgBox "Velocity ESP" & Chr(13) & Chr(10) & "(" & 
dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") & "-" & 
dtaCalcTable8.Recordset.Fields("Flow_Take_Off_Rate_SM") & "-" & 
dtaCalcTable9.Recordset.Fields("Flow_Take_Off_Rate_SM") & ") / 3600 *" & 
dtaCalcTable2.Recordset.Fields("Density") & "/" & mA1 & "/" & 
dtaPumps_Stations.Recordset.Fields("Density") 
      dtaPumps_Stations.Recordset.Fields("Velocity") = 
(dtaCalcTable1.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable8.Recordset.Fields("Flow_Take_Off_Rate_SM") - 
dtaCalcTable9.Recordset.Fields("Flow_Take_Off_Rate_SM")) / 3600 * 
dtaCalcTable2.Recordset.Fields("Density") / mA1 / 
dtaPumps_Stations.Recordset.Fields("Density") 
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   End If 
   '************************************************** 
    
End Sub 
Private Sub PS_PS_Calc() 
    
   Dim mLogX, mLog10 
   Dim FlowRate_Sm3 
    
   '------------------------------------------------- 
   'declare and start a new excel application 
   'Dim MyXLApp As New Excel.Application 
    
   'Open an Excel workbook 
   'MyXLApp.Workbooks.Open "C:\PipeLine System\Charts.xls" 'FileName:= 
    
   'Select the sheet that has the input cells 
   'MyXLApp.Sheets("Sheet1").Select 
   '------------------------------------------------- 
    
   'This must be calculated by formula 
   dtaCalcTable1.RecordSource = "Hidden_Data" 
   dtaCalcTable1.Refresh 
   mID1 = dtaCalcTable1.Recordset.Fields("ID1") 
   mA1 = dtaCalcTable1.Recordset.Fields("A1") 
          
   dtaCalcTable1.RecordSource = "CPF" 
   dtaCalcTable1.Refresh 
   dtaCalcTable8.RecordSource = "ElObeid" 
   dtaCalcTable8.Refresh 
   dtaCalcTable9.RecordSource = "Khartoum" 
   dtaCalcTable9.Refresh 
   dtaCalcTable2.RecordSource = "Overall_Fluid_Data" 
   dtaCalcTable2.Refresh 
   dtaCalcTable3.RecordSource = "Pipe_Specification" 
   dtaCalcTable3.Refresh 
   dtaCalcTable4.RecordSource = Mid(dtaPumps_Stations.RecordSource, 1, 3) '"PS1" 
'Should Be Variable PS1,PS2,PS3,PS4,PS5,PS6 
   dtaCalcTable4.Refresh 
   dtaCalcTable4.Recordset.MoveFirst 
   dtaCalcTable5.RecordSource = mA0_A6_PS 'A_High,A_Medium,A_Slow 
   dtaCalcTable5.Refresh 
   dtaCalcTable6.RecordSource = "Soil_Conditions" 
   dtaCalcTable6.Refresh 
   dtaPumps_Stations.RecordSource = mPumpStation '"PS1_PS2" 
   dtaPumps_Stations.Refresh 
   PreAmbTempWinter = dtaPumps_Stations.Recordset.Fields("Amb_Temp_Winter") 
      'First Record 
   '================================ 
   'Calculate Pressure,Temperature,Density,Velocity 
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   EspEquations 
       
   'MsgBox "Before " & dtaPumps_Stations.Recordset.Fields("Viscosity") 
   dtaPumps_Stations.Recordset.Fields("Viscosity") = 
dtaCalcTable5.Recordset.Fields("A0") + (dtaCalcTable5.Recordset.Fields("A1") * 
dtaPumps_Stations.Recordset.Fields("Temperature")) + 
(dtaCalcTable5.Recordset.Fields("A2") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 2)) + 
(dtaCalcTable5.Recordset.Fields("A3") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 3)) + 
(dtaCalcTable5.Recordset.Fields("A4") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 4)) + 
(dtaCalcTable5.Recordset.Fields("A5") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 5)) + 
(dtaCalcTable5.Recordset.Fields("A6") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 6)) 
   'MsgBox "Viscosity Formula1 " & Chr(13) & Chr(10) & 
dtaCalcTable5.Recordset.Fields("A0") & "+ (" & 
dtaCalcTable5.Recordset.Fields("A1") & "*" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & ") + (" & 
dtaCalcTable5.Recordset.Fields("A2") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 2)) + (" & 
dtaCalcTable5.Recordset.Fields("A3") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 3)) + (" & 
dtaCalcTable5.Recordset.Fields("A4") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 4)) + (" & 
dtaCalcTable5.Recordset.Fields("A5") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 5)) + (" & 
dtaCalcTable5.Recordset.Fields("A6") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 6))" 
 
   'MsgBox "Viscosity Value1 " & dtaPumps_Stations.Recordset.Fields("Viscosity") 
    
   'MsgBox "Viscosity Formula2 " & Chr(13) & Chr(10) & txtA0_A6(0) & "+ (" & 
txtA0_A6(1) & "*" & dtaPumps_Stations.Recordset.Fields("Temperature") & ") + (" 
& txtA0_A6(2) & "* (" & dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 
2)) + (" & txtA0_A6(3) & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 3)) + (" & txtA0_A6(4) & 
"* (" & dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 4)) + (" & 
txtA0_A6(5) & "* (" & dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 5)) 
+ (" & txtA0_A6(6) & "* (" & dtaPumps_Stations.Recordset.Fields("Temperature") 
& "^ 6))" 
   'MsgBox "Viscosity Value2 " & Chr(13) & Chr(10) & txtA0_A6(0) + (txtA0_A6(1) 
* dtaPumps_Stations.Recordset.Fields("Temperature")) + (txtA0_A6(2) * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 2)) + (txtA0_A6(3) * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 3)) + (txtA0_A6(4) * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 4)) + (txtA0_A6(5) * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 5)) + (txtA0_A6(6) * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 6)) 
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   dtaPumps_Stations.Recordset.Fields("Re") = 
dtaPumps_Stations.Recordset.Fields("Velocity") * mID1 * 
dtaPumps_Stations.Recordset.Fields("Density") * 10 ^ 3 / 
dtaPumps_Stations.Recordset.Fields("Viscosity") 
   'MsgBox "Re" & Chr(13) & Chr(10) & 
dtaPumps_Stations.Recordset.Fields("Velocity") & "*" & mID1 & "*" & 
dtaPumps_Stations.Recordset.Fields("Density") & "*  10 ^ 3 /" & 
dtaPumps_Stations.Recordset.Fields("Viscosity") 
    
   If (dtaPumps_Stations.Recordset.Fields("Re") < 2100) Then 
      dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Laminar" 
   ElseIf (dtaPumps_Stations.Recordset.Fields("Re") < 10000) Then 
      dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Transition" 
   Else 
      dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Turbulent" 
   End If 
    
   '----------------------- 
   ''dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") = (1.14 - 2 * 
Log(dtaCalcTable3.Recordset.Fields("Surface_Roughness") / 1000 / mID1 + 21.25 / 
dtaPumps_Stations.Recordset.Fields("Re") ^ 0.9)) ^ -2 
   'MsgBox "Friction Loss" & Chr(13) & Chr(10) & "(1.14 - 2 * ( Log(" & 
dtaCalcTable3.Recordset.Fields("Surface_Roughness") & "/ 1000 / " & mID1 & "+ 
21.25 / " & dtaPumps_Stations.Recordset.Fields("Re") & "^ 0.9) /  Log(10))) ^ -2" 
   mLogX = (Log(dtaCalcTable3.Recordset.Fields("Surface_Roughness") / 1000 / 
mID1 + 21.25 / dtaPumps_Stations.Recordset.Fields("Re") ^ 0.9) / Log(10)) 
   dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") = (1.14 - 2 * 
mLogX) ^ -2 
   'MyXLApp.Cells(12, 8) = "=(1.14-2* Log(" & 
dtaCalcTable3.Recordset.Fields("Surface_Roughness") & "/1000/" & mID1 & 
"+21.25/" & dtaPumps_Stations.Recordset.Fields("Re") & "^0.9))^(-2)" 
   'dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") = 
MyXLApp.Cells(12, 8) 
   '----------------------- 
    
   dtaPumps_Stations.Recordset.Fields("H_inner") = 0.023 * 
dtaPumps_Stations.Recordset.Fields("Re") ^ 0.8 * 
(dtaPumps_Stations.Recordset.Fields("Viscosity") * 10 ^ -3 * 
dtaCalcTable2.Recordset.Fields("CP") / dtaCalcTable2.Recordset.Fields("KF")) ^ 0.3 
   dtaPumps_Stations.Recordset.Fields("H_outer") = 2 * 
dtaCalcTable6.Recordset.Fields("K_Soil") / (dtaCalcTable3.Recordset.Fields("OD") / 
1000) / Log(1 + 2 * dtaCalcTable6.Recordset.Fields("Trench") / 
(dtaCalcTable3.Recordset.Fields("OD") / 1000) + Sqr((1 + 2 * 
dtaCalcTable6.Recordset.Fields("Trench") / (dtaCalcTable3.Recordset.Fields("OD") / 
1000)) ^ 2 - 1)) 
    
   dtaPumps_Stations.Recordset.Fields("Kt_Total_Heat_Transfer") = (1 / 
dtaPumps_Stations.Recordset.Fields("H_inner") + 1 / 
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(dtaPumps_Stations.Recordset.Fields("H_outer") * 
dtaCalcTable3.Recordset.Fields("OD") / 1000 / mID1)) ^ -1 
   'MsgBox "Heat Transfer" & Chr(13) & Chr(10) & "(1 / " & 
dtaPumps_Stations.Recordset.Fields("H_inner") & "+ 1 / (" & 
dtaPumps_Stations.Recordset.Fields("H_outer") & "*" & 
dtaCalcTable3.Recordset.Fields("OD") & "/ 1000 /" & mID1 & ")) ^ -1" 
    
   dtaPumps_Stations.Recordset.Fields("Amb_Temp_Winter") = PreAmbTempWinter 
   dtaPumps_Stations.Recordset.Fields("T_air") = 
dtaPumps_Stations.Recordset.Fields("Amb_Temp_Winter") 
    
   prePressure = dtaPumps_Stations.Recordset.Fields("Pressure") 
   preDensity = dtaPumps_Stations.Recordset.Fields("Density") 
   preFriction_Loss_Swamee = 
dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") 
   preVelocity = dtaPumps_Stations.Recordset.Fields("Velocity") 
   preKP = dtaPumps_Stations.Recordset.Fields("KP") 
   preElevation = dtaPumps_Stations.Recordset.Fields("Elevation") 
   preT_air = dtaPumps_Stations.Recordset.Fields("T_air") 
   PreTemperature = dtaPumps_Stations.Recordset.Fields("Temperature") 
   preKt_Total_Heat_Transfer = 
dtaPumps_Stations.Recordset.Fields("Kt_Total_Heat_Transfer") 
    
   Yield_Calculate 
    
   dtaPumps_Stations.Recordset.MoveNext 
       
   'Alarm Check 
   '------------------ 
   dtaPump_Alarm.Refresh 
   If (dtaPumps_Stations.Recordset.Fields("Pressure") - 
dtaCalcTable4.Recordset.Fields("PL")) >= 
dtaPump_Alarm.Recordset.Fields("Suction_Pressure_Alarm") Then MsgBox 
"Suction Pressure Alarm" 
   If ((dtaCalcTable4.Recordset.Fields("Motor_rpm") <= 
dtaPump_Alarm.Recordset.Fields("RPM_Alarm_Min")) Or 
(dtaCalcTable4.Recordset.Fields("Motor_rpm") >= 
dtaPump_Alarm.Recordset.Fields("RPM_Alarm_Max"))) Then MsgBox "RPM 
Alarm" 
   'MsgBox dtaCalcTable4.Recordset.Fields("Motor_rpm") 
   '------------------ 
    
   Do While Not dtaPumps_Stations.Recordset.EOF 
      'MsgBox "KP " & dtaPumps_Stations.Recordset.Fields("KP") 
      'Calculate Pressure,Temperature,Density,Velocity 
      EspEquations 
       
      dtaPumps_Stations.Recordset.Fields("Viscosity") = 
dtaCalcTable5.Recordset.Fields("A0") + (dtaCalcTable5.Recordset.Fields("A1") * 
dtaPumps_Stations.Recordset.Fields("Temperature")) + 
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(dtaCalcTable5.Recordset.Fields("A2") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 2)) + 
(dtaCalcTable5.Recordset.Fields("A3") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 3)) + 
(dtaCalcTable5.Recordset.Fields("A4") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 4)) + 
(dtaCalcTable5.Recordset.Fields("A5") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 5)) + 
(dtaCalcTable5.Recordset.Fields("A6") * 
(dtaPumps_Stations.Recordset.Fields("Temperature") ^ 6)) 
      'MsgBox "Viscosity Loop" & Chr(13) & Chr(10) & 
dtaCalcTable5.Recordset.Fields("A0") & "+ (" & 
dtaCalcTable5.Recordset.Fields("A1") & "*" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & ") + (" & 
dtaCalcTable5.Recordset.Fields("A2") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 2)) + (" & 
dtaCalcTable5.Recordset.Fields("A3") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 3)) + (" & 
dtaCalcTable5.Recordset.Fields("A4") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 4)) + (" & 
dtaCalcTable5.Recordset.Fields("A5") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 5)) + (" & 
dtaCalcTable5.Recordset.Fields("A6") & "* (" & 
dtaPumps_Stations.Recordset.Fields("Temperature") & "^ 6))" 
       
      dtaPumps_Stations.Recordset.Fields("Re") = 
dtaPumps_Stations.Recordset.Fields("Velocity") * mID1 * 
dtaPumps_Stations.Recordset.Fields("Density") * 10 ^ 3 / 
dtaPumps_Stations.Recordset.Fields("Viscosity") 
      'MsgBox "Re Loop" & Chr(13) & Chr(10) & 
dtaPumps_Stations.Recordset.Fields("Velocity") & "*" & mID1 & "*" & 
dtaPumps_Stations.Recordset.Fields("Density") & "* 10 ^ 3 / " & 
dtaPumps_Stations.Recordset.Fields("Viscosity") 
      If (dtaPumps_Stations.Recordset.Fields("Re") < 2100) Then 
         dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Laminar" 
      ElseIf (dtaPumps_Stations.Recordset.Fields("Re") < 10000) Then 
         dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Transition" 
      Else 
         dtaPumps_Stations.Recordset.Fields("Flow_Zone") = "Turbulent" 
      End If 
       
      '----------------------- 
      ''dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") = (1.14 - 2 * 
Log(dtaCalcTable3.Recordset.Fields("Surface_Roughness") / 1000 / mID1 + 21.25 / 
dtaPumps_Stations.Recordset.Fields("Re") ^ 0.9)) ^ -2 
      mLogX = (Log(dtaCalcTable3.Recordset.Fields("Surface_Roughness") / 1000 / 
mID1 + 21.25 / dtaPumps_Stations.Recordset.Fields("Re") ^ 0.9) / Log(10)) 
      dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") = (1.14 - 2 * 
mLogX) ^ -2 
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      'MsgBox "Friction Loss Loop" & Chr(13) & Chr(10) & "(1.14 - 2 * ( Log(" & 
dtaCalcTable3.Recordset.Fields("Surface_Roughness") & "/ 1000 / " & mID1 & "+ 
21.25 / " & dtaPumps_Stations.Recordset.Fields("Re") & "^ 0.9) /  Log(10))) ^ -2" 
      'MyXLApp.Cells(12, 8) = "=(1.14-2* Log(" & 
dtaCalcTable3.Recordset.Fields("Surface_Roughness") & "/1000/" & mID1 & 
"+21.25/" & dtaPumps_Stations.Recordset.Fields("Re") & "^0.9))^(-2)" 
      'dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") = 
MyXLApp.Cells(12, 8) 
      '----------------- 
       
      dtaPumps_Stations.Recordset.Fields("H_inner") = 0.023 * 
dtaPumps_Stations.Recordset.Fields("Re") ^ 0.8 * 
(dtaPumps_Stations.Recordset.Fields("Viscosity") * 10 ^ -3 * 
dtaCalcTable2.Recordset.Fields("CP") / dtaCalcTable2.Recordset.Fields("KF")) ^ 0.3 
      'MsgBox "H_Inner Loop" & Chr(13) & Chr(10) & "0.023 *" & 
dtaPumps_Stations.Recordset.Fields("Re") & "^ 0.8 * (" & 
dtaPumps_Stations.Recordset.Fields("Viscosity") & "* 10 ^ -3 * " & 
dtaCalcTable2.Recordset.Fields("CP") & "/" & 
dtaCalcTable2.Recordset.Fields("KF") & ") ^ 0.3" 
       
      dtaPumps_Stations.Recordset.Fields("H_outer") = 2 * 
dtaCalcTable6.Recordset.Fields("K_Soil") / (dtaCalcTable3.Recordset.Fields("OD") / 
1000) / Log(1 + 2 * dtaCalcTable6.Recordset.Fields("Trench") / 
(dtaCalcTable3.Recordset.Fields("OD") / 1000) + Sqr((1 + 2 * 
dtaCalcTable6.Recordset.Fields("Trench") / (dtaCalcTable3.Recordset.Fields("OD") / 
1000)) ^ 2 - 1)) 
      'MsgBox "H_Inner Loop" & Chr(13) & Chr(10) & "2 *" & 
dtaCalcTable6.Recordset.Fields("K_Soil") & "/ (" & 
dtaCalcTable3.Recordset.Fields("OD") & "/ 1000) / Log(1 + 2 *" & 
dtaCalcTable6.Recordset.Fields("Trench") & "/ (" & 
dtaCalcTable3.Recordset.Fields("OD") & "/ 1000) + Sqr((1 + 2 *" & 
dtaCalcTable6.Recordset.Fields("Trench") & "/ (" & 
dtaCalcTable3.Recordset.Fields("OD") & " / 1000)) ^ 2 - 1))" 
       
      dtaPumps_Stations.Recordset.Fields("Kt_Total_Heat_Transfer") = (1 / 
dtaPumps_Stations.Recordset.Fields("H_inner") + 1 / 
(dtaPumps_Stations.Recordset.Fields("H_outer") * 
dtaCalcTable3.Recordset.Fields("OD") / 1000 / mID1)) ^ -1 
      'MsgBox "Heat Transfer" & Chr(13) & Chr(10) & "(1 / " & 
dtaPumps_Stations.Recordset.Fields("H_inner") & "+ 1 / (" & 
dtaPumps_Stations.Recordset.Fields("H_outer") & "*" & 
dtaCalcTable3.Recordset.Fields("OD") & "/ 1000 /" & mID1 & ")) ^ -1.2" 
       
      dtaPumps_Stations.Recordset.Fields("Amb_Temp_Winter") = 
PreAmbTempWinter 
      dtaPumps_Stations.Recordset.Fields("T_air") = 
dtaPumps_Stations.Recordset.Fields("Amb_Temp_Winter") 
             
      prePressure = dtaPumps_Stations.Recordset.Fields("Pressure") 
      preDensity = dtaPumps_Stations.Recordset.Fields("Density") 
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      preFriction_Loss_Swamee = 
dtaPumps_Stations.Recordset.Fields("Friction_Loss_Swamee") 
      preVelocity = dtaPumps_Stations.Recordset.Fields("Velocity") 
      preKP = dtaPumps_Stations.Recordset.Fields("KP") 
      preElevation = dtaPumps_Stations.Recordset.Fields("Elevation") 
      preT_air = dtaPumps_Stations.Recordset.Fields("T_air") 
      PreTemperature = dtaPumps_Stations.Recordset.Fields("Temperature") 
      preKt_Total_Heat_Transfer = 
dtaPumps_Stations.Recordset.Fields("Kt_Total_Heat_Transfer") 
       
      'Check For Alarm 
      'Check_Alarm 
       
      Yield_Calculate 
       
      dtaPumps_Stations.Recordset.MoveNext 
           
   Loop 
    
   '------------------------------- 
   'You MUST always do this in order to free up your memory 
   'MyXLApp.Quit 
   'Set MyXLApp = Nothing 
   '------------------------------- 
    
   'Alarm Check 
   '------------------ 
   dtaPumps_Stations.Recordset.MovePrevious 
   'If dtaPumps_Stations.Recordset.Fields("Pressure") >= 
dtaPump_Alarm.Recordset.Fields("Discharge_Presure_Alarm_High") Then MsgBox 
"Discharge Presure High" 
   If (dtaCalcTable4.Recordset.Fields("Ph") - 
dtaPumps_Stations.Recordset.Fields("Pressure")) >= 
dtaPump_Alarm.Recordset.Fields("Discharge_Presure_Alarm_High") Then MsgBox 
"Discharge Presure High" 
   '------------------- 
   'If you're using the TI-89, the ln(x) function is the same as VB's log(x) function. 
   'If you want to use the ti-89's log(x) function in VB, you have to do log(x)/log(10). 
   'You should get the right answer. 
 
End Sub 
Private Sub Temperature_Calc() 
 
End Sub 
Private Sub Pressure_Calc() 
 
End Sub 
Private Sub grdDataTable_AfterColEdit(Index As Integer, ByVal ColIndex As 
Integer) 
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   'Select Case grdDataTable(Index).DataSource 
   Select Case grdDataTable(Index).Caption 
          Case "dtaA0_A6" 
               dtaA0_A6.Recordset.UpdateBatch adAffectAll 
          Case "dtaCity" 
               dtaCity.Recordset.UpdateBatch adAffectAll 
          Case "dtaTemperature" 
               dtaTemperature.Recordset.UpdateBatch adAffectAll 
          Case "dtaPumps" 
               dtaPumps.Recordset.UpdateBatch adAffectAll 
          Case "dtaPump_Alarm" 
               dtaPump_Alarm.Recordset.UpdateBatch adAffectAll 
          Case "dtaPumps_Stations" 
               dtaPumps_Stations.Recordset.UpdateBatch adAffectAll 
          Case "dtaYield" 
               dtaYield.Recordset.UpdateBatch adAffectAll 
          Case "dtaOthers" 'Overall Fluid Data,Pipe Specifications,Pressure,Soil 
Condition,Temperature 
               dtaOthers.Recordset.UpdateBatch adAffectAll 
   End Select 
    
End Sub 
Private Sub SSTab1_Click(PreviousTab As Integer) 
    
   fmPStation_Calc.Visible = False 
   fmPump_Calc.Visible = False 
    
   Select Case SSTab1.Caption 
          Case "Overall Fluid Data" 
               dtaOthers.RecordSource = "Overall_Fluid_Data" 
          Case "Pipe Specification" 
               dtaOthers.RecordSource = "Pipe_Specification" 
          Case "Pressure" 
               dtaOthers.RecordSource = "Pressure" 
          Case "Soil Conditions" 
               dtaOthers.RecordSource = "Soil_Conditions" 
          Case "Temperature" 
               dtaOthers.RecordSource = "Temperature" 
          '------------------------------------------- 
          Case "Pumps" 
               fmPStation_Calc.Visible = False 
               fmPump_Calc.Visible = False 'True 
          Case "Pump Stations" 
               fmPump_Calc.Visible = False 
               fmPStation_Calc.Visible = False 'True 
   End Select 
             
   dtaOthers.Refresh 
    
End Sub 
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'-------------------------- 
Private Sub cmdMSChart_Click() 
    
   frmMSChart.Show 
    
End Sub 
Private Sub cmdExcelChart_Click() 
    
   frmExcelChart.Show 
    
End Sub 
 
 
Charts 
Private Sub optGraph_Click(Index As Integer) 
    
   Dim i As Integer 
   Dim XData, YData, lbX, lbY 
   Dim XScaleMin, XScaleMax, YScaleMin, YScaleMax 
    
   Select Case Index 
           
          Case 0 'Temperature / Viscosity 
               dtaChartData.RecordSource = frmMain.dtaPumps_Stations.RecordSource 
               dtaChartData.Refresh 
               MSChart1.RowCount = dtaChartData.Recordset.RecordCount 
               MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.Auto = True 
               MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Auto = True 
                
               dtaChartData.Recordset.MoveLast 
               If dtaChartData.Recordset.Fields("Temperature") > 
dtaChartData.Recordset.Fields("Viscosity") Then 
                  lbX = "Temperature (C)" 
                  XData = "Temperature" 
                  lbY = "Viscosity (mpa.s)" 
                  YData = "Viscosity" 
               Else 
                  lbX = "Viscosity (mpa.s)" 
                  XData = "Viscosity" 
                  lbY = "Temperature (C)" 
                  YData = "Temperature" 
               End If 
                         
          Case 1 'Temperature / Density 
               dtaChartData.RecordSource = frmMain.dtaPumps_Stations.RecordSource 
               dtaChartData.Refresh 
               MSChart1.RowCount = dtaChartData.Recordset.RecordCount 
               MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.Auto = True 
               MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Auto = True 
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               dtaChartData.Recordset.MoveLast 
               If dtaChartData.Recordset.Fields("Temperature") > 
dtaChartData.Recordset.Fields("Density") Then 
                  lbX = "Temperature (C)" 
                  XData = "Temperature" 
                  lbY = "Density (Kg/m^3)" 
                  YData = "Density" 
               Else 
                  lbX = "Density (Kg/m^3)" 
                  XData = "Density" 
                  lbY = "Temperature (C)" 
                  YData = "Temperature" 
               End If 
                              
          Case 2 'Location / Pressure 
               dtaChartData.RecordSource = frmMain.dtaPumps_Stations.RecordSource 
               dtaChartData.Refresh 
               MSChart1.RowCount = dtaChartData.Recordset.RecordCount 
               MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.Auto = True 
               MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Auto = True 
                
               dtaChartData.Recordset.MoveLast 
               If dtaChartData.Recordset.Fields("KP") > 
dtaChartData.Recordset.Fields("Pressure") Then 
                  lbX = "Location (Km)" 
                  XData = "KP" 
                  lbY = "Pressure (Pascal)" 
                  YData = "Pressure" 
               Else 
                  lbX = "Pressure (Pascal)" 
                  XData = "Pressure" 
                  lbY = "Location (Km)" 
                  YData = "KP" 
               End If 
                                             
          Case 3 'Location / Temperature 
               dtaChartData.RecordSource = frmMain.dtaPumps_Stations.RecordSource 
               dtaChartData.Refresh 
               MSChart1.RowCount = dtaChartData.Recordset.RecordCount 
                              
               dtaChartData.Recordset.MoveLast 
               If dtaChartData.Recordset.Fields("KP") > 
dtaChartData.Recordset.Fields("Temperature") Then 
                  lbX = "Location (Km)" 
                  XData = "KP" 
                  lbY = "Temperature (C)" 
                  YData = "Temperature" 
               Else 
                  lbX = "Temperature (C)" 
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                  XData = "Temperature" 
                  lbY = "Location (Km)" 
                  YData = "KP" 
               End If 
                
               'Scale 
               '----------------------------- 
               dtaChartData.Recordset.MoveFirst 
               XScaleMin = dtaChartData.Recordset.Fields(XData) 
               YScaleMin = dtaChartData.Recordset.Fields(YData) 
               dtaChartData.Recordset.MoveLast 
               XScaleMax = dtaChartData.Recordset.Fields(XData) 
               YScaleMax = dtaChartData.Recordset.Fields(YData) 
                
               'MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.Auto = False 
               'MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.Minimum = XScaleMin 
               'MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.Maximum = XScaleMax 
               ''MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.MajorDivision = 5 
               ''MSChart1.Plot.Axis(VtChAxisIdX).ValueScale.MinorDivision = 5 
                
               If XData = "Temperature" Then 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Auto = False 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Minimum = 20 
'YScaleMin 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Maximum = 90 
'YScaleMax 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.MajorDivision = 5 
                  'MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.MinorDivision = 5 
               End If 
                
               If YData = "Temperature" Then 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Auto = False 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Minimum = 20 
'YScaleMin 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.Maximum = 90 
'YScaleMax 
                  MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.MajorDivision = 5 
                  'MSChart1.Plot.Axis(VtChAxisIdY).ValueScale.MinorDivision = 5 
               End If 
                
               '----------------------------- 
   End Select 
    
   MSChart1.Title = lbX & " / " & lbY 
   MSChart1.Column = 1 
   MSChart1.ColumnLabel = lbX 
   MSChart1.Column = 2 
   MSChart1.ColumnLabel = lbY 
                
   MSChart1.Plot.Axis(VtChAxisIdX).AxisTitle.VtFont.Size = 14 
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   MSChart1.Plot.Axis(VtChAxisIdX).AxisTitle.VtFont.VtColor.Automatic = True 
   MSChart1.Plot.Axis(VtChAxisIdY).AxisTitle.VtFont.Size = 14 
   MSChart1.Plot.Axis(VtChAxisIdY).AxisTitle.VtFont.VtColor.Blue = True 
   MSChart1.Plot.Axis(VtChAxisIdX).AxisTitle = lbX 
   MSChart1.Plot.Axis(VtChAxisIdY).AxisTitle = lbY 
         
   i = 1 
   dtaChartData.Refresh 
   Do While Not dtaChartData.Recordset.EOF 
      MSChart1.Row = i 
      MSChart1.Column = 1 
      MSChart1.Data = dtaChartData.Recordset.Fields(XData) 
      MSChart1.ColumnLabel = lbX 
      MSChart1.Column = 2 
      MSChart1.Data = dtaChartData.Recordset.Fields(YData) 
      MSChart1.ColumnLabel = lbY 
       
      dtaChartData.Recordset.MoveNext 
      i = i + 1 
   Loop 
   
End Sub. 
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 Appendix A8:  Viscosities at different temperatures with and without stirring 
(cooling): 
 
Viscosity (mpa.s) Temperature (°C) 
Dynamic Static 
70 10.13 10.13 
65 11.5 13.35 
60 13.7 21.18 
55 16.04 30.62 
50 20.33 46.73 
45 29.7 74.59 
40 82.3 101.52 
35 253.22 240.10 
30 253.22 253.22 
28 253.22 253.22 
25 253.22 253.22 
 
 
 
Appendix A9: Dynamic viscosities at different temperatures and type of 
cooling 
 
Viscosity (mpa.s) Temperature 
(°C) High cooling  
(1°C/ min) 
Medium cooling  
(0.5°C/ min) 
Slow cooling    
(0.01°C/ min) 
70 9.78 9.78 9.78 
65 10.54 14.04 16.8 
60 11.74 15.54 17.36 
55 13.44 17.61 20.14 
50 15.79 20.37 23.66 
45 19.27 24.61 30.85 
40 25.09 32 39.36 
35 42.7 88.57 121.78 
30 217.77 217.77 217.77 
28 217.77 217.77 217.77 
27 217.77 217.77 217.77 
26 217.77 217.77 217.77 
25 217.77 217.77 217.77 
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Appendix A10: Dynamic viscosities at different temperatures and different 
shear rates 
 
Shear Rate (1/Sec)  Temperature  
(°C) 5 10 20 50 100 200 300 500 
70 17.03 15.88 13.93 13.35 11.76 10.59 8.44 5.06 
65 18.42 16.8 15.19 14.73 13.21 12.34 8.44 5.06 
60 20.72 17.36 17.03 16.92 14.99 12.66 8.44 5.06 
55 24.4 20.14 20.12 19.8 17.08 12.66 8.44 5.06 
50 30.39 23.66 23.02 23.02 19.64 12.66 8.44 5.06 
45 50.18 30.85 29.01 28.78 24.01 12.66 8.44 5.06 
40 354.51 39.36 36.49 36.46 25.32 12.66 8.44 5.06 
35 480.2 121.78 106.47 50.64 25.32 12.66 8.44 5.06 
30 480.2 217.77 107.96 48.71 25.32 12.66 8.44 5.06 
28 480.2 217.77 107.96 48.71 25.32 12.66 8.44 5.06 
27 480.2 217.77 107.96 48.71 25.32 12.66 8.44 5.06 
26 480.2 217.77 107.96 48.71 25.32 12.66 8.44 5.06 
25 480.2 217.77 107.96 48.71 25.32 12.66 8.44 5.06 
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Appendix A11: Dynamic viscosities at different temperatures and thermal 
cycles 
 
Heating-1 (rate of 10 1/Sec) 
 
Temperature Viscosity Temperature Viscosity 
32.75 253.22 53.28 29.01 
32.63 253.22 53.83 27.85 
32.47 253.22 54.28 26.93 
32.40 253.22 54.75 26.01 
32.40 253.22 55.22 25.09 
32.55 253.22 55.67 23.94 
32.78 253.22 56.13 22.79 
33.08 253.22 56.58 22.10 
33.35 253.22 57.08 20.95 
33.70 253.22 57.50 20.72 
34.03 253.22 57.95 19.80 
34.40 253.22 58.40 19.34 
34.78 253.22 58.85 18.65 
35.22 253.22 59.28 18.19 
35.63 253.22 59.70 17.73 
36.00 253.22 60.08 17.27 
36.45 253.22 60.50 16.80 
36.88 246.08 60.95 16.34 
37.30 216.85 61.38 16.11 
37.72 191.07 61.83 15.65 
38.15 169.66 62.28 15.42 
38.60 150.78 62.70 15.19 
39.03 134.90 63.15 14.96 
39.47 121.32 63.60 14.73 
39.92 109.58 64.05 14.27 
40.28 100.14 64.47 13.81 
40.72 92.54 64.80 13.81 
41.15 85.63 65.18 13.35 
41.60 79.42 65.63 13.35 
42.08 73.89 66.05 13.12 
42.53 69.29 66.47 12.89 
42.97 65.38 66.93 12.66 
43.42 61.92 67.13 12.43 
43.88 59.16 67.40 12.20 
44.38 56.63 67.55 12.20 
44.80 54.10 67.75 12.20 
45.17 51.56 68.05 11.97 
45.63 49.49 68.32 11.51 
46.05 47.88 68.53 11.51 
46.47 46.50 68.65 11.51 
46.97 44.89 68.90 11.51 
47.40 43.28 69.13 11.51 
47.83 41.90 69.28 11.51 
48.28 40.75 69.40 11.28 
48.72 38.67 69.57 11.28 
49.17 37.52 69.75 11.28 
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Appendix A11: Continued 
49.63 36.83 69.85 11.28 
50.08 36.14 69.90 11.28 
50.40 34.99 69.90 11.28 
50.83 33.84 69.95 11.05 
51.30 33.15 69.95 11.05 
51.78 32.46 69.97 11.05 
52.22 31.54     
52.72 30.39     
 
Cooling (rate of 10 1/Sec) 
 
Temperature Viscosity Temperature Viscosity Temperature Viscosity Temperature Viscosity 
70.05 10.59 61.35 12.43 51.63 18.19 42.92 38.21 
70.10 10.59 61.15 12.43 51.45 18.42 42.75 38.90 
70.13 10.82 60.97 12.43 51.30 18.65 42.63 39.59 
70.13 10.59 60.80 12.66 51.10 18.88 42.45 40.52 
70.10 10.13 60.60 12.66 50.95 18.88 42.28 41.67 
70.05 10.13 60.42 12.66 50.78 19.34 42.13 42.59 
69.93 10.36 60.22 12.43 50.63 19.34 41.97 43.28 
69.80 10.36 60.05 12.66 50.42 19.57 41.83 43.97 
69.68 10.59 59.92 12.89 50.28 19.80 41.67 44.89 
69.55 10.59 59.75 12.89 50.10 20.03 41.53 46.50 
69.38 10.36 59.58 13.12 50.05 20.03 41.35 47.65 
69.20 10.13 59.38 12.89 49.88 20.26 41.20 48.80 
69.05 10.59 59.15 13.12 49.70 20.72 41.05 49.72 
68.88 10.82 59.03 13.12 49.55 20.72 40.88 50.87 
68.70 10.82 58.83 13.12 49.38 20.95 40.75 52.03 
68.55 10.82 58.60 13.35 49.20 21.41 40.58 53.87 
68.35 10.59 58.45 13.35 49.05 21.41 40.45 55.71 
68.18 10.59 58.25 13.35 48.88 21.87 40.28 57.32 
68.03 10.59 58.08 13.35 48.70 22.10 40.22 58.24 
67.82 10.82 57.88 13.35 48.53 22.33 40.08 59.85 
67.65 10.82 57.72 13.35 48.35 22.79 39.95 61.69 
67.47 11.05 57.53 13.58 48.20 23.25 39.80 63.54 
67.30 10.82 57.33 13.81 48.00 23.25 39.65 65.84 
67.07 10.82 57.17 13.58 47.85 23.71 39.50 68.37 
66.90 11.05 56.97 13.81 47.67 23.71 39.33 69.98 
66.72 11.05 56.78 14.04 47.50 23.94 39.20 71.82 
66.53 11.28 56.60 14.04 47.35 24.40 39.05 74.35 
66.35 11.28 56.42 14.27 47.20 24.86 38.90 78.27 
66.15 11.28 56.25 14.50 47.03 25.09 38.75 81.49 
65.95 11.05 56.05 14.50 46.83 25.55 38.60 86.10 
65.78 11.28 55.92 14.50 46.70 25.78 38.42 90.01 
65.53 11.51 55.70 14.73 46.53 26.01 38.30 95.53 
65.38 11.51 55.53 15.19 46.35 26.24 38.15 103.59 
65.18 11.74 55.35 15.42 46.17 26.70 38.00 113.72 
64.97 11.51 55.17 15.42 46.03 27.16 37.85 121.78 
64.82 11.28 54.97 15.42 45.85 27.39 37.70 127.76 
64.70 11.51 54.80 15.65 45.70 27.62 37.53 130.06 
64.53 11.74 54.63 15.65 45.53 28.08 37.40 136.28 
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Appendix A11: Continued 
 
64.32 11.74 54.42 15.88 45.35 28.54 37.28 148.71 
64.15 11.97 54.25 16.11 45.20 29.01 37.08 159.76 
63.95 11.74 54.10 16.11 45.15 29.70 36.95 167.59 
63.78 11.74 53.90 16.34 44.97 29.93 36.83 177.02 
63.60 11.74 53.72 16.34 44.83 30.62 36.67 181.63 
63.40 11.97 53.55 16.57 44.67 31.08 36.53 191.53 
63.25 11.97 53.40 16.57 44.50 31.31 36.40 210.86 
63.03 12.20 53.20 16.80 44.33 32.23 36.25 226.52 
62.85 12.20 53.03 17.03 44.17 32.92 36.10 237.80 
62.67 11.97 52.88 17.27 44.00 33.38 35.95 253.22 
62.47 11.97 52.70 17.27 43.88 33.84 35.83 253.22 
62.28 12.20 52.50 17.50 43.70 34.53   
62.10 12.43 52.30 17.50 43.53 35.22   
61.90 12.43 52.13 17.73 43.38 35.91   
61.72 12.20 51.97 17.96 43.22 36.83   
61.50 12.20 51.80 18.19 43.08 37.29   
 
Heating-2 (rate of 10 1/Sec) 
 
Temperature Viscosity Temperature Viscosity 
35.53 253.22 56.83 20.26 
35.38 253.22 57.28 19.80 
35.22 253.22 57.70 19.34 
35.25 253.22 58.17 18.88 
35.38 253.22 58.60 18.42 
35.60 253.22 59.05 18.19 
35.88 253.22 59.50 17.73 
36.17 253.22 59.92 17.50 
36.55 253.22 60.33 17.03 
36.90 253.22 60.78 16.80 
37.28 253.22 61.25 16.34 
37.67 253.22 61.67 16.11 
38.08 253.22 62.10 15.88 
38.50 253.22 62.53 15.42 
38.88 223.99 63.00 15.19 
39.53 200.27 63.40 14.73 
39.95 182.32 63.83 14.73 
40.25 165.51 64.32 14.50 
40.70 150.09 64.75 14.04 
41.15 136.05 65.07 14.04 
41.60 123.39 65.50 13.58 
42.05 111.88 65.95 13.58 
42.53 102.44 66.38 13.12 
42.95 93.23 66.80 13.12 
43.42 86.10 67.18 12.66 
43.88 79.19 67.45 12.66 
44.33 72.74 67.72 12.43 
44.83 66.76 68.13 12.20 
45.15 62.15 68.38 12.20 
45.60 57.32 68.50 12.20 
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Appendix A11: Continued 
 
46.05 54.10 68.60 12.20 
46.50 49.95 68.68 12.20 
46.97 46.73 68.82 11.97 
47.42 44.20 68.95 11.97 
47.85 41.67 69.03 11.74 
48.33 39.59 69.07 11.97 
48.78 37.52 69.10 11.74 
49.28 35.45 69.15 11.74 
49.70 33.61 69.22 11.74 
50.05 32.23 69.28 11.51 
50.47 31.31 69.32 11.74 
50.92 29.93 69.35 11.74 
51.40 28.78 69.40 11.74 
51.83 27.85 69.50 11.74 
52.28 26.70 69.68 11.51 
52.75 26.01 69.95 11.51 
53.17 25.09 70.07 11.51 
53.63 24.63   
54.10 23.94   
54.53 23.02   
54.97 22.33   
55.42 21.87   
55.88 21.41   
56.35 20.95   
 
 
Appendix A12: Dynamic viscosities at different temperatures and different 
shear rates 
 
Viscosity (mpa.s) Temperature( °C) 
Rate of (10 (1/Sec)) Rate (10, 9, 8 (1/Sec)) 
23.00 253.22 316.53 
24.00 253.22 316.53 
25.00 253.22 316.53 
26.00 253.22 316.53 
27.00 253.22 316.53 
28.00 253.22 316.53 
29.00 253.22 316.53 
30.00 253.22 316.53 
31.05 253.22 316.53 
31.05 253.22 316.53 
32.70 253.22 316.53 
33.05 253.22 316.53 
34.08 253.22 316.53 
35.25 253.22 316.53 
36.08 253.22 316.53 
37.35 195.21 253.22 
38.22 152.62 207.47 
39.15 123.16 158.55 
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Appendix A12: Continued 
 
 
40.05 102.21 118.84 
41.30 80.11 83.16 
42.20 70.21 72.23 
43.10 62.84 63.02 
44.03 56.63 56.97 
45.30 49.95 45.78 
46.25 45.58 42.20 
47.28 42.36 39.13 
48.33 39.36 36.58 
49.35 36.37 34.53 
50.22 34.07 32.23 
51.22 32.00 30.44 
52.17 29.93 28.65 
53.10 28.54 27.37 
54.03 27.16 26.09 
55.30 24.63 24.04 
56.15 23.94 18.88 
57.03 23.02 18.88 
58.35 21.87 18.65 
59.25 20.95 18.42 
60.03 19.80 17.96 
61.38 18.65 17.50 
62.30 18.19 16.80 
63.22 17.27 16.34 
64.15 16.57 15.65 
64.85 15.88 15.65 
65.07 15.42 15.42 
66.05 14.50 14.96 
67.03 12.89 13.81 
68.00 11.28 13.58 
69.22 11.51 12.89 
70.13 11.28 12.43 
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Appendix A13: Dynamic viscosities at different temperatures and different 
preheat temperatures 
 
 
Cooling from 70°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
70 8.52 
65 9.21 
60 10.36 
55 13.12 
50 48.57 
45 253.22 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
 
Cooling from 65°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
65 9.21 
60 11.51 
55 17.03 
50 80.80 
45 253.22 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
 
 
Cooling from 60°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
60 20.49 
55 23.48 
50 81.72 
45 253.22 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
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Cooling from 55°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
55 103.36 
50 110.27 
45 253.22 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
 
Cooling from 50°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
50 158.38 
45 253.22 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
 
Cooling from 45°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
45 253.22 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
 
 
Cooling from 40°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
40 253.22 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
 
Cooling from 35°C to 28°C 
Temperature( °C) Viscosity (mpa.s) 
35 253.22 
33 253.22 
30 253.22 
29 253.22 
28 253.22 
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Appendix A14: Dynamic viscosities at different temperatures and decreasing 
shear rates 
At 30°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
500 5.06 
300 8.44 
200 12.66 
100 50.64 
50 126.61 
20 253.22 
10 506.44 
5 506.44 
 
At 35°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
300 8.44 
200 12.66 
100 25.32 
50 50.64 
20 126.61 
10 238.49 
5 271.64 
 
At 40°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
500 5.06 
300 8.44 
200 12.66 
100 25.32 
50 43.23 
20 45 
10 46.04 
 
At 45°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
500 5.06 
300 8.44 
200 12.66 
100 25.32 
50 30.94 
20 32.11 
10 35.68 
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At 50°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
500 5.06 
300 8.44 
200 12.66 
100 23.2 
50 24.08 
20 22.11 
10 26.7 
 
At 55°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
500 5.06 
300 8.44 
200 12.66 
100 16.07 
50 17.45 
20 14.96 
10 18.19 
 
At 60°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
500 5.06 
300 8.44 
200 12.66 
100 16.21 
50 16.62 
20 14.27 
10 16.57 
 
At 65°C 
Shear Rate (1/Sec)  Viscosity (mpa.s)
500 5.06 
300 8.44 
200 10.97 
100 11.44 
50 10.41 
20 11.97 
10 10.13 
At 70°C 
Shear Rate (1/Sec)  Viscosity (mpa.s)
500 5.06 
300 5.81 
200 6.02 
100 6.95 
50 6.26 
20 7.37 
10 8.98 
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Appendix A15: Dynamic viscosities at different temperatures and increasing 
shear rates 
 
At 30°C 
Shear Rate (1/Sec) Viscosity (mpa.s)
5 506.4 
10 253.22 
20 126.61 
50 50.64 
100 25.66 
200 12.66 
300 8.44 
 
At 35°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
5 277.62 
10 253.22 
20 126.61 
50 50.64 
100 25.32 
200 12.66 
300 8.44 
At 40°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
10 46.04 
20 45.12 
50 43 
100 25.32 
200 12.66 
300 8.44 
500 5.06 
 
At 45°C 
Shear Rate (1/Sec)  Viscosity (mpa.s)
10 35.68 
20 33.26 
50 31.12 
100 25.32 
200 12.66 
300 8.44 
500 5.06 
At 50°C 
Shear Rate (1/Sec)  Viscosity (mpa.s)
10 26.7 
20 21.98 
50 23.71 
100 22.35 
200 12.66 
300 8.44 
500 5.06 
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At 55°C 
Shear Rate (1/Sec)  Viscosity (mpa.s)
10 18.19 
20 14.85 
50 16.99 
100 16.28 
200 12.66 
300 8.44 
500 5.06 
 
At 60°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
10 16.57 
20 13.93 
50 17.17 
100 16.07 
200 12.66 
300 8.44 
500 5.06 
 
 
At 65°C 
Shear Rate (1/Sec)  Viscosity (mpa.s) 
10 10.13 
20 10.7 
50 10.04 
100 11.03 
200 11.05 
300 8.44 
500 5.06 
 
 
At 70°C 
Shear Rate (1/Sec)  Viscosity (mpa.s)
10 8.98 
20 5.8 
50 7.25 
100 6.43 
200 6.8 
300 6.33 
500 5.06 
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Appendix A16: Dynamic viscosities at different shear rates (increasing & 
decreasing) and different temperatures 
 
Decreasing shear rates at (70°C) 
Shear Rate (1/Sec) Viscosity (mpa.s) 
300 5.76 
200 5.99 
100 6.15 
50 6.36 
20 6.49 
10 6.58 
5 7.37 
 
Increasing shear rates at (70°C) 
Shear Rate (1/Sec) Viscosity(mpa.s)
5 9.21 
10 8.98 
20 7.92 
50 7.87 
100 7.7 
200 7.46 
300 6.68 
 
Decreasing shear rates at (30°C) 
Shear Rate (1/Sec)  Viscosity (mpa.s)
300 8.44 
200 12.66 
100 25.32 
50 50.64 
20 126.65 
10 253.22 
5 506.44 
 
Increasing shear rates at (30°C) 
Shear Rate (1/Sec) Viscosity (mpa.s) 
5 506.44 
10 253.22 
20 126.61 
50 50.64 
100 25.32 
200 12.66 
300 8.44 
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Appendix A17: Yield stress at different temperatures and different shear 
rates: 
 
                                                                                            
Increasing shear rates Decreasing shear rates Temperature 
(°C) Yield  
Stress (Pa) 
Restart  
pressure (Pa) 
Yield 
 Stress (Pa) 
Restart  
pressure (Pa) 
70 2.2327 1275.828571 2.4187 1382.114286 
65 3.8741 2213.771428 3.9114 2235.085714 
60 4.8174 2752.8 5.1128 2921.6 
55 5.3418 3052.457143 5.7042 3259.542857 
50 7.2832 4161.828571 7.1856 4106.057143 
45 8.7713 5012.171428 8.4584 4833.371428 
40 9.274 5299.428571 9.413 5378.857143 
35 23.391 13366.28571 16.76 9577.142857 
30 25.322 14469.71428 25.322 14469.71428 
 
Appendix A18: Density at different temperatures: 
 
Temperature(°C) Density 
(kg/m3) 
70 0.815 
65 0.816 
60 0.818 
55 0.824 
50 0.825 
45 0.83 
40 0.836 
35 0.838 
30 0.84 
25 0.842 
 
Appendix A19: Elemental composition wt % ranges for crude oil: 
 
 
 
(Source: Banks & Kinge, 1984) 
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Appendix A20: Exporting pipeline specification 
 
Maximum capacity: 425000 b/d 
Design basics: 
- Pipeline specification: 
1. External diameter: 28 inch 
2. Wall thickens: 0.422 inch. Except 2 km for crossing the Nile (793.7km to 795.7km) 
and 1km for crossing Atbara River (1058.8 km to 1059.8 km), the thickness there is 
0.644 inch. 
- Flange rating specification: ANSI (Class 600) except the last part (Class 900). 
- Pipeline material: Carbon steels API SL Gr. X65 
- Length: 1504 km. 
- Design code; ASME B31.4 
 
Appendix A21: Pump station specification: 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A22: Heglig Field Processing Facility  
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A23: Unity Field Processing Facility 
 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A24: El Nar Field Processing Facility 
 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A25: El Toor Field Processing Facility 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A26: Toma South Field Processing Facility 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A27: Bamboo Field Processing Facility 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A28: Heglig Central Processing Facility 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A29: Pipeline Profile 
 
 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A30: Greater Nile Operation Petroleum Company pipeline 
operation data 
 
Pump  
Station 
Distance from  
C.P.F (km) 
Pressure Operation 
Data (bar) 
Temperature Operation 
Data (°C) 
Ps# 1 0 96.4 70 
Ps# 2 236.12 77.2 44 
Ps# 3 547.6 90.6 37.5 
Ps# 4 817 62.5 36 
Ps# 5 1085.7 72.8 39 
Ps# 6 1311.8 42.7 37 
B.M.T. 1504 51 37.5 
 
(Source: Petronas Research and Scientific services, 2004) 
 
 
 
 
 
 
Appendix A31: Nile Blend Crude Oil Temperature and Pressure along 
Pipeline 
 
Temperature (°C)  Pressure (bar) 
Location(Km) 
Calculated Value Experimental Value Calculated Value Experimental Value
Ps# 1 (0) 70.5 70 94.5 96.4 
Ps# 2 (236.12) 45 44 71.5 77.2 
Ps# 3 (547.6) 34.2 37.5 87.6 90.6 
Ps# 4 (817) 31.7 36 62.1 62.5 
Ps# 5 (1085.7) 30.8 39 79.3 72.8 
Ps# 6 (1311.8) 31 37 46.5 42.7 
B.M.T. (1504) 30.3 37 52.3 51 
 
(Source: Greater Nile Petroleum Operation Company, 1999) 
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Appendix A32: The User Guideline 
 
System specification: 
 
Pipeline data: To be specified in 'Input data' sheet 
Overall fluid data:  To be specified in 'Input data' sheet 
Soil data: To be specified in 'Input data' sheet 
Operational constraints: To be specified in 'Input data' sheet 
Temperature increase across pump: To be specified in 'Input data' sheet 
Ambient temperature along pipeline: To be specified in 'Input data' sheet 
Viscosity: Viscosity to be determined as a 6th order polynomial based on 
Experimental data using the spread sheet function 'Add trend line' 
Case specification: 
Flow rate at CPF/PS#1: To be specified in 'Case' sheet 
Take off rate at El Obeid: To be specified in 'Case' sheet 
Take off rate at Khartoum: To be specified in 'Case' sheet 
Export temperature from CPF: To be specified in 'Case' sheet 
Numbers of pumps at each pump station: To be specified in 'Case' sheet 
Suction pressure at each pump station: To be specified in 'Case' sheet 
 
